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Abstract
The regulation of the phosphatidate phosphatase gene PAH1 and its regulatory role on cell
homeostasis
By
Goldie Libby Sherr, M. Phil
Advisor: Dr. Chang Hui-Shen

The Saccharomyces cerevisiae gene, PAH1, encodes a phosphatidate (PA) phosphatase that
plays a fundamental role in lipid metabolism. PA phosphatases are key enzymes that catalyze the
PA dephosphorylation reaction to form diacylglycerides, the first step in the synthesis of
triacylglycerols. Pah1p, one of the main PA phosphatases in yeast, has not only emerged as a key
player in lipid biosynthetic pathways, but also acts as an important regulator of nuclear
membrane biogenesis, the transcriptional regulation of many inositol-sensitive upstream
activating sequence (UASINO) containing genes needed for phospholipid synthesis, vacuole
homeostasis, and lipid droplet formation. Due to its crucial role in lipid and overall cell
homeostasis, this thesis aimed to elucidate the role and regulation of the PAH1 gene. In the first
part of the study, we tried to evaluate how PAH1 affects other genes in the lipid biosynthetic
pathway as well as assess the impact that the crucial phospholipid precursors, inositol and
choline, have on cellular growth. Results showed that while there was not a large difference
between the growth rates of WT and pah1∆ strains when exposed to different concentrations of
the precursors, the pah1∆ strain did tend to grow slightly better than WT in the presence of
inositol. Furthermore, our RNA analysis showed that UAS INO genes were upregulated in the
pah1∆ strain when compared to WT cells, strongly suggesting the role of PAH1 as a negative
regulator in the lipid biosynthesis pathway. Interestingly, the HXK2 gene was the only gene
iv

tested that was downregulated in pah1Δ cells. Since HXK2 is involved in preventing apoptosis,
this implied that Pah1p might be involved in cellular apoptosis. Additional growth experiments
on pah1∆ were conducted in the presence of acetic acid and hydrogen peroxide. Results showed
that pah1Δ cells fared significantly better than WT cells after exposure to these apoptotic
reagents. RNA analysis confirmed these results, showing a significant upregulation of antiapoptotic genes in pah1∆. As such, this aim demonstrated that PAH1 plays an important
regulatory role in phospholipid biosynthesis and suggested that it also plays a role in apoptosis
by regulating anti-apoptotic genes as well.
For the second part of our study, we wanted to elucidate the conditions of PAH1
induction, as well as the ways in which it itself is regulated. Our experiments showed that PAH1
undergoes induction during the stationary phase of growth when inositol is present. These
findings were subsequently used to help determine the chromatin remodelers involved in PAH1
gene expression. Chromatin remodelers play a significant role in modifying and restructuring the
nucleosome and therefore play an essential role in the regulation of gene expression. Using
growth curve analysis, qRT-PCR, and ChIP, we set out to determine which chromatin
remodelers impact PAH1 gene expression. Our results showed that Snf2p plays a role in PAH1
gene induction and localizes at its promoter region. Interestingly, Snf2p is one of the chromatin
remodelers important for INO1 regulation, one of the most crucial genes in inositol production,
and a gene which is heavily regulated by PAH1. Taken together, these findings may indicate
another mode by which PAH1 can affect INO1 expression; by possibly using the same remodeler
to help keep gene expression in check. Overall, these finding give a better understanding of how
PAH1 gene regulation is controlled at the chromatin level.

v

For the last part of our study, we decided to look into another organelle that PAH1
impacts, the vacuole. Since PAH1 has been previously documented to influence vacuole
morphology by regulating the proteins involved in vacuole fusion, we wanted to determine if its
presence also affects proper vacuole homeostasis, particularly the maintenance of acidification
and the function of V-ATPase pumps. Using electron microscopy, we determined the vacuolar
phenotype of pah1Δ cells, which consisted of fragmented vacuoles in both exponential and
stationary phases of growth. This was followed by RNA analysis of V-ATPase genes. Our results
demonstrated that all genes remained at similar or greater levels than WT in pah1Δ cells,
suggesting that V-ATPase pump activity is not implicated despite the morphological defect.
Growth experiments and vacuolar pH measurements confirmed this finding. In order to see if
other important genes involved in vacuole fission and fusion were potential contributors to the
mutant phenotype in pah1Δ cells, we performed qRT-PCR to measure gene expression. Results
showed that the overexpression of genes like FAB1 and ATG18, which are crucial for normal
fragmentation, in pah1Δ cells can be a contributing factor to the fragmented vacuole phenotype.
Overall, our study has looked into three important areas in the cell with respect to PAH1.
We have elucidated the ways in which it impacts the lipid biosynthetic pathway, the modes in
which it itself is regulated, and the influence it has on vacuolar morphology and function. These
findings can be used to further understand the functional role of PAH1 and can provide insights
into the ways in which PAH1 impacts cell homeostasis.
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Chapter 1: Introduction
1. Introduction
1.1. Phospholipids
The plasma membrane is involved in many aspects of cellular development and growth.
Its role as a permeability barrier for the cell is just one of its many functions. In addition to
protecting the integrity of the internal cellular environment, it is also pivotal for supporting and
maintaining cellular shape (Yeagle, 1989). Its roles are even further reaching due to the
membrane’s several components. Phospholipids are the predominant molecules in cellular
membranes and as such, function as one of the main structural components of the cell (Quinn et
al., 1980). There, they form an amphipathic lipid bilayer, with their hydrophilic heads facing
outward and their hydrophobic fatty acid tails facing inward (Van der Rest et al., 1995). This
bilayer contains various proteins embedded throughout, along with cholesterol and carbohydrate
groups, which attach to the lipids and proteins (Benga and Holmes, 1984). There are four major
phospholipids found in the plasma membrane of the eukaryotic model organism Saccharomyces
cerevisiae. These phospholipids include phosphatidylinositol, phosphatidylcholine,
phosphatidylinositol, and phosphatidylserine and all are essential for cell survival (Figure 1.1;
Iwanyshyn et al., 2004; Henry et al., 2012). In addition to acting as the structural basis of
membranes, these phospholipids are involved in a number of other cellular processes that extend
far beyond lipid metabolism. They provide the foundation for the assembly and performance of
many catalytic reactions and assume roles as molecular chaperones, components in signaling
pathways, and precursors to macromolecules and secondary messengers (Greenberg and Lopes;
1996; Dowhan, 1997; Henry and Patton-Vogt, 1998; Strahl and Thorner; 2007). Since these
molecules are pivotal for cell function and survival, the regulation of these lipids is extensive.

1

The endoplasmic reticulum (ER) is the main site for lipid biosynthesis. There, phospholipids, as
well as other fats, are synthesized via the lipid biosynthetic pathway (Carman and Henry, 1989;
Van Meer et al., 2008; Henry et al. 2012). These pathways are highly regulated by various
mechanisms, many of which target the transcription of lipid biosynthetic genes. This therefore
helps ensure the proper production of lipids necessary for cell survival.

2

(Henry et al., 2012)

Figure 1. 1: Main phospholipids found in the plasma membrane of Saccharomyces cerevisiae.

3

1.2. Transcriptional regulators of the lipid biosynthetic pathway
The regulation of phospholipid composition in membranes is essential for correct cellular
growth and development (Cardozo-Gizzi and Caputo, 2013). Saccharomyces cerevisiae is a
common model system used to better understand phospholipid synthesis and its regulation.
While there are four main types of phospholipids found in Saccharomyces cerevisiae, their
plasma membranes are mainly composed of the two phospholipids, phophatidylinositol and
phosphatidylcholine (Carman and Henry, 1999; Santos-Rosa et al., 2005). The synthesis of these
and other phospholipids, as well as membrane biogenesis in general, is mainly regulated by the
crucial phospholipid precursors, inositol and choline. Both inositol and choline coordinately
regulate phospholipid metabolism by the response to their availability (Kelley et al., 1998; Dowd
et al., 2001; Boumann et al., 2006; Gaspar et al., 2006). When the intracellular concentration
levels of inositol and choline are low, the transcriptional activator complex, Ino2p/Ino4p,
activates the expression of many genes that encode phospholipid biosynthetic enzymes (Lopes
and Henry, 1991; Carman and Henry, 1999; Graves and Henry, 2000). Alternatively, when the
intracellular concentration of inositol is high, the negative regulator, Opi1p, a transcription factor
localized in the endoplasmic reticulum, is translocated to the nucleus and represses the
transcription of phospholipid biosynthetic genes (Carman and Henry, 1999; Carman and Han,
2011). Many of the genes necessary for phospholipid synthesis contain an inositol responsive
cis-acting element in the promoter region called the UAS INO element (Bachhawat et al., 1995;
Carman and Henry, 1999). Thus, when inositol and choline are not present, the activator
Ino2p/Ino4p specifically binds to the UASINO element and thus activates transcription (Carman
and Henry, 1999; Carman and Han, 2011). However, when inositol and choline are abundant,
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Opi1p, binds to the activator, Ino2p/Ino4p, and prevents transcription from occurring (Figure
1.2) (Carman and Henry, 1999; Carman and Han, 2011).

5

Figure 1.2: Induction and repression of INO1, a critical gene in the lipid biosynthetic pathway.
In the absence of inositol, the Ino2p/Ino4p activator complex binds to the promoter region at the UAS INO
and allows for transcription of INO1. However in the presence of inositol, the repressor Opi1p, which is
localized in the endoplasmic reticulum, is translocated into the nucleus and binds to the Ino2p/Ino4p
activator complex. This represses transcription of INO1.
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While inositol and choline are two crucial phospholipid precursors that play a role in
regulating and controlling lipid biosynthesis, there are many other factors that are involved in
this regulation. Phosphatidate (PA) phosphatase enzymes have recently emerged as pivotal
regulators of lipid metabolism. Their maintenance of PA and diacylglycerol (DAG) levels, two
major components of the lipid biosynthetic pathway, helps regulate the synthesis of
triacylglycerides and a variety of phospholipids (Pascaul and Carman, 2012). PA phosphatase
(PAP) enzymes are responsible for catalyzing the reaction that dephosphorylates PA, which in
turn produces DAG and a phosphate group (Figure 1.3) (Han et al, 2007). This reaction is crucial
in lipid biosynthesis since DAG can be used to either generate triacylglycerol (TAG), which
stores energy and fatty acids in lipid droplets or can be used to generate the phospholipids,
phosphatidylethanolamine (PE), and phosphotidylcholine (PC) (Siniossoglou, 2009).
Conversely, PA can be used to synthesize other phospholipids such as phosphatidylinositol (PI)
and phosphotidylserine (PS) if it is not first dephosphorylated by a PAP enzyme. Furthermore, it
can also be used to synthesize phosphatidylethanolamine (PE), and phosphotidylcholine (PC) via
the CDP-DAG pathway within the lipid biosynthetic pathway (Figure 1.3). Thus, the
concentrations of PA and DAG are crucial in maintaining the production of phospholipid levels,
as well as determining the types of phospholipids that are synthesized. Since PAP enzymes are
responsible for regulating PA and DAG levels, they play a critical role in regulating the lipid
biosynthetic pathway.
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Figure 1.3 : Lipid biosynthetic pathway of Saccharomyces cerevisiae.

(Wilmalathrathna et al. 2009)
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1.3. Phosphatidate Phosphatase (PAP) Enzymes
As explained previously, one of the more recently discovered regulators of the lipid
biosynthetic pathway are PAP enzymes. These enzymes catalyze the crucial step of PA
dephosphorylation, which in turn produces DAG. In Saccharomyces cerevisiae, there have been
multiple PAP enzymes identified that are encoded by genes found in the lipid biosynthetic
pathway. These genes include PAH1 (formerly SMP2), DPP1, LPP1, and APP1 (Pascual and
Carman, 2012). While all PAP enzyme-encoding genes share a common role in
dephosphorylating PA, they each have their own distinct characteristics that make them unique.
Their differences are quite vast and span a range of areas including physiological function,
cellular localization, substrate specificity, and cofactor requirement (Figure 1.4).
One of the major distinguishing characteristics of PAP enzymes is the requirement of the
Mg2+ cofactor to function. Both the protein products of DPP1 and LPP1 are Mg2+ independent,
while those of PAH1 and APP1 require magnesium to work (Toke et al., 1998; Han et al., 2006;
Chae et al., 2012). This is due to the different catalytic motifs present in each of these enzymes.
Pah1p has the DXDX(T/V) motif that is common in the superfamily of Mg2+ dependent
phosphatase enzymes, which gives it its phosphatase activity (Han et al., 2007). Dpp1p and
Lpp1p, however, contain a three domain lipid phosphatase motif that possesses their catalytic
activity (Pascual and Carman; 2012). Lastly, the APP1 gene has only recently been discovered as
a PAP encoding gene and as such, more research is still needed to help characterize its catalytic
activity and other defining characteristics.
There are multiple other factors that distinguish these PAP enzymes from one another.
Both Dpp1p and Lpp1p are small integral membrane proteins that have six transmembrane
domains in their sequence (Toke et al., 1998; Pascual and Carman, 2012). Pah1p however is
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considerably larger and does not contain any transmembrane domains (Han et al., 2006). These
differences greatly affect their localization. Pah1p is primarily found in the cytosol, but is
translocated to the membrane when needed to catalyze the reaction of converting PA, located on
the ER membrane, into DAG (Karanasios et al., 2010). Pah1p has also been found to be present
in the nucleus where it can act as a direct repressor of transcription for genes in the lipid
biosynthetic pathway (Santos-Rosa et al., 2005). Dpp1p and Lpp1p however are located in the
vacuole and Golgi apparatus membranes, respectively (Pascual and Carman, 2012). The distinct
function of each PAP enzyme helps to play a role in its localization. Dpp1p and Lpp1p have been
shown to be involved in signaling, while Pah1p is more directly involved with phospholipid
production (Toke et al., 1998; Carman and Han, 2006). As a result, these enzymes’ physiological
functions affect their localization.
Additionally, these PAP enzymes differ in their sensitivity to the thioreactive compound
N-ethylamleimide (NEM) and to the synthetic compound propranolol. While both the activity of
Dpp1p and Pah1p are not affected by NEM, Lpp1p activity is essentially hindered by it (Wu et
al., 1996; Furneisen and Carman, 2000; Han et al., 2006). The PAP activity of Pah1p however is
impacted by propranolol and inhibits its ability to function properly. Propranolol affects Lpp1p
activity as well, despite the fact that it is believed to inhibit the enzymes by interacting with the
Mg2+ binding location (Morlock et al., 1991; Furneisen and Carman, 2000; Pascual and Carman,
2012). Little is still known as to why these reagents affect these PAP enzymes differently. Due to
this, both of these inhibiting compounds are rarely used as methods to distinguish between the
enzymes, despite the fact that they impact these enzymes differently.
Lastly, the classes of PAP enzymes differ in respect to the specificity of their substrates.
While Dpp1p and Lpp1p can catalyze reactions involving multiple lipid phosphate substrates
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including PA, DGPP, and lysoPA, Pah1p is specific for the substrate PA (Kohei et al., 1984; Lin
and Carman, 1989; Toke et al., 1998; Faulkner et al., 1999; Pascual and Carman, 2012). As
mentioned earlier, the substrates and products that Dpp1p and Lpp1p act on have roles as
signaling molecules. Thus, these enzymes are involved in lipid signaling more so than in de novo
phospholipid and TAG synthesis (Toke et al., 1998; Carman and Han, 2006). Pah1p, however,
has a pivotal role in the lipid biosynthetic pathway and is extremely important for de novo
phospholipid synthesis and TAG production (Han et al., 2006; Sorger and Daum; 2003). Thus,
while all these PAP enzymes contain PA phosphatase activities, their differences range in such a
wide array of areas that their physiological functions are vastly different.
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Phosphatidate Phosphatase Enzymes Found in Saccharomyces cerevisiae



The APP1 PAP encoding enzyme was only recently discovered and more studies are being
conducted to characterize it.

Figure 1.4: Chart depicting the differences of PAP enzymes found in Saccharomyces cerevisiae.
PAP enzymes are differentiated from one another based off a number of categories, including cofactor
dependence, localization, catalytic motifs, physiological function, and substrate specificity.
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1.4 PAH1: A crucial PAP-encoding gene
PAH1 is a yeast PAP gene which encodes the PA phosphatase, Pah1p. It is part of a
subfamily of PA phosphatases that depend on the presence of Mg2+ for proper function (Han et
al., 2006). Its protein product, Pah1p, is 863 amino acids long and has a molecular weight of
about 95-kDa (Pascual and Carman, 2012). Since it is a PAP enzyme, Pah1p is necessary for
catalyzing the key step of dephosphorylating PA to form DAG. Over the past few years,
numerous studies have been conducted to characterize this protein and better understand the
ways in which it acts. Pah1p contains a DXDX(T/V) catalytic motif within its haloacid
dehalogenase (HAD)-like domain that gives it its catalytic function and contains an NLIP
domain which currently has an unknown function (Han et al., 2007) . The catalytic motif located
in the HAD-like domain is necessary for its ability to dephosphorylate its substrate, as studies
have shown that without it, Pah1p loses its phosphatase ability (Han et al., 2007). Additionally,
Pah1p does not contain any transmembrane domains (Karanasios et al., 2010). As a result, in
order to dephosphorylate PA, Pah1p must first be translocated onto the ER/nuclear membrane,
where PA is situated, so that it can function and catalyze the reaction. Studies have shown that
the translocation of Pah1p occurs when there are increased levels of PA in the cell. When PA
levels rise, Pah1p is recruited onto the nuclear/ER membrane (Siniossoglou, 2009). This process
is mediated by an amino terminal amphipathic helix that Pah1p contains in its amino terminal
end (Karanasios et al., 2010). However, this recruitment only takes place when Pah1p is first
dephosphorylated by a phosphatase complex of two proteins, the Nem1p-Spo7p complex
(Karanasios et al., 201). Thus, Pah1p itself must first be dephosphosphorylated in order to obtain
phosphatase ability and will remain inactive while in its phosphorylated state.
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1.4.1 The activation and deactivation of Pah1p.

The Nem1p-Spo7p complex is responsible for dephosphorylating Pah1p. Both Nem1p
and Spo7p come together to form a complex that is located in the endoplasmic reticulum
membrane (O’Hara et al., 2006). There, they help recruit Pah1p to the membrane and
dephosphorylate Pah1p, which allows Pah1p to bind to the membrane via its amphipathic helix
(Figure 1.5). Specifically, the Nem7p subunit targets Pah1p to the membrane and once
dephosphorylated by the Nem1p-Spo7p complex, the Pah1p helix becomes “primed” for binding
to the membrane and can dephosphorylate PA to generate DAG for lipid synthesis (Karanasios et
al., 2010).
Since dephosphorylation is the mechanism responsible for activating Pah1p, the
deactivation of Pah1p was therefore hypothesized to be the result of its phosphorylation. Pah1p
was discovered to be the target of many protein kinases, some of which include Pho85p-Pho80p,
Cdc28p-cyclin B, protein kinase A, and protein kinase C (Su et al., 2012; Hsieh et al., 2015;
Hsieh et al., 2016). Pah1p has been found to have multiple sites of phosphorylation (Figure 1.6),
seven of which are in the Ser/Thr-Pro motif that are targeted by protein kinases regulated during
the cell cycle (Choi et al., 2011, Hsieh et al., 2015). When these seven sites are phosphorylated,
Pah1p function is negatively regulated and its phosphatase activity is inhibited. Research has
shown that the protein kinase cyclin complex, Pho85p-Pho80p, phosphorylates Pah1p on all 7
sites (Choi et al., 2012; Su et al., 2014). When phosphorylated by Pho85-Pho80, Cdc28p-cyclin
B, and protein kinase A, Pah1p is sequestered away from the membrane, where PA resides, and
remains in the cytoplasm. There, it will remain inactive until it is recruited to the nuclear/ER
membrane by the Nem1p-Spo7p complex and subsequently dephosphorylated. Thus, the activity
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and localization of PAH1 is heavily dependent on its phosphorylated and dephosphorylated
states.
In addition, Pah1p is further regulated by proteasome protease activity and is targeted for
degradation during the stationary phase of growth (Hsieh et al., 2015). It is specifically targeted
by the 20S proteasome, and not the 26S proteasome, making it independent of an ubiquitin
directed degradation. This mode of regulation is in turn administered by Pah1p’s
phosphorylation state. When it is phosphorylated, and thus in its inactive state, degradation by
the proteasome is greatly reduced. However, when dephosphorylated, it is highly subjected to
degradation and therefore targeted in its active form (Hsieh et al., 2015). Thus, due to its
importance in regulating the lipid biosynthetic pathway, Pah1p levels are heavily monitored in
the cell.
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Figure 1.5: Pah1p activation by the Nem1p-Spo7p complex.
(A) In its phosphorylated state, Pah1p is localized in the cytosol and inactive, (B) The Nem1p-Spo7p
complex helps recruit Pah1p to the ER/nuclear membrane and dephosphorylates it, (C) Once
dephosphorylated, Pah1p regains phosphatase activity and is able to catalyze the reaction which
converts PA to DAG.
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Figure 1.6: Phosphorylation sites of Pah1p.
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1.4.2 PAH1: A Pivotal Player in Phospholipid Biosynthesis Regulation

While Pah1p is needed for catalyzing the reaction that produces DAG from PA, a crucial
step in the eventual biosynthesis of triglycerides and other phospholipids, it also plays a major
role in regulating the transcription of genes needed for phospholipid production. Many of the
genes that encode enzymes necessary for phospholipids biogenesis contain a sequence in their
promoters called the UASINO (Santos-Rosa et al., 2005). Out of 47 phospholipid genes, 22 have
been identified to contain a UASINO in their promoter region (Wimalarathna et al., 2011). In
Saccharomyces cerevisiae, the levels of PA play an important role in specifically controlling the
transcription of biosynthetic genes that contain a UAS INO. As explained earlier, the levels of PA
heavily depend on Pah1p (Siniossoglou, 2009). Thus, when the levels of Pah1p are high, PA
levels will be lower. Conversely, when levels of Pah1p are lower, levels of PA will be higher.
This has major implications on the transcriptional regulation of genes in the lipid biosynthetic
pathway, since the transcriptional repressor Opi1p is bound to PA on the ER/nuclear membrane
(Loewen et al, 2004). As a result, when PA levels are high, Opi1p will remain bound to PA on
the ER membrane and will be unable to enter the nucleus and block transcription. This in turn
will allow the transcriptional activator complex, Ino2p/Ino4p, to bind to the UAS INO and activate
transcription (Siniossoglou, 2009). When the levels of PA are low however, nothing will prevent
Opi1p from entering the nucleus, and it is thus able to repress transcription (Figure 1.7: Model 1)
(Siniossoglou, 2009). Since Pah1p regulates PA levels, the presence of Pah1p plays a major role
in the repression and derepression of phospholipid biosynthetic genes containing a UAS INO
(Santos-Rosa et al., 2005).
While the above model is one way to explain the role of Pah1p in mediating regulation in
phospholipid gene transcription, a second model has also emerged to explain another way in
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which Pah1p can act as a transcriptional regulator. A recent study using chromatin
immunoprecipitation has shown that Pah1p can actually negatively regulate transcription by
directly binding to the promoter regions of certain genes that contain a UAS INO (Santos-Rosa et
al., 2005). Using three biosynthetic genes (INO1, INO2, and OPI3), it was found that when
Pah1p becomes dephosphorylated by Nem1p-Spo7p, it will be recruited directly onto the
promoter of these UASINO-containing genes and can stop transcription (Santos-Rosa et al., 2005).
These findings suggest a more direct role that Pah1p takes in preventing transcription from
occurring; by physically entering the nucleus and impeding gene expression (Figure 1.7:Model
2). Thus, depending on the model of regulation used, the involvement of Pah1p in regulating
gene transcription can be either direct or indirect.
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Pah1p

Pah1p

Figure 1.7: Two models Pah1p acting as a negative regulator of lipid biosynthetic genes.
A) When the levels of PA are high, Opi1p, becomes bound to PA on the ER membrane and is unable to
enter the nucleus. As a result, the transcriptional activator complex, Ino2p/Ino4p, binds to the UASINO
and activates transcription. When PA levels are low however, nothing prevents Opi1p from entering the
nucleus, and it is thus able to repress transcription. B) Additional model, which is identical as first
model, except that Pah1p, also enters nucleus and binds promoter to block transcription.
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1.4.3 Impact of PAH1 and Pah1p on cell physiology and homeostasis

Due to its importance in the lipid biosynthetic pathway, multiple studies have been
conducted to help further characterize the important role of the PAH1 gene. Deletion
experiments have been pivotal in gaining insight into the role of PAH. Studies have shown that
the pah1Δ mutant has increased levels of PA in the cell and has an atypical increase in the
expansion of the nuclear and ER membrane (Barbosa et al., 2015). The pah1Δ mutant also shows
an increase in expression of certain genes involved in phospholipid biosynthesis since the
deletion of PAH1 leads to a derepression of enzymes in the CDP-diacylglycerol pathway and the
Kennedy pathway, the two main pathways in the lipid biosynthetic pathway used for the
synthesis of phospholipids (Soto-Cardalda et al., 2012). In addition, the levels of phospholipids,
sterol esters and fatty acids rise in these mutants. This in turn leads to the cells having fatty acid
toxicity (Fakas et al., 2011). Conversely, TAG synthesis in the pah1Δ mutant is drastically
lower. This is due to the lack of DAG, which Pah1p converts from PA, and is the precursor for
TAG. Thus, without PAH1 present, DAG is unable to be produced and TAG cannot be
synthesized. Moreover, studies have shown that cells lacking PAH1 also have a respiratory
deficiency since they are unable to grow on non-fermentable carbon sources and exhibit
temperature sensitivity (Hsieh et al., 2015).
PAH1 has also been shown to play important roles in the formation of lipid droplets
(Adeyo et al., 2011). Cytosolic lipid droplets provide eukaryotic cells with a compact source of
energy, but have also been shown to be used as storage units and are involved in organelle
trafficking and interorganellar communication (Cermelli et al., 2006; Guo et al., 2009; Murphy
et al., 2009; Zehmer et al., 2009; Salo et al., 2011). The production of lipid droplets depends on
the presence of DAG, a product of the dephosphorylation of PA by Pah1p (Adeyo et al., 2011).
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As such, studies have shown that the absence of PAH1 causes a marked decrease in lipid droplets
in the cell, thereby confirming the importance of the presence of PAH1 in the formation of lipid
droplets (Adeyo et al., 2011).
Adding to the list of areas in which this PAP enzyme affects, PAH1 has been shown to be
crucial for vacuole morphology and homeostasis. The deletion of the PAH1 gene causes a
morphological defect in the vacuole, in which the vacuole cannot remain intact and appears
fragmented. A study has shown that this fragmentation is due to the implication of the vacuole
fusion machinery when PAH1 is not present, leaving the vacuole fragments unable to fuse back
together into a single vacuole (Sasser et al., 2012). This is due to the lack of phosphastase
activity provided by Pah1p, preventing SNAREs from binding to Sec18p, the protein responsible
for priming the SNARE complexes for fusion. In addition, when PAH1 is not present, a number
of other crucial factors that make up the machinery for fusion are also absent, including Vps39p,
which is a subunit of the homotypic fusion and vacuole protein sorting (HOPS) tethering
complex, as well as phosphatidylinositol 3-phosphate, which is a lipid needed for SNARE
activity and fusion (Sasser et al., 2012). Thus, PAH1 is critical for proper vacuole morphology
and homeostasis.
Overall, the importance of PAH1 in proper cell function and development has been
shown to be extensive. Its deletion has been shown to impact morphological structures, lipid
production, and cellular function throughout the cell. Since its importance has only been recently
discovered, more research is bound to highlight additional areas in the cell that it has an effect
on.
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1.4.4 Regulation of PAH1

While the regulation of Pah1p has been studied extensively at the protein level, the
regulation of PAH1 gene expression has only recently been emerging. The management of the
PAH1 gene is critical since it acts on the substrate PA. PA is the precursor molecule which is
needed for multiple pathways in lipid synthesis and leads to the production of molecules such as
phospholipids or TAGs, depending on the pathway taken. As mentioned earlier, it also tethers
Opi1p to the ER membrane and thus helps control regulation of genes in the lipid biosynthetic
pathway. During the exponential phase of growth, the level of PAP activity is generally low and
phospholipids needed for the membrane are synthesized. Once cells reach the stationary phase,
PA is mainly used to produce TAGs and as a result PA phosphatase activity is amplified (Pascual
et al., 2013).
Recently studies have shown that PAH1 undergoes induction during times of zinc
deficiency (Soto-Cardalda et al., 2012). In Saccharomyces cerevisiae, the synthesis of membrane
phospholipids is regulated in response to zinc homeostasis. During times of zinc depletion, zinc
transporters are induced through Zap1p, while changes in the composition of phospholipid
membranes occur as well (Eide, 2009). Certain phospholipid synthetic genes are induced by
Zap1p while others are repressed by it. PAH1 is one of the genes that become activated when
zinc levels drop (Eide, 2009). This induction of Pah1p by zinc deficiency occurs via a
transcriptional mechanism. Zap1p interacts with PAH1 at one of the three upstream activating
sequence zinc responsive elements (UASZRE sequences) on its promoter region (Soto-Cardalda et
al., 2012). As a result, PAH1 plays a major role in phospholipid synthesis via zinc regulation.
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In addition to regulation by zinc, recent studies have shown that induction of PAH1 also
occurs in response to palmitoleic acid (Fakas et al., 2011). When growth medium is
supplemented with palmitoleic acid, the level of Pah1p phosphatase activity increases, an
observation that is not seen when palmitoleic acid is not introduced. This supplementation is then
followed by an increase in the amount of TAG present in the cell. The induction of PA
phosphatase activity by palmitoleic acid is specific for PAH1, and is not seen with any of the
other PA phosphatase encoding genes. As of now, the mechanism for this means of regulation is
still being studied and currently remains unclear as to how exactly PAH1 is regulated in this
manner (Fakas et al., 2011).
Furthermore, PAH1 expression is also regulated by the growth stage of the cell. Studies
have shown that PAH1 undergoes induction during the stationary phase of growth in yeast cells
(Pascual et al., 2013). This is consistent with the fact that PAH1 is the main PAP encoding gene
responsible for TAG formation. Since TAG production increases during stationary phase, when
phospholipid synthesis decreases, it is logical that PAH1 expression would increase during
stationary phase to aid in the TAG production. Moreover, the addition of inositol aids in the
induction of PAH1 during stationary phase and increases its expression even more so.
Interestingly, it was recently uncovered by Dr. Chang-Hui Shen’s lab that the PAH1 gene also
contains a UASINO in its promoter region (Wimalarathna et al., 2011). This is an important
finding, since as mentioned earlier the UASINO is the site where the Ino2p-Ino4p activator
complex binds to initiate transcription and where the Opi1p repressor will dock when repressing
transcription. Studies have also shown that Pah1p has a direct role in repressing transcription by
binding to the UASINO of genes (Santos-Rosa et al., 2005). Thus, it would seem that inositol
would play a role in helping to regulate its own expression.
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1.5 Significance of Study
Pah1p is part of a family of proteins called lipins, which are types of PA phosphatases.
There have been numerous PAP encoding genes found in higher eukaryotic organisms.
Homologs of Pah1p have been discovered in plants, worms, flies, mice and humans (Golden et
al., 2009; Nakamura et al., 2009; Han and Carman, 2010; Eastmond et al., 2011; Ugrankar et al.,
2011; Fang et al., 2014). These genes have been shown to be crucial for the regulation of fat
metabolism, adipogenesis, and the biogenesis of organelles (Reue and Zhang, 2008; Karanasios
et al., 2010; Harris and Finck, 2011; Mietkiewska et al., 2011). These PAP enzymes are a part of
the superfamily of haloacid dehalogenase (HAD)-like proteins, all of which possess the key
DXDX(T/V) catalytic domain in the HAD-like domain. In addition, they also contain the NLIP
domain, which as of yet has a mostly unknown function, but does contain a conserved glycine
residue necessary for its fat regulating function, (Péterfy et al., 2001; Han et al., 2007).
Mammalian cells in particular have three lipins. These lipins include lipin-1, lipin-2, and
lipin-3 (Reue and Dwyer, 2009). The Saccharomyces cerevisiae PAH1 gene is the yeast
homologue of LPIN1, which encodes for the Lipin 1 protein (Han et al., 2006). LPIN1 contains
the same greatly conserved domains found in PAH1. As explained earlier, it contains the N-LIP
domain, as well as the HAD-like domain (in the C-LIP domain) which houses the DXDXT motif
responsible for PA phosphatase activity. Lipin-1is mainly found in muscle and adipose tissue and
like its yeast homolog, is a PA phosphatase that plays a major role in phospholipid biosynthesis
and TAG formation. Mammalian lipins are crucial for proper adipogenesis and are necessary for
adipocyte differentiation to occur (Phan et al., 2005). Studies using mice have shown that
knocking out lipin 1 inhibits normal development of adipose tissue (Péterfy et al., 2001). The
lack of lipin 1 leads to lipodystrophy, a condition in which adipose tissue cannot develop
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properly due to deficiency in adipogenesis. Conversely, the overexpression of lipin 1 has been
shown to cause obesity (Agarwal and Garg, 2006; Han et al., 2007). As such, lipins play a major
role in fat metabolism (Reue, 2009). Studying lipins and finding ways in which to target them for
drug development could possibly be a means to treat obesity (Carman and Han, 2006). This
could have profound implications, since obesity is a major health concern in the United States
(Wang and Beydoun, 2007) and could help treat the obesity epidemic. Therefore, by using yeast
as a model system and examining the functional role of Pah1p, we can get a better understanding
of the role that lipins have in lipid metabolism and the ways in which they can be regulated.
Additionally, other metabolic disorders have also been associated with defects in lipins
including lipodystrophy, insulin resistance, metabolic syndrome, type 2 diabetes, rhabdomylysis
and inflammation (Phan and Reue, 2005; Pascual and Carman, 2012). Mutations in the human
LPIN1 gene have recently been discovered to be a newfound cause of the rare disease known as
myoglobinuria, a condition in which rhabdomyolysis occurs and the skeletal muscle fibers
deteriorate (Michot et al., 2010). Thus, by using yeast as a model organism to better
understanding the role that the PAH1 gene plays both in the cell homoeostasis and in the lipid
biosynthetic pathway, we can gain insight into the way it impacts fat metabolism and potential
ways to cure these disorders.
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Chapter 2: Materials and Methods
2. Materials and Methods

2.1 Media and agar used in this study
SC (Synthetic complete media) – To make 1000mL, add 20g Dextrose (ThermoFisher
Scientific), 6.7g Yeast Nitrogen Base with ammonium sulfate (MP Biomedicals, Cat:
114027522), 0.79g Complete Supplement Mixture (MP Biomedicals, Cat: 4500 022) and top to
1000mL with water. Autoclave.
SC plus inositol - To make 1000mL, add 20g Dextrose (ThermoFisher Scientific), 6.7g Yeast
Nitrogen Base with ammonium sulfate (MP Biomedicals, Cat: 114027522), 0.79g Complete
Supplement Mixture (MP Biomedicals, Cat: 4500 022), 10mg myo-inositol (Sigma, Cat: I5125)
and top to 1000mL with water. Autoclave.
SC minus inositol - To make 1000mL, add 20g Dextrose (ThermoFisher Scientific), 6.7g YNB
without inositol (yeast nitrogen base) with ammonium sulfate (MP Biomedicals, Cat: 4027 412),
0.79g Complete Supplement Mixture (MP Biomedicals, Cat: 4500 022) and top to 1000mL with
water. Autoclave.
SC minus zinc - To make 1000mL, add 20g Dextrose (ThermoFisher Scientific), 6.7g Yeast
Nitrogen Base minus copper minus zinc with ammonium sulfate (MP Biomedicals, Cat: 4027
412), 0.04mg/L copper sulfate, 0.79g Complete Supplement Mixture (MP Biomedicals, Cat:
4500 022) and top to 1000mL with water. Autoclave.
SC plus geneticin - To make 1000mL, add 20g Dextrose (ThermoFisher Scientific), 6.7g YNB
without inositol (yeast nitrogen base) with ammonium sulfate (MP Biomedicals, Cat: 4027 412),
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0.79g Complete Supplement Mixture (MP Biomedicals, Cat: 4500 022), 200μg/mL G418Geneticin (ThermoFisher, Cat: 11811023 ) and top to 1000mL with water. Autoclave.
SC buffered to pH 5.5/pH 7.0 - To make 1000mL, add 20g Dextrose (ThermoFisher Scientific),
6.7g Yeast Nitrogen Base with ammonium sulfate (MP Biomedicals, Cat: 114027522), 0.79g
Complete Supplement Mixture (MP Biomedicals, Cat: 4500 022) Dissolved in 1:9 MES: H2O
solution up to 1000mL. Buffer to desired pH using hydrochloric acid or NaOH before
autoclaving.
SC plus CaCl2 (Synthetic complete media) – To make 1000mL, add 20g Dextrose
(ThermoFisher Scientific), 6.7g Yeast Nitrogen Base with ammonium sulfate (MP Biomedicals,
Cat: 114027522), 0.79g Complete Supplement Mixture (MP Biomedicals, Cat: 4500 022),
60mM calcium chloride, and top to 1000mL with water. Autoclave.
SM (Spheroplast Medium) – To make 1000mL, add 20g Dextrose (ThermoFisher Scientific),
6.7g Yeast Nitrogen Base with ammonium sulfate (MP Biomedicals, Cat: 114027522), 0.79g
Complete Supplement Mixture (MP Biomedicals, Cat: 4500 022), 18.22% D-sorbitol (w/v),
50mM Tris HCl (pH 8), and top to 1000mL with water. Autoclave.
YPD (yeast extract peptone dextrose) – To make 1000mL, add 20g of bactoyeast extract
(Difco, Cat: 212750), 40g of bacto-peptone (Becton Dickinson, Cat: 211705), 40g of dextrose
(Fisher Scientific), and 20g bacto agar (Becton Dickinson, Cat: 214010) and top to 1000mL with
water. Autoclave.
*To turn any of the above medium into plates add 1.5% Difco Agar (BD, Cat: 214530) to the
solution as well before autoclaving.
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2.2 Reagents and Solutions
10x Buffer – To prepare, add: 1M Tris-HCl pH 8, 1M MgCl2 to DEPC water. Filter sterilize.
Acid Phenol – pH 4.5 (Shelton Scientific, Cat: IB05184).
BCECF-AM –1.6mM of BCECF-AM (Invitrogen, Cat: B3051) in DMSO.
Calibration buffer – To prepare add: 50mM HEPES (Fisher Scientific, Cat: BP308), 50mM
KCl (Fisher Scientific), 50mM MES (BioWorld, Cat: 41320024 1), 50mM NaCl (Fisher
Scientific), 0.2M ammonium acetate (Fisher Scientific), 10mM 2-deoxyglucose (Sigma, Cat:
D8375), 10mM sodium azide (Sigma, Cat: S8031), and 15µM nigericin and buffer to desired pH
using hydrochloric acid or sodium hydroxide.
Chloroform – (Acros, Cat: 61003-0040).
Deoxycholic Acid – (Sigma, Cat: D2510).
DEPC treated water – (Invitrogen, Cat: 46-2224)
DNase 1– (Qiagen, Cat: 79254).
EDTA – 0.5M solution - DNase RNase and proteases free (Quality Biological, Cat: 351 027
100).
Formaldehyde: 37.5% (Sigma, Cat: 252549).
Glycerol – (Invitrogen, Cat: 15514-029).
Glycine – 2.5M (Fisher Scientific, Cat: G46-1).
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High Salt Buffer – To prepare: Add 0.1% SDS, 2mM EDTA pH 8, 20mM Tris-HCl pH 8, 1%
Triton X-100, 0.5M NaCl to water. Filter sterilize.
LiCl Buffer – To prepare: Add 250mM LiCl, 10mM Tris-HCl pH 8, 1mM EDTA pH 8, 1%
Triton X-100, 0.1% deoxycholic acid to water. Filter sterilize.
Low Salt Buffer - To prepare: Add 0.1% SDS, 2mM EDTA pH 8, 20mM Tris-HCl pH 8, 1%
Triton X-100, 0.15M NaCl to water. Filter sterilize.
Lysis Buffer – To prepare: 0.05M Tris HCl pH 7.5, 0.15 M NaCl, 1mM EDTA, 1% Triton X100 to water. Filter sterilize.
Lyticase enzyme – 20mg/ml enzyme solution was prepared using powder lyticase from
arthrobacter leuteus, crude (Sigma, Cat: L4025). Stored at -20oC.
MES buffer ([2-(N-morpholino) Ethanesulfonic acid]) – To prepare, add: 20mM MES
(BioWorld, Cat: 41320024 1) to water, and buffer it using sodium hydroxide.
Nigericin –5mM of nigericin (Sigma, Cat: N7143) was dissolved in DMSO.
Phenol saturated - pH 6.6 (Fisher Scientific, Cat: BP1750-400).
Proteinase K from tritirachium album – (Sigma-Aldrich, Cat: P2038-100MG).
Proteinase inhibitor cocktail –100X cocktail (Sigma- Aldrich, Cat: P8340-5ML).
RNA sample buffer – To prepare, add: 2mM EDTA, 10mM Tris HCl (pH 8), 1% βmercaptoethanol, 1% SDS and 10% glycerol and top with water.
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Sodium acetate – Prepare by adding 204.05 g of sodium acetate in 500mL water to make a 3M
solution. Adjust the pH using hydrochloric acid.
Sorbitol – Prepare by adding 9.10g of D-sorbitol (Acros organics, Cat: 132730010) in 50 ml
distilled water to make 1M solution. Autoclave.
SYBER® GreenER™ Two-Step qRT-PCR Kit Universal (Invitrogen, Cat No: 11765-100),
consists of two kits.
Taq Man Gene Expression Master Mix – (Applied Biosystems, Cat: 4369016).
TE – 50X solutions was prepared by adding 10mM Tris and 0.1mM EDTA. Sterilized by
filtering.
TES (Tris-EDTA-SDS) buffer –To prepare, add: 10 mM Tris HCl pH 7.5, 10 mM EDTA and
0.5% SDS to deionized water. Filter sterilize.
Trichostatin A- 10mM solution was prepared by adding 1mg trichostatin A to 330ul 100%
ethanol (Wako, Cat: 203-17561) and allowing to dissolve.
Tris HCl – 1M solution was prepared by added 39.41g Tris HCl in 250ml distilled autoclaved
water. Sodium hydroxide was used to buffer the pH.
Triton X-100 – (Sigma, Cat: T8532-500ML).
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2.3 Yeast Strains
Table 2.1: Genotypes of yeast strains used in this study.
Strains

Genome type

WT (BY4741)

MATa his3Δ200 leu2Δ0 met15Δ0 ura3Δ0

WT (BY4733)

MATa his3Δ200 leu2Δ0 met15Δ0 trp1 Δ63 ura3Δ0

pah1Δ

MATa his3Δ200 leu2Δ0 met15Δ0 ura3Δ0 pah1Δ

snf2Δ

MATa his3Δ200 leu2Δ0 met15Δ0 ura3Δ0 snf2Δ

ino80Δ

MATa ino80Δ::trp1 his3Δ200 leu2Δ0 met15Δ0 trp1Δ63 ura3Δ0
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2.4 Experimental Procedures: Cell Growth
2.4.1 Cell culture

Yeast strains were inoculated from a single colony into appropriate media. Cultures were
grown at 30°C at 300 rpm overnight. The optical density was measured at A600nm using Lambda
35 UV/VIS spectrometer (Perkin Elmer).

2.4.2 Glycerol stock preparation

Glycerol stocks were prepared by mixing 100% glycerol and appropriate media in 1:1
ratio.

Overnight culture of particular yeast strain was mixed with glycerol followed by

immediate freezing in dry ice. Glycerol stocks were stored in -80oC.

2.5 Growth Analysis
Wild type and pah1∆ strains were grown in SC media (synthetic complete media) in the
presence and absence of 100μM of myo-inositol, the presence and absence of 100μM choline, as
well as 10μM of inositol and 10μM of choline. They were all started at an optical density (A600)
of around 0.2. Growth experiments were performed in duplicates, where the optical density of
the cells were measured every two hours for the first eight hours and then again at the 24th hour
until stationary phase was reached. Cells were grown at 30°C.
The average of the 24th hour OD readings for each strain and condition was used in the
calculation to derive the average number of cell generations for that specific cell type:
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Average # of generations = [(log# of cells at the end of 24 hours – log# of cells at the start of 24
hours)/log(2)]
This was then followed by determining the generation time in minutes/generation using the
average # of generations:
Generation time (min/gen) = [(60min/hr * 24)/number of generations in 24 hours]
For the acetic acid hypersensitivity growth curve the same calculations were performed. The
strains used for this growth curve, wild type and pah1∆ strains, were the same listed in Table 3.1
and were grown in SC media (synthetic complete media) in the presence of 100μM myo-inositol
as well as in the presence of 0mM, 5mM, 10mM, 25mM, 50mM, and 100mM acetic acid.

2.6 Total mRNA Preparation
2.6.1. Cell preparation and RNA isolation
WT and pah1Δ cells (Table 3.1) were grown from a single colony until mid-logarithmic
phase (0.8 A600) in SC media with 10μM myo-inositol, followed by an additional two hours in
the presence of 100μM myo-inositol. RNA was extracted from yeast cells through acid phenol
(pH 4.3) chloroform extraction in which the cells were resuspended in TES (10mM EDTA;
10mM Tris-HCl pH 7.5; 0.5% SDS), and then incubated at 65°C with equal parts acid phenol for
60 minutes. This was followed by a five-minute incubation on ice before centrifugation at 4°C.
The top layer of the sample was transferred to a new test tube and mixed with equal parts acid
phenol for a second time. Samples were incubated on ice for 5 minutes before centrifugation at
4°C and then separated by transferring the top layer of the sample to a fresh test tube and mixing
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with equal parts chloroform. Samples were centrifuged, then separated again from their bottom
layer and transferred to a new test tube. Ethanol precipitation was then performed by adding 1
mL of 100% ethanol and 40μL of 3M NaOAc to the sample. The samples were then stored in dry
ice for 20 minutes, followed by a fifteen-minute centrifugation. The supernatant was discarded
and pellets were washed in ethanol (70%) and centrifuged again for three minutes. The
supernatant was removed and the pellets were left to dry for 10 minutes. This was followed by
resuspending the pellets in RNA sample buffer. RNA concentration was quantified by reading
absorbance at 260nm (A260). Subsequently, total RNA was stored at -80oC until further use.

2.6.2 DNase Treatment of RNA samples

DNase treatment was performed to remove any DNA from the isolated RNA samples.
RNA was mixed with 10X buffer (0.1 M Tris-HCl pH 8, 5mM CaCl2 and 0.025M MgCl2),
DNase, and DEPC water. Samples were placed in 37°C water bath for 60 minutes, followed by
phenol:chloroform extraction. A 3:1 ratio of phenol:chloroform was added to the samples, mixed
and then placed on ice for a five minute incubation. Samples were then centrifuged for 10
minutes and then the top layer was transferred to a new test tube to be used for ethanol
precipitation. Ethanol (100%) and 20μL of 3M NaOAc were added to supernatant, mixed and
then placed on dry ice for 20 minutes. Samples were centrifuged for 13 minutes, followed by
removal of supernatant, and a washing of the pellet in 70% ethanol. This was followed by
centrifugation and the removal of the supernatant. Pellets were placed in a speed vacuum to dry
and then resuspended in TE buffer that was prepared using DEPC water. RNA concentration was
again quantified by reading absorbance at 260nm.
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2.6.3 Preparation of cDNA: First Strand Synthesis

In order to prepare the cDNA needed for qRT-PCR, the SuperScript III First Strand
Synthesis SuperMix kit from Invitrogen (Catalog: 11752-050) was used. The reaction was
performed using a polymerase chain reaction (PCR) thermocycler. Each DNase free mRNA
sample (1 μg) was mixed with 2x RT Reaction mix, RT enzyme mix, and DEPC water. Samples
were placed in the PCR thermocycler and underwent the reaction using the following
thermocycler program: 10 minute incubation at 25°C, 30 minute incubation at 50°C, and 5
minute incubation at 85°C. Samples were then cooled on ice for a few minutes before adding E.
coli RNase H and then placed in a 37°C waterbath for 20-30 minutes. First strand synthesis
samples were stored at -20°C until further use.

2.6.4 Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)

The cDNA prepared from first strand synthesis was amplified and quantified using qRTPCR. The SYBR GreenER® qPCR Supermix universal kit from Invitrogen (catalog number:
11762-500) was used to quantify cDNA templates. Forward and reverse primers were used that
targeted the open reading frame (ORF) in the qPCR reaction. The reaction setup for each sample
contained the following: 10μL of SYBR GreenER® qPCR Supermix, 0.4 μL each of forward
and reverse primers, 0.4 μL of ROX reference dye, 1 μL of the cDNA template, and RNA and
DNA free water to a volume of 20μL. Samples were added to a 96 well plate and then sealed and
placed in the Applied Biosystems 7500 real time PCR machine. The program used had a 2
minute incubation at 50°C, followed by 10 minutes at 95°C, and 40 cycles of 15 seconds at 90°C
and 1 minute at 60°C. PCR reactions were performed in triplicates.
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2.6.5 Analysis of RNA quantity
A ΔCT value was obtained by subtracting the respective gene CT from the CT value of the
constitutive housekeeping gene (ACT1). Therefore, the relative mRNA levels were expressed as
2^-(ΔCT). Data results were graphed as a mean of the repeats ±standard deviation.

2.7 Cell Survival and Serial Dilutions for Acetic Acid Sensitivity Assay
Yeast strains were grown in synthetic complete media with 100 μM of inositol over night
at 30°C. For acetic acid cell survival and sensitivity, cells were spun down and diluted to an
A600nm of 1.0 and placed in pH 3 SC media containing either 0mM acetic acid, 80mM acetic acid,
and 120mM acetic acid (methods followed from Agimoni; 2013) and grown at 30°C, 300 RPM,
for 200 minutes. Cells were collected at the following time points: 0 minutes, 90 minutes, 200
minutes. At each time point, all cells were diluted to A600nm of 1.0 and then serially diluted by
performing three 100-fold serial dilutions (10-6). 15μL of cells were then plated on YPD plates
for each strain and each time point from the 10 -6 dilution. After 200 minutes, instead of three 10fold serial dilutions, five 10-fold serial dilutions were performed. 15μL of cells were still plated
on YPD plates from the 10-6 dilution, but on a separate YPD plate, a 5μL droplet of each dilution
(starting from 10 -2 to 10-10) was plated as well for each condition. Plates were placed in a 30°C
incubator for three days. Similar to calculating colony forming units (CFUs), cells were counted
on each plate to determine cell survival and viability. Three to four repeats were conducted per
condition and then averaged ± standard deviation. Mean data was converted into percentages and
plotted as cell survival against time. Serial dilution plates were photographically captured.
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2.8 Cell Survival and Serial Dilutions for Hydrogen Peroxide Sensitivity Assay
Yeast strains from Table 3.1 were grown in synthetic complete media with 100 μM of
inositol over night at 30°C. For hydrogen peroxide exposed cell survival and sensitivity, cells
were spun down and diluted to an A600nm of 1.0 and placed in synthetic complete media with 100
μM of inositol that contained either 0mM H2O2 or 1mM H2O2 (Agimoni; 2016) and grown at
30°C, 300 RPM, for 4 hours. Cells were collected at the following time points: Hour 0, Hour 2,
and Hour 4. At each time point, all cells were diluted to A600nm of 1.0 and then serially diluted by
performing three 10-fold serial dilutions (10 -6). 15μL of cells were then plated on YPD plates for
each strain and each time point from the 10 -6 dilution. After 4 hours, instead of three 100-fold
serial dilutions, five 100-fold serial dilutions were performed. 15μL of cells were still plated on
YPD plates from the 10 -6 dilution, but on a separate YPD plate, a 5μL droplet of each dilution
(starting from 10 -2 to 10-10) was plated as well for each condition. Plates were placed in a 30°C
incubator for three days. Similar to calculating colony forming units (CFUs), cells were counted
on each plate to determine cell survival and viability. Three to four repeats were conducted per
condition and then averaged ± standard deviation. Mean data was converted into percentages and
plotted as cell survival against time. Serial dilution plates were photographically captured.
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2.8 Chromatin Immunoprecipitation (ChIP)
2.8.1. Cell preparation and crosslinking
ChIP was performed on WT strain (Table 4.1). WT was streaked from a single colony
and grown in 6mL SC media with 10µM inositol until saturation. Cells were transferred to
250mL of SC media with 100µM inositol and grown to stationary phase so that cells would be
harvested in a stage where PAH1 would be induced. Prior to harvesting, cells were cross-linked
with formaldehyde for 25 minutes and then quenched with glycine for an additional 5 minutes.
Cells were then pelleted, collected and then treated with cell wash buffer (20mM Tris-HCl pH8;
200mM NaCl) to be washed. Cells were then stored at -80ºC until they were ready to be lysed.

2.8.2. Lysate Preparation

In order to lyse cells, the pellets were mixed with 400µl of lysis buffer that contained
PMSF (50mM Tris-HCl pH 7.5, 0.15 M NaCl, 1mM EDTA pH 8, 1% Triton X-100, 1.5µM
trichostatin A, 0.2mM PMSF) as well as 0.4µl Protease inhibitor cocktail set III (CalBioChem
Catalog number: 539134). The cells with the lysis buffer mixture were then carefully added to
acid washed glass beads in an epindorf tube and subsequently vortexed at 4ºC for 20-25minutes.
Cells were then separated from beads by centrifugation at 2K for 10 seconds. The supernatant
was collected and placed in a new test tube so that it could undergo centrifugation at 13K for 15
minutes at 4ºC. Supernatant was discarded and the remaining pellet was mixed with chilled lysis
buffer that did not contain PMSF. Samples were sonicated and then centrifuged at 2K for 60
seconds at 4ºC. Supernatant was then placed in a fresh test tube and stored in -80ºC.
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2.8.3. Input sample preparation
Elution buffer (1% SDS + 0.1 M NaHCO3) and 5M NaCl were added to the 10μl of
lysate,. Tubes were incubated at 65oC for 4 hrs. Then, 8μl 0.5M EDTA, 16μl 1M Tris HCl pH
6.5 and 1μl Protinase K were added to the tubes and incubated again at 45oC for 1 hour. After
this, phenol chloroform extraction was performed, followed by the ethanol precipitation. DNA
quantification was done using spectrophotometer.

2.8.4. Immunoprecipitation

Sonicated lysates that contained 11μg total DNA were used for immunoprecipitation (IP).
They were diluted 10-fold in ChIP dilution buffer and incubated with 1µL TSA and 1µL
protease inhibitor cocktail, along with 35 µL protein A agarose slurry. Samples were placed at
4ºC for an hour on a rotation rack to preclear and reduce nonspecific background. They were
then breifly centrifuged at 2K for 15 seconds and the supernatant was transferred to a new
epindorf tube. Antibodies against Snf2p were added and allowed to incubate overnight. The
negative control samples (mock samples) were not treated with antibodies.
After overnight IP, 60 µL protein A agarose slurry was added to samples and incubated
for one hour. Samples were briefly centrifuged were washed once with low salt buffer, high salt
buffer, and LiCl solution, respectively. Subsequently, the samples were washed with 1X TE and
then washed again with 1X TE. The protein-DNA complex was eluted from the resin by adding
250µl of freshly prepared elution buffer and rotating for two fifteen-minute time intervals. The
supernatant was collected after centrifugation and 5M NaCl was added to each test tube to
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reverse cross-link the samples by heating them at 65oC for 5-6 hours. Then, 8ul of 0.5 M EDTA,
16ul of 1M Tris-HCl, pH6.5 and 2 µl of Proteinase K was added and incubated for 2 hours at
45oC. The DNA was then recovered by phenol/chloroform extraction and ethanol precipitation.
Finally, the pellet was re-suspended in 20 µl of TE.

2.8.5. Quantitative PCR (qPCR)

qPCR was used to analyze and determine the abundance of DNA fragments that were
bound by the protein of interest. Mock and input samples were also tested. Input samples were
prepared as all the DNA sequences in the genome from the lysate of the cell without any
selection or IP. Mock samples were prepared exactly as IP samples, just without the addition of
an antibody to be used to subtract out any background signal. qPCR was performed using the
Applied Biosystems, 7500 real-time PCR system). IP samples were calculated as follows:
(2^-(IP Ct # – mock Ct #) – (Input Ct # – mock Ct #)) *(A260 * 50 µg/mL * 50 dilution factor)
The IP samples were then graphed as an average of repeats ± standard deviation that was then
normalized to mock and input samples.

2.9 Vacuolar Morphology: Electron Microscopy

WT and pah1∆ were grown from a single colony until mid-logarithmic phase
(exponential phase) and stationary phase in SC media with 0.002% (w/v) of myo-inositol. Cells
were fixed with glutaraldehyde, calcium chloride, and sodium cacodylate buffer for one hour on
39

ice. The fixative was removed and cells were washed twice with the sodium cacodylate buffer .
Cells were then treated with lyticase for about 30 minutes at room temperature to break open the
cell wall. Following, cells were washed with buffer and then treated with osmium tetroxide for
two hours on ice. They were then washed with the buffer and left overnight in 4°C. The next day,
cells were dehydrated with 50%, 60%, and 70% ethanol, followed by an overnight incubation
with 70% ethanol and 3% uranyl acetate reagent. Cells were washed with 80%, 90%, and 100%
ethanol, followed by two incubations/washes with propylene oxide. A 1:1 ratio of propylene
oxide and resin was added, followed by fresh resin to embed and placed in the oven to set.
Samples were cut into ultra-thin sections and prepared for imaging using the Leica UCT
Ultramicrotome. EM microscopy was performed using the Fei Technai Spirit Transmission
Electron Microscope.

2.10 Growth analysis on SC and YPD plates (containing either CaCl2 or buffered pH)
Individual colonies were incubated overnight in SC + 100mM inositol media (dextrosenitrogen base-amino acids). On the following day, each strain's OD was measured and then
either diluted or concentrated so that all strains contained the same OD for their starting point.
The strains were then diluted 100 fold in SC medium and 5ul of each diluted strain were plated
on SC+ inositol plates that contained 60mM of CaCl2 for the calcium chloride sensitivity assay
and on YPD plates buffered to pH 5.5 and pH 7.0 for the pH sensitivity assay. Plates were
incubated at 30°C for two days before analyzed.
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2.11 Growth analysis in liquid broth buffered to appropriate pH
Cells were grown in SC media (synthetic complete media) containing 0.002% (w/v) of
myo-inositol. Media was buffered to pH 5.5 and pH 7. Growth experiments were performed in
duplicates where the optical density (OD) of the cells and pH of the growth medium was
measured every two hours for 8 hours and then resumed at 24 hours to 30 hours at 30°C.

2.12 Vacuolar pH analysis
WT, pah1Δ and vma3Δ cells were grown until stationary phase in SC media with 100μM
of inositol buffered to pH 7.0. Cells were then incubated with 1mM of BCECF-AM dye for 30 to
40 minutes at 30°C in the dark. Cells were then spun down, washed twice with media, and
resuspended in fresh media. Cells were then stored on ice. Next, calibration samples were made
for all three strains. Cells with the BCECF dye were incubated with 15μM of nigericin and the
calibration buffers (50mM HEPES , 50mM MES, 10mM 2-deoxyglucose , 50mM potassium
chloride, 50mM sodium chloride, 0.2M ammonium acetate, 10mM 2-deoxyglucose ) that
ranged from pH 5.0 to pH 7.0 for thirty minutes at 30°C. The unknown samples were prepared
by resuspending cells with BCECF with 1mM MES buffer at pH 7. All samples were plated in a
96 well plate. The SpectraMas M5 microplate reader was used to measure the excitation
wavelength (450nm and 490nm) with emission wavelength of 535nm. The calibration curves
were made by taking the ratio of fluorescence at 490nm to 450nm. The fluorescence ratio was
then plotted against pH (Figure 5.3A and 5.3B). Unknown samples were then plotted on standard
curve to determine their pH.
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Chapter 3: Characterization of the pah1Δ strain and the regulatory role of the PAH1 gene
in the lipid biosynthetic pathway
Characterization of the PAH1 gene in the lipid biosynthetic pathway
PAH1 encodes the PAP enzyme, Pah1p, which plays a crucial role in regulating the lipid
biosynthetic pathway. The negative regulator Opi1p, which is bound to PA on the nuclear-ER
membrane during gene activation, enters the nucleus when gene repression is required. It binds
to the promoter region of UASINO genes and blocks transcription. Conversely, when these genes
are in need of activation, the Ino2p-Ino4p activator complex binds to the UASINO of these genes
and Opi1p will remain bound to PA outside of the nucleus. This process however has been
shown to be heavily dependent on Pah1p, which mediates the levels of PA by catalyzing the step
of PA dephosphorylation and turning it into DAG. It thus diminishes PA levels, thereby allowing
Opi1p to enter the nucleus. As such, Pah1p negatively regulates these genes. However the effect
it has on specific genes has only been minimally researched.
While studies have shown Pah1p negatively regulates the lipid biosynthetic pathway, its
effect has only been tested on three biosynthetic genes, INO1, INO2, and OPI3. For instance,
while INO1 is a good model gene to use, these studies have not shown how Pah1p affects other
genes important in inositol production. Thus, the functional role of Pah1p in regulating other
genes in the pathway of inositol production has yet to be investigated. Furthermore, the impact of
PAH1 on the transcription of the other genes nearby in the lipid biosynthetic pathway has not
been directly studied as well. The lipid biosynthetic pathway consists of over 50 genes and a
more thorough analysis of the effect of Pah1p on these genes, both those containing a UAS INO
and those without, is needed. Therefore, we aim to investigate PAH1’s effect on a number of
sub-pathways within the lipid biosynthetic pathway.
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In addition, further studies have shown that the synthesis of phospholipids, as well as
membrane biogenesis in general, is mainly regulated by the crucial phospholipid precursors,
inositol and choline. However, the relationship of these precursors in conjunction with the
regulatory role of PAH1 has not been fully studied. In order to elucidate the above relationship,
we chose to study the effect of PAH1 upon the entire process of de novo inositol synthesis as
well as look at its impact on other crucial genes in the lipid biosynthetic pathway in the presence
of inositol.
To test our hypothesis, and examine the implications of PAH1 on lipid biosynthetic gene
regulation, especially in relation with the two crucial phospholipid precursors inositol and
choline, growth analysis followed by RNA analysis, was performed. Additionally, we used a
sensitivity assay to confirm the results of HXK2 gene regulation, a gene which was
downregulated by pah1∆, a result which we had not previously encountered before. Since PAH1
negatively regulates certain genes in the lipid biosynthetic pathway, its deletion should cause an
upregulation of these genes or at least remain at similar levels to wild type for the genes that is
does not affect. Finding a gene in which the reverse happens, suggests that PAH1 affects
pathways other than the lipid biosynthetic pathway and may be involved in other areas of cell
homeostasis.
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3.1 Materials and methods
3.1.1 Growth analysis
Yeast strains used in this experiment are shown in Table 3.1. Wild type and pah1∆ strains
were grown in SC media (synthetic complete media) in the presence and absence of 100μM of
myo-inositol, the presence and absence of 100μM choline, as well as 10μM of inositol and 10μM
of choline. They were all started at an optical density (A600) of around 0.2. Growth experiments
were performed in duplicates, where the optical density of the cells were measured every two
hours for the first eight hours and then again at the 24th hour until stationary phase was reached.
Cells were grown at 30°C.
Table 3.1: Yeast strain genotypes used in Chapter 3
Strain

Genome type
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0

Wild type (BY4741)
pah1Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0

The average of the 24th hour OD readings for each strain and condition was used in the
calculation to derive the average number of cell generations for that specific cell type:
Average # of generations = [(log# of cells at the end of 24 hours – log# of cells at the start of 24
hours)/log(2)]
This was then followed by determining the generation time in minutes/generation using the
average # of generations:
Generation time (min/gen) = [(60min/hr * 24)/number of generations in 24 hours]
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For the acetic acid hypersensitivity growth curve the same calculations were performed.
The strains used for this growth curve, wild type and pah1∆ strains, were the same listed in Table
3.1 and were grown in SC media (synthetic complete media) in the presence of 100μM myoinositol as well as in the presence of 0mM, 5mM, 10mM, 25mM, 50mM, and 100mM acetic
acid.
3.1.2 RNA analysis: Total mRNA preparation and quantification
WT and pah1Δ cells (Table 3.1) were grown from a single colony until mid-logarithmic
phase (0.8 A600) in SC media with 10μM myo-inositol, followed by an additional two hours in
the presence of 100μM myo-inositol. RNA was extracted from yeast cells through acid phenol
(pH 4.3) chloroform extraction in which the cells were resuspended in TES (10mM EDTA;
10mM Tris-HCl pH 7.5; 0.5% SDS), and then incubated at 65°C with equal parts acid phenol for
60 minutes. This was followed by a five-minute incubation on ice before centrifugation at 4°C.
The top layer of the sample was transferred to a new test tube and mixed with equal parts acid
phenol for a second time. Samples were incubated on ice for 5 minutes before centrifugation at
4°C and then separated by transferring the top layer of the sample to a fresh test tube and mixing
with equal parts chloroform. Samples were centrifuged, then separated again from their bottom
layer and transferred to a new test tube. Ethanol precipitation was then performed by adding 1
mL of 100% ethanol and 40μL of 3M NaOAc to the sample. The samples were then stored in dry
ice for 20 minutes, followed by a fifteen-minute centrifugation. The supernatant was discarded
and pellets were washed in ethanol (70%) and centrifuged again for three minutes. The
supernatant was removed and the pellets were left to dry for 10 minutes. This was followed by
resuspending the pellets in RNA sample buffer. RNA concentration was quantified by reading
absorbance at 260nm (A260). Subsequently, total RNA was stored at -80oC until further use.
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3.1.3 DNase Treatment of RNA samples

DNase treatment was performed to remove any DNA from the isolated RNA samples.
RNA was mixed with 10X buffer (0.1 M Tris-HCl pH 8, 5mM CaCl2 and 0.025M MgCl2),
DNase, and DEPC water. Samples were placed in 37°C water bath for 60 minutes, followed by
phenol:chloroform extraction. A 3:1 ratio of phenol:chloroform was added to the samples, mixed
and then placed on ice for a five minute incubation. Samples were then centrifuged for 10
minutes and then the top layer was transferred to a new test tube to be used for ethanol
precipitation. Ethanol (100%) and 20μL of 3M NaOAc were added to supernatant, mixed and
then placed on dry ice for 20 minutes. Samples were centrifuged for 13 minutes, followed by
removal of supernatant, and a washing of the pellet in 70% ethanol. This was followed by
centrifugation and the removal of the supernatant. Pellets were placed in a speed vacuum to dry
and then resuspended in TE buffer that was prepared using DEPC water. RNA concentration was
again quantified by reading absorbance at 260nm.
3.1.4 Preparation of cDNA: First Strand Synthesis

In order to prepare the cDNA needed for qRT-PCR, the SuperScript III First Strand
Synthesis SuperMix kit from Invitrogen (Catalog: 11752-050) was used. The reaction was
performed using a polymerase chain reaction (PCR) thermocycler. Each DNase free mRNA
sample (1 μg) was mixed with 2x RT Reaction mix, RT enzyme mix, and DEPC water. Samples
were placed in the PCR thermocycler and underwent the reaction using the following
thermocycler program: 10 minute incubation at 25°C, 30 minute incubation at 50°C, and 5
minute incubation at 85°C. Samples were then cooled on ice for a few minutes before adding E.
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coli RNase H and then placed in a 37°C waterbath for 20-30 minutes. First strand synthesis
samples were stored at -20°C until further use.

3.1.5 Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)

The cDNA prepared from first strand synthesis was amplified and quantified using qRTPCR. The SYBR GreenER® qPCR Supermix universal kit from Invitrogen (catalog number:
11762-500) was used to quantify cDNA templates. Forward and reverse primers were used that
targeted the open reading frame (ORF) in the qPCR reaction. Primers used in this study are
shown in Table 3.2.
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Table 3.2: List of primers used for qRT-PCR for RNA analysis
HXK2 primers
Forward:
Reverse:
INO1 primers
Forward:
Reverse:
DPP1 primers
Forward:
Reverse:
LPP1 primers
Forward:
Reverse:
INM1 primers
Forward:
Reverse:
PIS1 primers
Forward:
Reverse:
APP1 primers
Forward:
Reverse:
TGL3 primers
Forward:
Reverse:
TGL4 primers
Forward:
Reverse:
ACT1 primers
Forward
Primer:
Reverse
Primer:
DGA1 primers
Forward:
Reverse:

5’ CCAATGGCCATCAACTGTGA ‘3
5’ TGGCCTGGTCTTGGAGATTC ‘3
5’ CCATGGTTAGCCCAAACGA ‘3
5’ GCCTTCAAGCGTTGTTGCA ‘3
5’ AAGGCTTGCCATTGGACACT ‘3
5’ CCCAGTCCTGCAAAGCTTTC ‘3
5’ AAAGCACTCCAAGCGGACAT ‘3
5’ GGGCACCAAATGCAACTTCT ‘3
5’ GGGATGGTGGTTGCTATTCG ‘3
5’ TGTTCCCCTCACAGCCAAAT ‘3
5’ GATGCGCTAGACGGAACCAT ‘3
5’ TCAAGCCAGCGGTACTGGAT‘3
5’ CCCAAGAAGGTGCCATTGA ‘3
5’ ACCCAGCCTTGTAGCGGTAA ‘3
5’ TCCTCGATAGCAACAGCGAC ‘3
5’ GTGCGCGCATAGGAATTCTG ‘3
5’ TCCGCAGGAACTGGAATTCT ‘3
5’ TGGGCATCCAAGAGCACAA ‘3

5’ CCAAGCCGTTTTGTCCTTGT ‘3
5’ ACCGGCCAAATCGATTCTC ‘3
5’ GGCGACCCCTTTTGAAAGAA ‘3
5’ TGCTGGTGTCGAGATTGCAA ‘3
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TGL5 primers
Forward:
Reverse:
CDS1 primers
Forward:
Reverse:
BIR1 primers
Forward:
Reverse:
TRR1 primers
Forward:
Reverse:
TRX1 primers
Forward:
Reverse:
TRX2 primers
Forward:
Reverse:

5’ ACGCCGCTATTCGAGAAAGA ‘3
5’ GACGAGAAATGGGCATGTCA ‘3
5’ CAAGGCAGCTCCATCACATA ‘3
5’ TGCAGGACTCATGCCATTTA ‘3
5’ GGGGGTTTCGGACTGGAAAA ‘3
5’ GCTGGAGTCGTATCGCATGA ‘3
5’ AGCGTGCTGAGAAGAACGAA‘3
5’ CTTTGTTGCTGGAGTGTGGC ‘3
5’ ACTTGGTGCGGTCCATGTAA‘3
5’ TTGGCACCAACAACCTTTGC‘3
5’ AGTGCTTTAGCATCTGGCGA‘3
5’ CTGGTAACCTCCTTACCGCC‘3

The reaction setup for each sample contained the following: 10μL of SYBR GreenER®
qPCR Supermix, 0.4 μL each of forward and reverse primers, 0.4 μL of ROX reference dye, 1
μL of the cDNA template, and RNA and DNA free water to a volume of 20μL. Samples were
added to a 96 well plate and then sealed and placed in the Applied Biosystems 7500 real time
PCR machine. The program used had a 2 minute incubation at 50°C, followed by 10 minutes at
95°C, and 40 cycles of 15 seconds at 90°C and 1 minute at 60°C. PCR reactions were performed
in triplicates.
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3.1.6 Analysis of RNA quantity
A ΔCT value was obtained by subtracting the respective gene CT from the CT value of the
constitutive housekeeping gene (ACT1). Therefore, the relative mRNA levels were expressed as
2^-(ΔCT). Data results were graphed as a mean of the repeats ±standard deviation.
3.1.7 Acetic Acid Sensitivity Growth Analysis

Using the yeast strains listed in Table 3.1, growth analysis was performed under varying
concentrations of acetic acid. Yeast strains were grown in synthetic complete media with 100 μM
of inositol over night at 30°C and subsequently washed and diluted to A600nm 0.2. Cells from both
strains were placed in medium containing either 0mM, 5 mM, 10mM, 25mM, 50mM and
100mM acetic acid and grown at 30°C and 300 RPM. Growth of the cells was measured
spectrophotometrically using A600nm and were measured every two hours for the first eight hours
and then again at the 24th hour until stationary phase was reached. Calculations to analyze data
were the same as 3.1.1 growth analysis.

3.1.8 Cell Survival and Serial Dilutions for Acetic Acid Sensitivity Assay
Yeast strains from Table 3.1 were grown in synthetic complete media with 100 μM of
inositol over night at 30°C. For acetic acid cell survival and sensitivity, cells were spun down
and diluted to an A600nm of 1.0 and placed in pH 3 SC media containing either 0mM acetic acid,
80mM acetic acid, and 120mM acetic acid (methods followed from Agimoni; 2013) and grown
at 30°C, 300 RPM, for 200 minutes. Cells were collected at the following time points: 0 minutes,
90 minutes, 200 minutes. At each time point, all cells were diluted to A600nm of 1.0 and then
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serially diluted by performing three 100-fold serial dilutions (10 -6). 15μL of cells were then
plated on YPD plates for each strain and each time point from the 10 -6 dilution. After 200
minutes, instead of three 10-fold serial dilutions, five 10-fold serial dilutions were performed.
15μL of cells were still plated on YPD plates from the 10 -6 dilution, but on a separate YPD plate,
a 5μL droplet of each dilution (starting from 10 -2 to 10-10) was plated as well for each condition.
Plates were placed in a 30°C incubator for three days. Similar to calculating colony forming
units (CFUs), cells were counted on each plate to determine cell survival and viability. Three to
four repeats were conducted per condition and then averaged ± standard deviation. Mean data
was converted into percentages and plotted as cell survival against time. Serial dilution plates
were photographically captured.

3.1.9 Cell Survival and Serial Dilutions for Hydrogen Peroxide Sensitivity Assay
Yeast strains from Table 3.1 were grown in synthetic complete media with 100 μM of
inositol over night at 30°C. For hydrogen peroxide exposed cell survival and sensitivity, cells
were spun down and diluted to an A600nm of 1.0 and placed in synthetic complete media with 100
μM of inositol that contained either 0mM H2O2 or 1mM H2O2 (Agimoni et al., 2016) and grown
at 30°C, 300 RPM, for 4 hours. Cells were collected at the following time points: Hour 0, Hour
2, and Hour 4. At each time point, all cells were diluted to A600nm of 1.0 and then serially diluted
by performing three 10-fold serial dilutions (10-6). 15μL of cells were then plated on YPD plates
for each strain and each time point from the 10 -6 dilution. After 4 hours, instead of three 100-fold
serial dilutions, five 100-fold serial dilutions were performed. 15μL of cells were still plated on
YPD plates from the 10 -6 dilution, but on a separate YPD plate, a 5μL droplet of each dilution
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(starting from 10 -2 to 10-10) was plated as well for each condition. Plates were placed in a 30°C
incubator for three days. Similar to calculating colony forming units (CFUs), cells were counted
on each plate to determine cell survival and viability. Three to four repeats were conducted per
condition and then averaged ± standard deviation. Mean data was converted into percentages and
plotted as cell survival against time. Serial dilution plates were photographically captured.
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3.2 Results
3.2.1 The pah1𝜟 mutant exhibits a greater growth pattern than WT cells, with the greatest
difference seen under conditions of high concentrations of inositol and choline present.

Results showed that in media containing neither inositol nor choline, both WT and pah1𝛥
grew well, with the WT strain reaching an average optical density (OD) A600nm at hour 24 of
approximately 5.3 ±0.28. The pah1𝛥 mutant however had a slightly higher growth than WT at
hour 24 with an average optical density of 5.8 ± 0.14, and grew 5.40% ± 3.56 better than WT
(Figure 3.1A; Table 3.3; Table 3.4). This percent difference in growth however was not
significant (p=0.15). For cells grown in media that contained 10μM of inositol and 0μM of
choline the growth difference was even greater between WT and the pah1𝛥 mutant, with a
percent growth difference of 7.75% ± 0.71 (Figure 3.1E, Table 3.4), though again the difference
in growth was not significant (p=0.185). The biggest change in growth however occurred
between the two strains when there was at least 100μM of inositol or 100μM of choline in the
media. For WT cells grown in media containing 100μM of inositol and 100μM of choline, the
average OD was about 5.4 ± 0.14, while the average OD of the pah1𝛥 mutant cells was 6.5 ±
0.35, causing pah1𝛥 mutant cells to have a significant difference in growth that was 10.8% ±
1.66 than WT (p= 0.05; Figure 3.1B; Table 3.3; Table 3.4). Similar differences in growth were
observed for cells grown in media that contained just one of crucial phospholipid precursors at
the 100μM concentration level. The pah1𝛥 strain grew 11.7% ± 1.17 better than WT when
grown in media containing 100μM choline and 0μM inositol, and 11.6% ± 3.61 better when
grown in media containing 100μM choline and 10μM inositol (Figures 3.1D, 3.1F; Table 3.4).
Interestingly though, only the latter was significant, signifying the importance of inositol in the
media. The biggest percent growth difference that was significant occurred when cells were

53

grown in media containing 100μM inositol and 0μM choline. The average OD of WT cells at
hour 24 was 5.3 ± 0.42, while pah1𝛥 mutant cells had an average OD of 6.7 ± 0.07, which led to
an increase of 12.3% ± 0.46 in growth and a p value of p=0.047 (Figure 3.1C; Table 3.1; Table
3.4).
Consistent with our results, when the number of generations per 24 hour period was
calculated, along with the generation times, pah1𝛥 strain had a higher number of generations and
an overall faster generation time than WT. For instance, for cells grown in media that had neither
inositol nor choline present, WT had 4.27 generations in 24 hours and a generation time of
337.32 minutes per generation compared to the 4.48 generations of the pah1𝛥 strain and a
generation time of 321.43 minutes/generation (Table 3.3). For cells grown in media containing
100μM inositol and 0μM choline the number of generations for WT was 4.35 generations/24
hours and for pah1𝛥 was 4.95 generations/24 hours. The generation time for WT in this
condition was 331.05 minutes/generation while for pah1𝛥 was 290.82 minutes per generation.
Taken together, these results demonstrated that the pah1𝛥 strain exhibited a higher growth
pattern than WT in all conditions tested, but showed an even greater difference when higher
concentrations of inositol and choline were present.
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Figure 3.1: The pah1Δ mutant exhibits higher growth patterns compared to WT in all conditions tested,
with significant differences for conditions that contain 100 μM inositol or 100 μM choline with 10 μM
inositol.
WT and pah1Δ cells were grown in 10μM inositol SC media and were then washed and diluted to an
Absorbance600nm of 0.2 in SC media containing various concentrations of inositol and choline. Optical
density (A600nm) was read for first 8 hours of exponential phase and then resumed at 21 hours and taken
until stationary phase was reached.
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Figure 3.2: WT and pah1Δ mutant exhibit no significant difference of growth between growth
conditions, except for the pah1Δ mutant between the 0 μM inositol and 100 μM inositol conditions.
WT and pah1Δ cells were grown in 10μM inositol SC media and were then washed and diluted to an
Absorbance600nm of 0.2 in SC media containing various concentrations of inositol and choline. Optical
density (A600nm) was read for first 8 hours of exponential phase and then resumed at 21 hours and taken
until stationary phase was reached.
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Table 3.3: pah1Δ vs WT Growth Experiment 24th Hour Analysis

Condition
0µM
Inositol,
0µM
Choline
100µM
Inositol,
100µM
Choline
100µM
Inositol,
0µM
Choline
0µM
Inositol,
100µM
Choline
10µM
Inositol,
0µM
Choline
10µM
Inositol,
100µM
Choline

Average
O.D WT
(24th
Hour)

Average
O.D
pah1Δ
(24th
Hour)

5.3 ± 0.28

5.8 ± 0.14

5.4 ± 0.14

# of
generations
in 24 hours
for WT

# of
generations in
24 hours for
pah1Δ

Generation Time
(min/generation)
for WT

4.27

4.48

337.32

321.43

6.5 ± 0.35

4.38

4.91

329.01

293.44

5.3 ± 0.42

6.7 ± 0.07

4.35

4.95

331.05

290.82

4.5 ± 1.8

5.9 ± 1.6

4.55

4.68

316.54

307.6

4.6 ± 0.35

5.8 ± 0.78

4.08

4.61

353.35

312.14

4.8 ± 0.28

6.4 ± 0.21

4.18

4.53

344.55

317.9

Table 3.4: pah1Δ vs WT Percent Difference in Growth
Condition
0µM Inositol, 0µM Choline
100µM Inositol, 100µM Choline
100µM Inositol, 0µM Choline
0µM Inositol, 100µM Choline
10µM Inositol, 0µM Choline
10µM Inositol, 100µM Choline

Percent Growth Difference between
pah1∆ and WT
5.40% ± 3.56
10.8% ± 1.66 (p=0.05)
12.3% ± 0.46 (p=0.047)
11.7% ± 1.17
7.75% ± 0.71
11.6% ± 3.61 (p=0.025)
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Generation Time
(min/generation)
for pah1Δ

3.2.2 The pah1Δ strain has higher gene expression for UASINO genes and some non UASINO
genes, thus exhibiting the importance of Pah1p as a negative regulator, while having the
reverse effect for the HXK2 gene.

Growth analysis suggested that pah1𝛥 exhibits greater differences from WT when grown
in the presence of 100μM of inositol. In order to better elucidate the role of PAH1 on gene
regulation, we decided to examine its impact on closely related genes in the lipid biosynthetic
pathway. The effect of PAH1 on other genes has only been minimally tested and most
importantly not on all genes involved in inositol synthesis. While INO1 has been studied
previously to determine the impact that PAH1 has on it, other genes in the same pathway have
not (Santos-Rosa et al., 2005). Furthermore, INO1 expression has yet to be examined in a study,
which tests both the importance of PAH1 as well as the crucial phospholipid precursor, inositol,
together on its gene expression. In order to test this, we decided to perform a time course RNA
analysis study. Since the presence of inositol led to the greatest difference in growth analysis, our
RNA analysis was carried out by introducing inositol to the cells and collecting those cells
throughout their growth process at designated time points (0, 60 and 120 minutes). The mRNA
from the WT and pah1𝛥 strains was then used as a template to be converted into cDNA and
subsequently quantified using qRT-PCR, with primers targeting the open reading frame of the
genes being tested. Genes chosen for this analysis included those in the lipid biosynthetic
pathway that were nearby to PAH1. These genes included PIS1, CDS1, DPP1, LPP1, APP1,
TGL3, TGL4, TGL5, and DGA1. Genes that are involved in de novo inositol synthesis were also
tested. These included HXK2, INO1, and INM1. Lastly, our results were normalized using the
constitutive housekeeping gene, ACT1, which acted as our internal control. However, we used an
additional control, POL1, another constitutive housekeeping gene, to serve as an external control.
Thus, POL1 gene expression was tested as well.
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Our results showed and confirmed that PAH1 does in fact negatively regulate UASINO
genes, including all the novel UASINO genes tested (Figure 3.3). Perhaps one of the most
regulated UASINO genes by PAH1 is INO1 (Figure 3.3A). As can be seen, INO1 expression is
significantly higher in pah1∆ cells than in WT for all time points collected, heavily suggesting
that Pah1p acts as a negative regulator when present. Starting from time point 0 minutes, INO1
expression in pah1∆ is about double that of WT (0.271 ± 0.02 and 0.546 ± 0.016; p<0.01). Under
normal circumstances, the addition of inositol should repress the transcription of INO1, since the
cell no longer requires the production of inositol as it is now available in the environment. This is
clearly seen in WT, with INO1 expression plummeting drastically (0.007±0.0003) after 60
minutes of exposure to inositol (Figure 3.3A). While there is a decrease in INO1 expression in
pah1∆ at 60 minutes compared to 0 minutes, there is still a relatively high level of INO1
expression, which is comparable to levels in WT at time point 0 minutes (0.20±0.04). This
suggests that while other regulatory machinery is still employed to help suppress INO1
expression, the deletion of PAH1 omits a key component that is needed for INO1 repression.
Thus, it still exhibits INO1 mRNA after exposure to inositol that is comparable to levels found in
WT without the addition of inositol. The difference of expressions levels between both strains is
significant at 60 minutes (p=0.002) The same effect is still seen after 120 minutes with INO1
expression levels in WT being significantly lower than those of pah1∆ (0.009±0.002 and
0.21±0.016; p<0.01) as well (Figure 3.3 A).
While the repressing regulatory role of PAH1 is most clearly seen with INO1, the effect is
similar with other UASINO genes tested as well. Genes such as PIS1, CDS1, and INM1, all of
which contain a UASINO have significantly higher levels of expression, at all tested time points,
in pah1∆ cells than in WT cells (Figure 3.3B, 3.3C, and 3.3D). The TGL4 gene, which is one of
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the genes responsible for converting triacylglycerols back into diacylglycerols, also has
significantly higher expression levels in pah1∆ cells than in WT (Figure 3.3E), strongly
suggesting that PAH1 does not only regulate UASINO genes, but those without UASINO as well.
However, it should be noted that most non-UASINO genes tested in this study did not have a
significant difference between gene expression in WT and pah1∆. These genes included LPP1,
DPP1, APP1, TGL3, TGL5, and DGA1 (Figures 3.4). Therefore while PAH1 can affect gene
expression of other genes, its main impact is on genes that contain a UASINO, since all genes with
a UASINO that were tested showed significant upregulation compared to WT. Additionally we
also did RNA analysis on POL1, which acted as our external control. POL1 is a constitutive
housekeeping gene and thus should not exhibit any changes between WT or pah1∆, nor should it
change in response to inositol. As can be seen, POL1 expression remained the same for all
strains and time points collected after introduction of inositol (Figure 3.4G), thus acting as the
control gene for this experiment.
Another interesting observation that was noted was that the pah1∆ strain did not always
respond to the addition of inositol the way that WT did. Most genes in the lipid biosynthetic
pathway will either upregulate or downregulate in response to the addition of inositol. For
instance, as was noted earlier, the INO1 gene will greatly downregulate in response to inositol,
which was an effect we saw in both WT and pah1∆, to varying degrees. The expression level
pattern in response to inositol of other genes that we tested were also consistent with previous
findings (Wimalarathna et al, 2011), including INM1 (upregulated), CDS1 (downregulated), and
TGL3 (downregulated). For other genes, however, pah1∆ did not necessarily respond to inositol
the same way that WT did. For example, PIS1 should become upregulated in the presence of
inositol (Wimalarathna et al., 2011). The results that we collected for WT was in accordance
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with that trend and upregulated, as the PIS1 mRNA levels increased significantly after 60 and
120 minutes (p=0.013; p=0.017). However, the mRNA levels of pah1∆ did not significantly
increase in response to inositol (Figure 3.3B). While this phenomenon was not seen in most
genes tested, it was seen in a few (i.e., PIS1, Figure 3.3B and TGL4, Figure 3.3E). This suggests
that the effect that the inositol would usually play in gene expression is canceled out by the
constant upregulation that the pah1∆ causes. Thus, in genes like INO1, which is involved in the
rate limiting step of de novo inositol synthesis (Greenberg and Lopes, 1996) there would be
multiple modes of regulation, with PAH1 being just one method of repression. However there
may be other genes that do not possess as many modes of regulation and whose main regulatory
system relies heavily upon the repressive role of PAH1, thus being dependent on its function.
Therefore, for the genes that lack the Pah1p repressor, their constant upregulation would be
indifferent to the effects of inositol or other precursors.
Perhaps one of the most surprising results from the RNA analysis we discovered was
regarding the HXK2 gene, a gene that codes for hexokinase-2 protein during growth on glucose,
and which is necessary for the production of inositol (Moreno and Herrero, 2002). As was
mentioned earlier, aside for the INO1 gene, the other genes necessary for the production of
inositol has yet to be looked into in regard to their expression levels in pah1∆ cells. We therefore
looked into expression of INM1 (as explained above) and HXK2 in the pah1∆ mutant strain since
both are crucial genes needed for de novo inositol synthesis (Figure 1.3). Being a UASINO gene,
INM1 followed the pattern of INO1, in that its expression level was higher in pah1∆ than in WT.
While HXK2 does not contain a UASINO,we were curious to see if its expression would still be
higher in pah1∆ than in WT since it plays such a crucial role in inositol production. While we
hypothesized that it would be probable to see an increased expression level of HXK2 in pah1∆
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compared to WT, it would not be surprising if levels remained comparable to each other since
the majority of non- UASINO genes did not show a significant difference between the strains.
Results showed that at 0 minutes, HXK2 levels were in fact comparable between WT cells and
pah1∆ cells and were not significantly different (0.227±0.041 and 0.185± 0.038; p=0.398).
However, with the addition of inositol, the expression of HXK2 increased with time in the WT
strain after 60 minutes and 120 minutes (Figure 3.5). This was expected since HXK2 had
previously been determined to upregulate in response to inositol (Wimalarathna et al., 2011).
HXK2 levels however did not change in the pah1∆ cells as they did in WT. While this
phenomenon of pah1∆ cells not following the same response to inositol as WT was seen with
other genes (i.e. PIS1, TGL4), this situation was unique in that WT had higher gene expression
compared to pah1∆. Stated differently, in all the other genes we tested there was either no
significant difference between WT and pah1∆ or, pah1∆ cells always exhibited higher gene
expression levels. In this case, however, HXK2 gene expression was vastly greater in WT. At 60
minutes, HXK2 expression levels in WT was more than quadruple that in pah1∆ (0.673±0.037
and 0.161±0.003; p=0.003) and at 120 minutes, it was almost triple the amount (0.416±0.041 and
0.169±0.04; p=0.026). Thus, HXK2 is the sole gene in this study that actually had expression
levels lower in pah1∆ than in WT.
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Figure 3.3: The pah1Δ mutant exhibits an upregulation in gene expression of UAS INO genes and some
non-UASINO genes compared to WT.
WT cells were grown to mid logarithmic phase (1.0±0.2 A600nm) in 10µM inositol SC media and were
then washed and grown in SC media that contained 100μM inositol. mRNA was then extracted from
cells using acid phenol chloroform and purified further with treatment of DNase. RNA was converted to
cDNA and was amplified/quantified using qPCR with primers targeting the open reading frame
sequence of tested gene. Expression levels of mRNA were normalized to the housekeeping gene ACT1.
All experiments were done with at least two repeat colonies and all qPCR reactions were done in
triplicates. Data was graphed as a mean ± standard deviation.
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Figure 3.4: The pah1Δ mutant exhibits similar gene expression levels to WT for most non-UASINO genes.
WT cells were grown to mid logarithmic phase (1.0±0.2 A600nm) in 10µM inositol SC media and were
subsequently washed and grown in SC media that contained 100μM inositol. mRNA was then extracted
from cells using acid phenol chloroform and purified further with treatment of DNase. RNA was
converted to cDNA and was amplified/quantified using qPCR with primers targeting the open reading
frame sequence of tested gene. Expression levels of mRNA were normalized to the housekeeping gene
ACT1. All experiments were done with at least two repeat colonies and all qPCR reactions were done in
triplicates. Data was graphed as a mean ± standard deviation.
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Figure 3.5: HXK2 gene expression remains constant in the pah1Δ mutant strain and does not upregulate in response to inositol as does WT.
WT cells were grown to mid logarithmic phase (1.0±0.2 A600nm) in 10µM inositol SC media and were
subsequently washed and grown in SC media that contained 100μM inositol. mRNA was then extracted
from cells using acid phenol chloroform and purified further with treatment of DNase. RNA was
converted to cDNA and was amplified/quantified using qPCR with primers targeting the open reading
frame sequence of tested gene. Expression levels of mRNA were normalized to the housekeeping gene
ACT1. All experiments were done with at least two repeat colonies and all qPCR reactions were done in
triplicates. Data was graphed as a mean ± standard deviation.
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3.2.3 The pah1∆ mutant exhibits higher tolerance to acetic acid induced apoptosis than
WT.

While nearly all genes tested during RNA analysis were either upregulated or remained at
similar levels to wildtype, there was one gene that did not upregulate or remain at similar levels
to WT with the introduction of inositol. Our mRNA analysis showed that HXK2 expression was
significantly reduced in pah1Δ cells compared to WT when inositol was introduced. While
HXK2 levels increased in wildtype after induction with inositol, the levels did not in pah1Δ cells.
HXK2 encodes for the hexokinase-2-protein during growth on glucose (Moreno and Herrero,
2002). It plays a crucial role in glucose metabolism since it’s responsible for phosphorylating
glucose at C6 which can be further phosphorylated in the glycolytic pathway, or can be
converted into inositol-3-phosphate in the phospholipid biosynthetic pathway.
Furthermore, other research has shown that HXK2 may play a role in protecting cells
against apoptosis since previous studies have shown that hxk2Δ cells demonstrated acetic acid
hypersensitivity (Amigoni; 2013). Therefore, we hypothesized that since HXK2 levels remained
significantly lower in pah1Δ cells compared to wildtype it would be more susceptible to acetic
acid induced apoptosis than wildtype.
Our results showed that WT cells grew well under normal conditions in SC media. As we
began to introduce different concentrations of acetic acid into the growth media WT cells
survival began to change (Figure 3.5). At 5mM, 10mM, and 25mM concentrations of acetic acid,
growth rate decreased to 3.58% ± 4.07, 12.05% ± 0.07, and 21.08% ± 3.35, respectively (Table
3.5). WT cells were unable to grow anymore at a 50mM concentration of acetic acid. For pah1Δ
cells the trend of cell growth was similar to WT when higher concentrations of acetic acid were
introduced (Figure 3.7). At 5mM, 10mM, and 25mM concentrations of acetic acid, the growth
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rate decreased to 2.18% ± 1.82, 9.86% ± 1.76, and 27.59% ± 7.95, respectively (Table 3.6).
There was no significant difference between the 5mM, 10mM, and 25mM growth drop between
WT and pah1Δ. However unlike WT cells, at the 50mM acetic acid concentration pah1Δ cells
were able to grow to a small degree. Their growth rate dropped to 94.69% ± 0.26 compared to
0mM, but this was statistically significant (p<0.01) compared to the 100% decrease in growth of
WT.
These results were therefore surprising, since pah1Δ cells seemed to grow even better
than wildtype despite the fact that HXK2 levels were diminished in pah1Δ. In order to confirm
this finding further, we decided to approach this question differently and characterize the
relationship of pah1Δ cells to apoptosis with a more sensitive assay. Instead of measuring cell
growth in the presence of acetic acid, we decided to assess cell sensitivity by performing a
“death curve” and looking at cell survival (Amigoni; 2013). This would more accurately portray
the apoptotic effect of acetic acid. In addition, cells would only be exposed for 90 minutes and
200 minutes at higher concentrations of acetic acid (80mM and 120mM) and then be grown on
regular YNB plates to assess their recovery.
Our results confirmed our initial observation, but to an even greater extent. Upon just an
initial glance at the growth plates containing acetic acid exposed cells, there were an
overwhelmingly greater number of pah1∆ colonies than WT (Figure 3.9). This was seen for both
cells exposed to 80mM acetic acid and 120mM acetic acid. Though they were smaller colonies
(which is consistent with growth rate of pah1∆ on plates), the number of colonies for pah1∆
could be seen to far outnumber WT even before quantifying the results. Once quantified, the data
showed that pah1∆ cells survived significantly better than WT. At 0mM concentration of acetic
acid, both WT and pah1∆ exhibited a similar trend in cell survival as was to be expected. WT
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cell number increased from 100% to 143.2%, while pah1∆ increased from 100% to 146.1% after
90 minutes. Both cells declined slightly after 200 minutes, but at a comparable rate with cells
being at 86.6% for WT and 78.3% for pah1Δ, respectively (Figure 3.10C). At an exposure of
80mM acetic acid, cell survival differed drastically between both strains. After only 90 minutes,
WT cell survival plummeted from 100% down to only 26.03% and after 200 minutes, it
decreased to 2.05% (Figure 3.10A). Exposure to 120mM acetic acid yielded even stronger
declines in cell survival for WT. At 90 minutes, WT cell survival went down 6.85% and after
200 minutes, it decreased to 0.68% (Figure 3.10A). The pah1∆ cells however fared much better
when exposed to acetic acid. At 80mM acetic acid, cells actually grew after 90 minutes of
exposure going from 100% to 122.9% and then dropping in number after 200 minutes of
exposure down to 109.6% (Figure 3.10B). At 120mM, the exposure to acetic acid had a more
drastic effect on pah1∆ but was still significantly better than WT, with cells dropping down to
65.2% after 90 minutes and 23.7% after 200 minutes (Figure 3.10B). Thus pah1∆ cells seem
much more likely to withstand acetic acid induced apoptosis than WT.
These results were further confirmed with our serial dilution sensitivity assay. This assay
was performed at the end of our experiment, in which the cells that had been growing for 200
minutes in various concentrations of acetic acid were diluted to the same OD and then plated in
five 100-fold dilutions. At 0mM acetic acid, both WT and pah1∆ grew at comparable rates and
both had nice cell growth visible at 10-8 dilution (Figure 3.11A). At 80mM acetic acid, pah1∆
still grew well, with the last visible growth still seen at the 10 -8 dilution but on a much smaller
scale than had been at 0mM. The last visible growth for WT cells at this concentration was at the
10-6 dilution and again, cell growth was minimal (Figure 3.11B). Lastly at 120mM acetic acid,
pah1∆ cells grew nicely all the way to the 10-6 dilution. The last visible growth for WT was only
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at the 10-2 dilution (Figure 3.11C). Taken together, these experiments show that the pah1∆
mutant can survive at much higher concentrations of acetic acid than can WT. These finding are
extremely interesting since pah1∆ has lower expression levels of HXK2, a gene that has been
shown to be involved in protecting against apoptosis. Despite lower HXK2 expression levels than
WT cells grown in SC media with inositol, pah1∆ is greater at withstanding apoptosis than WT.
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Figure 3.6: WT growth diminishes with increasing concentrations of acetic acid.
WT and pah1Δ cells were grown in SC+ media and were then washed and diluted to an Absorbance 600nm
of 0.2 in SC media containing various concentrations of acetic acid. Optical density (A600nm) was read for
the first 8 hours of exponential phase and then was resumed at 24 hours and read until stationary phase
was reached.

Table 3.5: WT Percent Difference in Growth at 24th Hour
WT: Acetic Acid Concentration Comparison

Decrease in growth rate %

0mM
0mM

5mM
10mM

3.58% ± 4.07
12.05% ± 0.07

0mM

25mM

21.08% ± 3.35

0mM

50mM

100% ± 0.00

0mM

100mM

100% ± 0.00
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Figure 3.7: pah1Δ growth diminishes with increasing concentrations of acetic acid.
WT and pah1Δ cells were grown in SC+ media and were then washed and diluted to an Absorbance 600nm
of 0.2 in SC media containing various concentrations of acetic acid. Optical density (A600nm) was read for
the first 8 hours of exponential phase and then was resumed at 24 hours and read until stationary phase
was reached.

Table 3.6: pah1∆ Percent Difference in Growth at 24th Hour
pah1∆: Acetic Acid Concentration Comparison

Decrease in growth rate %

0 mM
0 mM

5mM
10mM

2.18% ± 1.82
9.86% ± 1.76

0 mM

25mM

27.59% ± 7.95

0 mM

50mM

94.69% ± 0.26

0 mM

100mM

100% ± 0.00
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WT VS pah1∆ Growth Curve
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Figure 3.8: WT and pah1Δ cell growth diminishes with increasing concentrations of acetic acid.
WT and pah1Δ cells were grown in SC+ media and were then washed and diluted to an Absorbance 600nm
of 0.2 in SC media containing various concentrations of acetic acid. Optical density (A 600nm) was read for
the first 8 hours of exponential phase and then was resumed at 24 hours and read until stationary phase
was reached.

Table 3.7: WT and pah1∆ Growth Experiment 24th Hour Analyses

Condition
0mM Acetic Acid

Average O.D
WT (24th
Hour)
5.2 ± 0.0

Average O.D
pah1Δ (24th
Hour)
6.6 ± 0.0

5mM Acetic Acid

4.4 ± 0.28

6.0 ± 0.57

10mM Acetic Acid

3.3 ± 0.28

4.6 ± 0.14

25mM Acetic Acid

2.45 ± 0.49

2.45 ± 0.35

50mM Acetic Acid

0.21 ± 0.01

0.27 ± 0.03

100mM Acetic Acid

0.2 ± 0.0

0.18 ± 0.01

# of
generations
in 24 hours
for WT

# of
generations
in 24 hours
for pah1Δ

4.700908133
4.533883972
4.157283095
3.727556
0.072156976
0

4.940549753
4.836983241
4.453616402
3.579442602
0.263060618
0
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Generation Time
(min/generation)
for WT

306.3237909
317.6084807
346.3800678
386.3121037
19956.49049
-

Generation Time
(min/generation)
for pah1Δ

291.4655397
297.7062206
323.3327413
402.2972736
5474.023479
-
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Figure 3.9: The pah1𝜟 mutant has greater cell survival to acetic acid induced apoptosis than WT.
WT and pah1𝜟 cellular growth on YPD plates after 0, 90 and 200 minute exposures to 80mM acetic
acid. All cells were initially grown in synthetic complete medium with 100 μM inositol overnight and
then diluted to an A600nm of 1.0 and grown in pH 3 SC media with appropriate concentration of acetic
acid. Cells aliquots were collected at predetermined time points and diluted back again to a starting
optical density (A600nm) of 1.0 (to ensure same cell number for each strain). Three serial dilutions were
performed and plated from the 10-6 dilution for each condition of each strain. YPD plates were grown
for 3 days at 30°C. Experiments were repeated in triplicates.
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Figure 3.10: The pah1𝜟 mutant has greater cell survival to acetic acid induced apoptosis than WT.
WT and pah1𝜟 cellular growth on YPD plates after 0, 90 and 200 minute exposures to 80mM acetic
acid. All cells were initially grown in synthetic complete medium with 100 μM inositol overnight and
then diluted to an A600nm of 1.0 and grown in pH 3 SC media with appropriate concentration of acetic
acid. Cells aliquots were collected at predetermined time points and diluted back again to a starting
optical density (A600nm) of 1.0 (to ensure same cell number for each strain). Three serial dilutions were
performed and plated from the 10-6 dilution for each condition of each strain. YPD plates were grown
for 3 days at 30°C. Experiments were repeated in triplicates.
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Figure 3.11: The pah1𝜟 mutant has less sensitivity to acetic acid and can withstand exposure to higher
concentrations of acetic acid compared to WT.
WT and pah1𝜟 cellular growth on YPD plates after 200 minute exposure to (A) 0mM acetic acid, (B)
80mM acetic acid, (C) 120mM acetic acid. All cells were initially grown in synthetic complete medium
with 100 μM inositol overnight and then diluted to an A600nm of 1.0 and grown in pH 3 SC media with 0,
80, or 120mM acetic acid. Cells were collected after 200 minutes and diluted back again to a starting
optical density (A600nm) of 1.0 (to ensure same cell number for each strain). Five serial dilutions were
performed and plated for each condition of each strain. YPD plates were grown for 3 days at 30°C.
Plates were repeated in triplicates.
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3.2.4 The pah1∆ mutant exhibit higher tolerance to hydrogen peroxide induced apoptosis
than WT.
Due to the surprising results that pah1∆ cells were better at withstanding acetic acid
induced apoptosis than WT despite having lower HXK2 levels in SC with 100 μM inositol
media, we wanted to confirm that pah1∆ cells were in fact able to resist apoptosis that was
caused by other reagents as well. This would be done conducting the same experiment that was
performed with acetic acid but with another apoptotic factor. We therefore decided to expose the
cells to a well-known apoptotic reagent, hydrogen peroxide. Both WT and pah1∆ were grown
under normal conditions and then employed the death curve assay using hydrogen peroxide.
Results yielded similar outcomes in terms of the anti-apoptotic property of pah1∆ cells
compared to WT. Cell survival dropped drastically in WT cells when they were exposed to 1mM
of hydrogen peroxide. This could be seen after just looking at the colony growth of both strains
on the YPD plates (Figure 3.12). This was confirmed after quantification. After 2 hours of
exposure to the reagent, WT cell survival went from 100% down to just 5.98%. After 4 hours of
exposure, cells continued to die yielding only a 0.71% of survival. The pah1∆ cells however
fared much better. While exposure to hydrogen peroxide caused cell death, it was not as severe
as WT. After 2 hours of exposure to the reagent, pah1∆ cells went from 100% cell survival down
to 21.4% and after 4 hours of exposure even recovered slightly and maintained a 34.5% survival
(Figure 3.13A). Thus, after observing both strains after 4 hours of exposure to hydrogen
peroxide, pah1∆ cells significantly survived better (p=0.001) than WT (Figure 3.13B). These
results were confirmed further with our serial dilution sensitivity assay. Both WT and pah1∆
cells grew well and were both visible at the 10-10 dilution. However once these strains were
exposed to 1mM hydrogen peroxide, WT was only seen at the 10 -2 dilution, while pah1∆ still
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grew to the 10-10 dilution (Figure 3.14). Taken together, these results confirm that pah1∆
withstands hydrogen peroxide better than WT and is able to resist apoptosis better as well

.
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Figure 3.12: The pah1𝜟 mutant has greater cell survival to H2O2-induced apoptosis than WT after just 2
hours of exposure and even greater after 4 hours.
WT and pah1𝜟 cellular growth on YPD plates after 0, 2 or 4 hours of exposure to 1mM hydrogen
peroxide. All cells were initially grown in synthetic complete medium with 100 μM inositol overnight
and then diluted to an A600nm of 1.0 and grown in SC media with 100 μM inositol and with or without the
addition of hydrogen peroxide. Cell aliquots were collected at predetermined time points and diluted
back again to a starting optical density (A600nm) of 1.0. Three serial dilutions were performed and plated
from the 10-6 dilution for each condition of each strain. YPD plates were grown for 3 days at 30°C.
Plates were repeated in triplicates.
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Figure 3.13: The pah1𝜟 mutant has less sensitivity to hydrogen peroxide and can withstand longer
exposure compared to WT.
WT and pah1𝜟 cellular growth on YPD plates after 0, 2 and 4 hours exposure to 0mM and 1mM acetic
acid. All cells were initially grown in synthetic complete medium with 100 μM inositol overnight and
then diluted to an A600nm of 1.0 and grown in SC+ media with appropriate concentration of acetic acid.
Cells aliquots were collected at predetermined time points and diluted back again to a starting optical
density (A600nm) of 1.0 (to ensure same cell number for each strain). Three serial dilutions were
performed and plated from the 10-6 dilution for each condition of each strain. YPD plates were grown
for 3 days at 30°C. Experiments were repeated in at least triplicates.
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Figure 3.14: The pah1𝜟 mutant has less sensitivity to hydrogen peroxide and can withstand longer
exposure compared to WT.
WT and pah1𝜟 cellular growth on YPD plates after 4 hours of exposure to (A) 0mM hydrogen peroxide,
(B) 1mM hydrogen peroxide. All cells were initially grown in synthetic complete medium with 100 μM
inositol overnight and then diluted to an A600nm of 1.0 and grown in SC media with 100 μM inositol and
with or without the addition of hydrogen peroxide. Cells were collected after 4 hours and diluted back
again to a starting optical density (A600nm) of 1.0 (to ensure same cell number for each strain). Five serial
dilutions were performed and plated for each condition of each strain. YPD plates were grown for 3
days at 30°C. Plates were repeated in triplicates.
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3.2.5 Anti-apoptotic genes are upregulated in pah1∆ cells compared to WT when subjected
to hydrogen peroxide exposure.

Due to the fact that our previous experiments showed that pah1∆ cells are better able to
withstand exposure to apoptotic inducing agents than WT, we wanted to confirm this finding
further. Since pah1∆ cells seem to possess a somewhat anti-apoptotic property compared to WT,
we hypothesized that pah1∆ cells would have higher expression of anti-apoptotic genes than WT.
In order to test this hypothesis, we performed mRNA analysis using genes that have been
previously documented to prevent apoptosis. Cells were grown in SC medium with 100μM
inositol and upon reaching exponential phase about half were collected. The other half of the
cells was then exposed to 1μM hydrogen peroxide for four hours and then collected. Both the
cells that were treated with hydrogen peroxide and those that were collected before treatment
were processed for their RNA and then tested to assess the levels of anti-apoptotic genes.
The first gene that we tested was BIR1, which has an important role in counteracting
apoptosis. It is the only gene in Saccharomyces cerevisiae that belongs to the inhibitor of
apoptosis protein (IAPs) family. Genes in this family are able to modulate caspases which
become activated during apoptosis (Owsianowski et al., 2007). Since it plays a major role in
responding to apoptotic factors, we decided to test it. Results showed that before treatment, both
WT cells and pah1∆ cells exhibited similar expression levels of BIR1 (0.09 ± 0.022 and 0.11 ±
0.023; Figure 3.15). However after exposure to hydrogen peroxide, WT cells had a drastic
decrease in BIR1 expression compared to unexposed levels (0.01±0.001 and 0.09 ± 0.022;
p=0.045). The pah1∆ mutant cells however did not have a decrease in expression. In fact,
expression levels rose when compared to the cells before treatment (0.19 ± 0.051 and 0.11 ±
0.023), however the change was not significant enough to be considered substantial. Even so,
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these findings suggest that pah1∆ mutant cells have significantly greater BIR1 expression after
hydrogen peroxide exposure than WT (0.19 ± 0.051 and 0.01±0.001; p=0.037), which would
give them greater protection against apoptosis.
In order to strengthen this finding further we decided to examine the genes of the
thioredoxin system. The thioredoxin system helps maintain a reduced cellular environment and
consists of thioredoxins that are heat stable proteins which reduce various other proteins and thus
protect against oxidative damage (Grant, 2001; Holmgren, 1989). The cytoplasmic thioredoxin
system of Saccharomyces cerevisiae consists of the thioredoxin encoding genes TRX1 and TRX2,
in addition to TRR1 which encodes for a thioredoxin reductase, an important regulatory enzyme
of the system. Together, these genes protect the cell against oxidative stress by regulating the
redox state of the thioredoxin system. Previous research has shown that deletion of the TRX2
gene leads to extreme sensitivity to hydrogen peroxide (Kuge and Jones; 1994), suggesting its
role in protecting the cells against the reagent. We therefore decided to test these genes and
examine their levels in both WT and pah1∆ mutant cells.
Our results showed that before treatment with hydrogen peroxide, both WT and pah1∆
cells exhibited similar expression levels for TRX2 (0.84±0.23 and 1.04±0.01) and TRR1
(1.04±0.15 and 1.3±0.32). However after exposure to the reagent for four hours, both TRX2 and
TRR1 expression was significantly higher in pah1∆ cells than in WT cells (TRX2: 0.34±0.12 and
4.13 ± 1.29, p=0.05; TRR1: 0.6 ±0.02 and 3.9±1.1, p=0.05). The third gene, TRX1, actually had
higher gene expression levels in pah1∆ cells both before and after treatment of hydrogen
peroxide compared to WT (Figure 3.16A). Thus, our data suggests that the reason pah1∆ cells

95

have greater protection from hydrogen peroxide might be a result of the increase in expression of
the anti-apoptotic gene BIR1 (Figure 3.15) as well as TRX1, TRX2 and TRR1 (Figure 3.16).
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Figure 3.15: WT cells have a decrease in BIR1 gene expression, a gene that is involved in inhibiting
apoptosis, after exposure to hydrogen peroxide, while the pah1Δ mutant maintains levels.
WT cells were grown to mid logarithmic phase (1.0±0.2 A600nm) in 10µM inositol SC media and were
subsequently washed and grown in SC media that contained 100μM inositol and 1μM hydrogen
peroxide for 4 hours. mRNA was then extracted from cells using acid phenol chloroform and purified
further with treatment of DNase. RNA was converted to cDNA and was amplified/quantified using
qPCR with primers targeting the open reading frame sequence of tested gene. Expression levels of
mRNA were normalized to the housekeeping gene ACT1. All experiments were done with at least two
repeat colonies. Data was graphed as a mean ± standard deviation.
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Figure 3.16: The pah1Δ mutant exhibits higher expression levels of genes within the thioredoxin system
compared to WT after hydrogen peroxide exposure.
WT cells were grown to mid logarithmic phase (1.0±0.2 A600nm) in 10µM inositol SC media and were
subsequently washed and grown in SC media that contained 100μM inositol and 1μM hydrogen
peroxide for 4 hours. mRNA was then extracted from cells using acid phenol chloroform and purified
further with treatment of DNase. RNA was converted to cDNA and was amplified/quantified using
qPCR with primers targeting the open reading frame sequence of tested gene. Expression levels of
mRNA were normalized to the housekeeping gene ACT1. All experiments were done with at least two
repeat colonies. Data was graphed as a mean ± standard deviation.
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3.3 Discussion
In the yeast Saccharomyces cerevisiae, PAH1 has been shown to be an important gene in
the lipid biosynthetic pathway. In an attempt to better characterize its role as a regulator as well
as determine the effect of the two crucial phospholipid precursor molecules, inositol and choline,
on its function we employed a number of experiments including growth curve analyses and time
course RNA analysis via qRT-PCR for both the wildtype strain and the pah1∆ mutant strain.
Growth curve experiments showed that while both strains grew well in media containing
various concentrations of inositol and choline, the pah1∆ mutant always seemed to grow a little
bit better. This effect was specifically significant however when cells were grown in the presence
of either 100μM inositol or 100μM choline with some inositol present. This indicated the
importance of these molecules in the increased growth of the pah1∆ strain. In addition, the
greater growth pattern of pah1∆ is most probably due to the fact that many of the genes involved
in phospholipid biosynthesis are unregulated when PAH1 is deleted and thus leads to greater
growth.
RNA analysis confirmed the role of the PAH1 gene as a negative regulator in the lipid
biosynthetic pathway. The following genes were examined in the lipid biosynthetic pathway to
see the effect that the deletion of PAH1 caused on their expression levels: DPP1, LPP1, APP1,
TGL3, TGL4, TGL5, DGA1, CDS1, PIS1, INO1, INM1, HXK2, and POL1. Most of these genes
were chosen due to their close proximity to PAH1 in the lipid biosynthetic pathway. POL1, while
not in the lipid biosynthetic pathway, was chosen to act as the external control since it is a
constitutive housekeeping gene and should not be affected by PAH1. The other genes were
chosen due to their involvement in inositol production, and while INO1 expression had been
looked into previously in respect to the affect PAH1 has on it, the other genes had not been.
100

Results confirmed that UASINO genes upregulate in the pah1∆ strain compared to WT, thus
confirming that PAH1 negatively regulates UASINO genes. This was seen for all UASINO genes
tested in this study. However, our results showed that PAH1 can regulate non-UASINO genes as
well. While most non-UASINO genes showed no significant difference between WT and pah1∆,
some did, including TGL4, thus suggesting that PAH1 can regulate non-UASINO genes.
In addition, the pah1∆ strain did not always respond to the addition of inositol the same
way that WT did. Most genes in the lipid biosynthetic pathway will either upregulate or
downregulate in response to the addition of inositol. While this phenomenon was not seen in
most genes tested, it was seen in a few (PIS1, Figure 3.4B and TGL4, Figure 3.2E). This
suggested that the effect that inositol would usually play in gene expression is canceled out by
the constant upregulation that the pah1∆ mutant causes. Thus, in genes like INO1, which are
involved in the rate limiting step of de novo inositol synthesis (Ford et al., 2007, 2008; Esposito
et al., 2009; Konarzewska et al., 2012) there would be multiple modes of regulation, with PAH1
being just one mode of repression. However there may be other genes that do not possess as
many methods of regulation and whose main regulatory system would rely heavily upon the
repressive role of PAH1, thus being dependent on its function. Therefore, for these genes that
lack the Pah1p repressor, their constant upregulation would be indifferent to the effects of
inositol or other precursors.
Another interesting finding of our RNA analysis showed that one of the genes involved in
inositol synthesis, HXK2, did not have a significant difference in expression in pah1∆, compared
to WT. However once inositol was introduced, only HXK2 levels in WT were upregulated while
those in pah1∆, were not. This led to a significant difference in HXK2 expression level, with
levels in pah1∆ being significantly lower than WT. This was the only gene in our study which
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expressed lower levels in pah1∆ than WT, with all other genes either being upregulated or
remaining comparable to WT.
The lower levels of HXK2 in pah1∆ cells grown with the addition of inositol led us to
believe that these cells would be more susceptible to apoptosis, since HXK2 has been shown to
be involved in preventing apoptosis (Agimoni, 2013). It was therefore quite surprising when
testing this hypothesis, that pah1∆ fared far better than WT at resisting apoptosis. Cell survival
was markedly increased in pah1∆ compared to WT when exposed to high levels of acetic acid.
This result was confirmed again using another apoptotic reagent, hydrogen peroxide. Again,
pah1∆ cell survival was significantly higher than WT when exposed to this apoptotic reagent.
Taken together, these results greatly suggest that pah1∆ cells can withstand apoptosis
much better than WT cells, despite the fact that there are lower levels of HXK2. This finding was
confirmed further when RNA analysis was performed on cells treated with hydrogen peroxide
and then qPCR was conducted to measure mRNA levels of anti-apoptotic genes in WT and
pah1∆ cells. As our hypothesis surmised, RNA levels for anti-apoptotic genes such as BIR1 was
upregulated in pah1∆ cells compared to WT cells after exposure to hydrogen peroxide. Genes in
the thioredoxin system, which protect the cell against oxidative damage, also had higher
expression levels in pah1∆ cells compared to WT. This is an interesting and novel finding, since
this is the first reporting of pah1∆ displaying anti-apoptotic properties. This suggests a whole
new area of study in which PAH1 may be involved in regulating genes involved in the apoptotic
pathway. Further studies would be necessary to directly confirm this relationship and to identify
other genes that would be affected PAH1.
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Chapter 4: Regulation of the PAH1 gene
Regulation of the PAH1 gene
Studies have shown that the PAH1 gene plays a crucial role in lipid homeostasis. PAH1
encodes for the phosphitidate phosphatase that catalyzes the pivotal step in the synthesis of
triacylglycerol. It dephosphorylates PA, which in turn is converted into diacylglycerol, a
molecule which can be used to form triacylglycerides as well as be used in the formation of lipid
droplets. In addition, its impact on PA and the way in which it regulates is abundance, helps
maintain nuclear/endoplasmic reticulum growth. PAH1 has also been shown to be involved in
negatively regulating the lipid biosynthetic pathway as well as maintaining proper protein
trafficking needed for vacuole homeostasis. It therefore plays a pivotal role in not just lipid
metabolism, but on overall cell homeostasis.
While a large extent of research has gone into characterizing the impact of PAH1 on cell
homeostasis, the regulation of the PAH1 gene still needs to be elucidated. The regulation of
Pah1p, the protein product of PAH1, however has greatly been characterized. Studies have
shown the significance of phosphorylation and dephosphorylation deactivating and activating
Pah1p. In order to attain phosphatase activity, Pah1p must be dephosphorylated and in order to
be deactivated it must be phosphorylated (Santos-Rosa et al., 2005). Thus, phosphorylation and
dephosphorylation play a major role in the regulation of Pah1p.
Few studies however have looked into the factors that impact PAH1 gene regulation,
though recent developments have found a few important conditions in which PAH1 expression is
impacted. Research has shown that the PAP activity encoded by the PAH1 gene is affected by
intracellular levels of zinc. Zinc is an essential nutrient in yeast and higher eukaryotes and tight
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regulation of its intracellular levels is wielded through the use of zinc transporters. Thus, if there
is a deficiency in zinc, there is an induction of activity of these transporters as well as a change in
the composition of membrane phospholipids (Soto-Cardalda, 2012). PAH1 contains zincresponsive upstream activating sequences in its promoter region, which becomes the binding site
of Zap1p, a protein which binds there when zinc levels deplete, thus inducing transcription of the
PAH1 gene. As a result, PAH1 is induced when zinc levels decrease.
Additionally, a study by Pascual et al. has found that the crucial phospholipid precursor,
inositol, can cause the upregulation of the PAH1 gene expression as well, but only in the
stationary phase of growth (Pascual et al., 2013). The reason why this is so interesting is because
many genes usually become impacted by this crucial precursor within a few hours of being
introduced to it in the growth medium. For instance, as was shown in chapter 3, INO1 gene
expression responds to inositol within just 60 minutes of exposure. We therefore wanted to
elucidate the role of inositol in upregulating the PAH1 gene. RNA analysis is a very effective
method in determining transcription rates, and while other studies have shown the Pah1p protein
levels to increase in the stationary phase, PAH1 transcriptional activity has yet to be looked at.
We therefore wanted to further clarify the extent to which PAH1 was being induced by inositol
based on the stage of growth. In addition, no one has yet compared the multiple inducing factors
and determined which had the strongest effect on the upregulation of PAH1. We therefore want
to find the best condition under which PAH1 would be upregulated.
Furthermore, the importance of PAH1 on fat regulation has been proven to be crucial for
cell homeostasis (Han et al., 2007, Adeyo et al., 2011; Sasser et al., 2012; Soto-Cardalda et al.,
2012). Therefore, insight into the different ways in which PAH1 is regulated is crucial for a
better understanding of how this gene functions. One area of study that has yet to be looked at in
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terms of PAH1 gene regulation is the chromatin remodeler activity at the PAH1 promoter.
Chromatin remodelers perform one of the most significant roles in modulating gene expression.
They play a crucial role in modifying and restructuring the nucleosome, one of the most basic
levels of DNA packaging that consists of DNA wrapped around eight histone proteins (Clapier
and Cairns, 2009). As such chromatin remodelers are responsible for making the highly
packaged DNA accessible so that transcription can occur. They therefore play an essential role in
the regulation of gene expression. Here, we intended to identify which chromatin remodelers
play a role in PAH1 gene expression. In order to address this question, growth curves of
chromatin remodeler deletion strains were conducted to show the importance of these remodelers
on cell growth. Next, we performed real time PCR on both WT and chromatin remodeler
deletion strains using the PAH1 primer to assess PAH1 expression levels. This was followed by
chromatin immunoprecipitation to determine the presence of the remodeler at the PAH1
promoter region.
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4.1 Materials and Methods
4.1.1 RNA analysis: Total mRNA preparation and quantification
WT and pah1Δ cells were grown from a single colony until mid-logarithmic phase (0.8
A600) in SC media with 10μM myo-inositol, followed by an additional two hours in the presence
of 100μM myo-inositol. RNA was extracted from yeast cells through acid phenol (pH 4.3)
chloroform extraction in which the cells were resuspended in TES (10mM EDTA; 10mM TrisHCl pH 7.5; 0.5% SDS), and then incubated at 65°C with equal parts acid phenol for 60 minutes.
This was followed by a five-minute incubation on ice before centrifugation at 4°C. The top layer
of the sample was transferred to a new test tube and mixed with equal parts acid phenol for a
second time. Samples were incubated on ice for 5 minutes before centrifugation at 4°C and then
separated by transferring the top layer of the sample to a fresh test tube and mixing with equal
parts chloroform. Samples were centrifuged, then separated again from their bottom layer and
transferred to a new test tube. Ethanol precipitation was then performed by adding 1 mL of 100%
ethanol and 40μL of 3M NaOAc to the sample. The samples were then stored in dry ice for 20
minutes, followed by a fifteen-minute centrifugation. The supernatant was discarded and pellets
were washed in ethanol (70%) and centrifuged again for three minutes. The supernatant was
removed and the pellets were left to dry for 10 minutes. This was followed by resuspending the
pellets in RNA sample buffer. RNA concentration was quantified by reading absorbance at
260nm (A260). Subsequently, total RNA was stored at -80oC until further use.
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4.1.2 DNase Treatment of RNA samples

DNase treatment was performed to remove any DNA from the isolated RNA samples.
RNA was mixed with 10X buffer (0.1 M Tris-HCl pH 8, 5mM CaCl2 and 0.025M MgCl2),
DNase, and DEPC water. Samples were placed in 37°C water bath for 60 minutes, followed by
phenol:chloroform extraction. A 3:1 ratio of phenol:chloroform was added to the samples, mixed
and then placed on ice for a five minute incubation. Samples were then centrifuged for 10
minutes and then the top layer was transferred to a new test tube to be used for ethanol
precipitation. Ethanol (100%) and 20μL of 3M NaOAc were added to supernatant, mixed and
then placed on dry ice for 20 minutes. Samples were centrifuged for 13 minutes, followed by
removal of supernatant, and a washing of the pellet in 70% ethanol. This was followed by
centrifugation and the removal of the supernatant. Pellets were placed in a speed vacuum to dry
and then resuspended in TE buffer that was prepared using DEPC water. RNA concentration was
again quantified by reading absorbance at 260nm.

4.1.3 Preparation of cDNA: First Strand Synthesis

In order to prepare the cDNA needed for qRT-PCR, the SuperScript III First Strand
Synthesis SuperMix kit from Invitrogen (Catalog: 11752-050) was used. The reaction was
performed using a polymerase chain reaction (PCR) thermocycler. Each DNase free mRNA
sample (1 μg) was mixed with 2x RT Reaction mix, RT enzyme mix, and DEPC water. Samples
were placed in the PCR thermocycler and underwent the reaction using the following
thermocycler program: ten-minute incubation at 25°C, 30 minute incubation at 50°C, and 5
minute incubation at 85°C. Samples were then cooled on ice for a few minutes before adding E.
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coli RNase H and then placed in a 37°C waterbath for 20-30 minutes. First strand synthesis
samples were stored at -20°C until further use.

4.1.4 Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)

The cDNA prepared from first strand synthesis was amplified and quantified using qRTPCR. The SYBR GreenER® qPCR Supermix universal kit from Invitrogen (catalog number:
11762-500) was used to quantify cDNA templates. Forward and reverse primers were used that
targeted the open reading frame (ORF) in the qPCR reaction. Primers used in this study are
shown in Figure 4.1 and Table 4.1.
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Table 4. 1: List of primers used for qRT-PCR for RNA analysis
PAH1 primers
Forward:
Reverse:

5’CCACTTGCATCGCCAAAACT ‘3
5’ TAGTCGCGGCTGCAGAAGAT‘3

ACT1 primers
Forward :
Reverse:

5’ CCAAGCCGTTTTGTCCTTGT ‘3
5’ ACCGGCCAAATCGATTCTC ‘3

Figure 4.1: Primers used in qPCR experiment.
Forwards and revers primers used in mRNA experiments to target the ORF of PAH1 and ACT1 genes.

109

4.1.6 Growth experiment for the chromatin remodeler deletion strains.

WT, snf2Δ, and ino80Δ yeast strains (Table 4.2) were grown in SC media (synthetic
complete media) in the presence and absence of 100μM of myo-inositol. Strains were all started
at an optical density (A600) of around 0.2. Growth experiments were performed in duplicates,
where the optical density of the cells was measured every two hours for the first eight hours and
then again at the 24th hour until stationary phase was reached. Cells were grown at 30°C.
Calculations:
The average of the 24th hour OD readings for each strain and condition was used in the
calculation to derive the average number of cell generations for that specific cell type:
Average # of generations = [(log# of cells at the end of 24 hours – log# of cells at the start of 24
hours)/log(2)]
This was followed by determining the generation time in minutes/generation using the average #
of generations:
Generation time (min/gen) = [(60min/hr * 24)/number of generations in 24 hours]
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Table 4. 2: Yeast strain genotypes used in Chapter 4
Strains

Genome type

WT (BY4741)

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0

pah1Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pah1Δ

snf2Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 snf2Δ

ino80Δ

MATa ino80Δ::trp1 his3Δ200 leu2Δ0 met15Δ0 trp1Δ63 ura3Δ0
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4.1.5 Chromatin immunoprecipitation (ChIP)
4.1.5.1 Cell Preparation and Crosslinking

ChIP was performed on WT strain (Table 4.2). WT was streaked from a single colony
and grown in 6mL SC media with 10µM myo-inositol until saturation. Cells were transferred to
250mL of SC media with 100µM myo-inositol and grown to stationary phase so that cells would
be harvested in a stage where PAH1 would be induced. Prior to harvesting, cells were crosslinked with formaldehyde for 25 minutes and then quenched with glycine for an additional 5
minutes. Cells were then pelleted, collected and then treated with cell wash buffer (20mM TrisHCl pH8; 200mM NaCl) to be washed. Cells were then stored at -80ºC until they were ready to
be lysed.
4.1.5.2 Lysate Preparation

In order to lyse cells, the pellets were mixed with 400µl of lysis buffer that contained
PMSF (50mM Tris-HCl pH 7.5, 0.15 M NaCl, 1mM EDTA pH 8, 1% Triton X-100, 1.5µM
trichostatin A, 0.2mM PMSF) as well as 0.4µl Protease inhibitor cocktail set III (CalBioChem
Catalog number: 539134). The cells with the lysis buffer mixture were then carefully added to
acid washed glass beads in an Epindorf tube and subsequently vortexed at 4ºC for 20-25minutes.
Cells were then separated from beads by centrifugation at 2K for 10 seconds. The supernatant
was collected and placed in a new test tube so that it could undergo centrifugation at 13K for 15
minutes at 4ºC. Supernatant was discarded and the remaining pellet was mixed with chilled lysis
buffer that did not contain PMSF. Samples were sonicated and then centrifuged at 2K for 60
seconds at 4ºC. Supernatant was then placed in a fresh test tube and stored in -80ºC.
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4.1.5.3 Input Sample Preparation
Elution buffer (1% SDS + 0.1 M NaHCO3) and 5M NaCl were added to the 10μl of
lysate,. Tubes were incubated at 65oC for 4 hrs. Then, 8μl 0.5M EDTA, 16μl 1M Tris HCl pH
6.5 and 1μl Protinase K were added to the tubes and incubated again at 45 oC for 1 hour. After
this, phenol chloroform extraction was performed, followed by the ethanol precipitation. DNA
quantification was done using spectrophotometer.
4.1.5.4 Immunoprecipitation

Sonicated lysates that contained 11μg of total DNA were used for immunoprecipitation
(IP). They were diluted 10-fold in ChIP dilution buffer and incubated with 1µL TSA and 1µL
protease inhibitor cocktail, along with 35 µL protein A agarose slurry. Samples were placed at
4ºC for an hour on a rotation rack to preclear and reduce nonspecific background. They were
then briefly centrifuged at 2K for 15 seconds and the supernatant was transferred to a new
Epindorf tube. Antibodies against Snf2p were added and allowed to incubate overnight. The
negative control samples (mock samples) were not treated with antibodies.
After overnight IP, 60 µL protein A agarose slurry was added to samples and incubated
for one hour. Samples were briefly centrifuged and washed once each with low salt buffer, high
salt buffer, and LiCl solution, respectively. Subsequently, the samples were washed with 1X TE
twice. The protein-DNA complex was eluted from the resin by adding 250µl of freshly prepared
elution buffer and rotated for two fifteen-minute time intervals. The supernatant was collected
after centrifugation and 5M NaCl was added to each test tube to reverse cross-link the samples
by heating them at 65oC for 5-6 hours. Then, 8ul of 0.5 M EDTA, 16ul of 1M Tris-HCl, pH6.5
and 2 µl of Proteinase K was added and incubated for 2 hours at 45oC. The DNA was then
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recovered by phenol/chloroform extraction and ethanol precipitation. Finally, the pellet was resuspended in 20 µl of TE.
4.1.5.5 Quantitative PCR (qPCR)

qPCR was used to quantify the abundance of DNA fragments that were bound by the
protein of interest. Mock and input samples were also tested. Input samples were prepared as all
the DNA sequences in the genome from the lysate of the cell without any selection or IP. Mock
samples were prepared exactly as IP samples, just without the addition of an antibody to be used
to subtract out any background signal. qPCR was performed using the Applied Biosystems, 7500
real-time PCR system). Forward and reverse primers were used that target different areas of the
URS and ORF in the qPCR reaction. Primers used in this study are shown in

Figure 4.2 and

Table 4.3.
IP samples were calculated as follows:
(2^-(IP Ct # – mock Ct #) – (Input Ct # – mock Ct #)) *(A260 * 50 µg/mL * 50 dilution factor)
The IP samples were then graphed as an average of repeats ± standard deviation that was then
normalized to mock and input samples.
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Table 4.3: List of Primers Used for qPCR (On ChIP samples)

ChIP Primers
PAH1(-600 to -400 base pairs upstream of ORF) primers:
Forward:
5’ CAGTGGGTCTTGTACTTATC 3’
Reverse:
5’ AGTTTGGACCCTGTTCAAG 3’
PAH1(-400 to -200 base pairs upstream of ORF) primers:
Forward:
5’ AGGGTCCAAACTCATCTTGTATATC 3’
Reverse:
5’ GTCCTTGCTCTTCCTTCTACC 3’
PAH1(-200 to -1 base pairs upstream of ORF) primers:
Forward:
5’ AGAAGGAAGAGCAAGGACAA 3’
Reverse:
5’ AATCGACCGATGTGTCTATC 3’
PAH1 ORF primers:
Forward:
5’ ATGCAGTACGTAGGCAGAG 3’
Reverse:
5’ GCTTCTCCAGAATCACTCAG 3’
*Used for Input, IP, and Mock samples

Figure 4. 2: PAH1 URS Map and Primers used for qPCR on ChIP samples.
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4.2 Results
4.2.1 PAH1 is induced under various conditions, with greatest induction occurring during
stationary phase with 100µM inositol added to media.

In order to find the conditions in which PAH1 gene expression is induced we started off
by performing RNA analysis. Since the impact of a gene’s effect on the cell is greatest when the
gene is at its highest expression level, it was important to find the conditions at which the gene is
induced before we looked into other regulatory factors. Previous studies have shown that the
PAH1 promoter region includes both a UASZRE (Soto-Cardalda, 2012) as well as a UASINO
(Wimalarathna, 2011), indicating that both zinc and inositol impact the induction of PAH1. In
fact, studies have demonstrated that the removal of zinc from growth media as well as addition
of inositol and entry into stationary phase cause PAH1 to become upregulated. However, there
has been no study comparing these conditions to determine which of these factors cause the
highest upregulation of PAH1. This information is crucial, since all other experiments will rely
on this information so that PAH1 can be expressed at its maximum expression level. To confirm
the best conditions of PAH1 induction, we conducted RNA analysis to measure PAH1
transcription levels in WT cells grown in various environments. These environments included
cells grown in regular SC media and were compared to those grown in SC media without zinc.
Cells were also grown in SC media containing various concentration of inositol during
exponential phase and were compared to cells grown in SC media with various concentrations of
inositol during stationary phase. The RNA of these cell samples were isolated, subjected to
DNase treatment to remove any DNA, and subsequently used to perform quantitative reverse
transcriptase polymerase chain reaction (qRT-PCR) by turning the mRNA into cDNA. For
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repressing and inducing conditions, the results were examined at the open reading frame (ORF)
of PAH1 and were subsequently normalized to the housekeeping gene ACT1.
The first factor that we tested was the impact of zinc on PAH1 gene expression. The
RNA levels demonstrated a significant difference (p=0.04) between cells grown with zinc versus
those grown without, with the cells grown in media lacking zinc to have higher PAH1 expression
levels (Figure 4.3). Our results clearly showed that zinc is a negative regulator to PAH1
expression. These findings are in agreement with previous results (Soto-Cardalda et al., 2012).
Next, we compared the levels of PAH1 in cells grown with normal zinc levels, but with
100µM inositol added. Cells were collected in both the exponential phase and stationary phase of
cell growth. Again, PAH1 RNA levels demonstrated a significant difference (p=0.001) between
cells collected in exponential phase and those in stationary phase. PAH1 was substantially
upregulated in stationary phase compared to levels in exponential phase (Figure 4.4). This too
was in agreement with previous findings (Pascual et al., 2013). However, the true test was to
determine which of the above conditions (Figure 4.3, Figure 4.4) had the greatest impact on
PAH1 levels. When compared, it can be seen that cells grown with 100µM inositol and collected
in stationary phase were significantly higher than cells grown in media without zinc (0.017 ±
0.0004 and 0.0056 ± 0.00061; p=0.023) (Figure 4.5). This novel finding demonstrated that while
PAH1 can be upregulated in various environments, it is most highly induced when cells enter
stationary phase and have excess inositol in their media.
In order to further clarify our finding we wanted to determine whether it was the inositol
or the growth stage that most greatly impacted PAH1 expression. We therefore performed
additional RNA analysis of PAH1 gene expression in cells grown in various concentrations of
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inositol in both exponential and stationary phases. The results showed that while PAH1 was
induced during the stationary phase in all cells that have inositol, they are significantly induced
during the stationary phase when in the presence of 100µM inositol, a condition that contains
excess amounts of inositol (Figure 4.6).
While differences in PAH1 expression are seen in the stationary phase based off of the
amount of inositol present, the same could not be said for the exponential phase of growth. The
various concentrations of inositol had no impact on PAH1 levels in exponential phase, thus
demonstrating that it is the growth phase that plays a more significant role in PAH1 gene
induction than the inositol. However, it seems that in order for induction to occur, at least some
inositol must be present in the media. Cells that were grown without inositol did not show a
significant change in PAH1 levels in exponential versus stationary phase (Figure 4.6). These data
therefore demonstrate that the highest level of PAH1 expression is found in cells that have
entered the stationary phase of growth and are grown with excess inositol.
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Normalized mRNA level (PAH1/ACT1)

0.01

p = 0.04

0.008

0.006

0.004

0.002

0

With Zinc

Without Zinc

Figure 4.3: PAH1 is induced in growth environments that do not contain zinc.
WT cells were grown to mid logarithmic phase (1.0±0.2 A600nm) in 10µM inositol SC media and were
subsequently washed and grown in either regular SC media (which contains zinc) or SC media lacking
zinc. mRNA was then extracted from cells using acid phenol chloroform and purified further with
treatment of DNase. RNA was converted to cDNA and was amplified/quantified using qPCR with
primers targeting the open reading frame sequence of PAH1. Expression levels of mRNA were
normalized to the housekeeping gene ACT1. All experiments were done with at least two repeat colonies
and all qPCR reactions were done in triplicates. Data was graphed as a mean ± standard deviation.
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Figure 4.4: PAH1 gene expression is significantly induced in cells grown to stationary phase with 100µM
inositol and normal levels of zinc.
WT cells were grown to mid logarithmic/exponential phase and stationary phase in 100µM inositol SC
media and collected. mRNA was then extracted from cells using acid phenol chloroform and purified
further with treatment of DNase. RNA was converted to cDNA and was amplified/quantified using
qPCR with primers targeting the open reading frame sequence of PAH1. Expression levels of mRNA
were normalized to the housekeeping gene ACT1. All experiments were done with at least two repeat
colonies and all qPCR reactions were done in triplicates. Data was graphed as a mean ± standard
deviation.
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Figure 4.5: PAH1 gene induction is significantly higher in cells grown to stationary phase with 100µM
inositol compared to cells grown without zinc.
WT cells were grown in 10µM inositol SC media and were subsequently washed and grown in either SC
media lacking zinc grown to mid logarithmic phase or SC media containing 100µM inositol grown to
stationary phase. mRNA was then extracted from cells using acid phenol chloroform and purified
further with treatment of DNase. RNA was converted to cDNA and was amplified/quantified using
qPCR with primers targeting the open reading frame sequence of PAH1. Expression levels of mRNA
were normalized to the housekeeping gene ACT1. All experiments were done with at least two repeat
colonies and all qPCR reactions were done in triplicates. Data was graphed as a mean ± standard
deviation.
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Figure 4.6: PAH1 gene induction is significantly higher in cells grown to stationary phase with 100µM
inositol compared to cells grown with less inositol in stationary phase.
WT cells were grown in 10µM inositol SC media and were subsequently washed and grown in various
concentrations of inositol (0, 10, 100 µM) and collected in both exponential and stationary phases.
mRNA was then extracted from cells using acid phenol chloroform and purified further with treatment
of DNase. RNA was converted to cDNA and was amplified/quantified using qPCR with primers
targeting the open reading frame sequence of PAH1. Expression levels of mRNA were normalized to the
housekeeping gene ACT1. All experiments were done with at least two repeat colonies and all qPCR
reactions were done in triplicates. Data was graphed as a mean ± standard deviation.
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4.2.2 Snf2p and Ino80p are crucial chromatin remodelers for INO1 expression, a gene
regulated by PAH1.

Since we found that the best inducing condition to upregulate the PAH1 gene was under
stationary phase with excess inositol, we wanted to use this information to find possible
chromatin remodelers that impact PAH1 gene expression. Chromatin remodelers play a crucial
role in modifying and restructuring the nucleosome, one of the most basic levels of DNA
packaging that consists of DNA wrapped around eight histone proteins. As such chromatin
remodelers are responsible for making the highly packaged DNA accessible so that transcription
can occur. We therefore wanted to look into possible chromatin remodelers that may affect
PAH1 gene expression. Since inositol plays a role in PAH1 upregulation, we decided to look at
the two chromatin remodelers which are important for INO1 expression, Snf2p and Ino80p.
INO1 is the gene responsible for the rate limiting step of de novo inositol synthesis. Thus, since
PAH1 is impacted by inositol, it is likely that it would have the same remodelers as INO1.
Additionally, since INO1 is highly regulated by PAH1, as was shown in our first aim (Figure
3.3A), we hypothesize that that they would use the same remodelers to help keep gene
expression in check.
We therefore decided to first demonstrate the importance of SNF2 and INO80 in inositol
production by doing growth curve analysis. WT, snf2∆ and ino80∆ strains were grown in either
SC media that was depleted of inositol or contained 100μM inositol and observed until stationary
phase was reached. Results showed that all strains grew well in conditions that contained excess
inositol. WT, snf2Δ and ino80Δ strains all exhibited optical densities that were higher than 5.5 at
hour 24 (A600 of 5.8±0.28, 6.3±0.00, and 5.65±0.08, respectively; Figure 4.7A) and all had
similar numbers of generations and generation times (Table 4.4). However, cell growth in media
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depleted of inositol showed vastly different results for the mutants. WT cells grew slightly
poorer in 0μM inositol conditions than in 100μM inositol, with an A600 of 4.65±0.35 (Figure
4.6B). However, snf2∆ and ino80∆ strains were unable to properly grow in conditions that
lacked inositol and had extremely low optical densities (A600 of 0.37±.07 and 0.30±.08,
respectively) as well as incredibly long generation times (Table 4.4). The difference between
snf2∆ cells grown in excess inositol and those grown without inositol was a staggering 85.4%
difference in growth rate and the difference for ino80∆ was even higher at 90% (Table 4.5). The
difference between WT cells grown without inositol and snf2∆ cells grown without inositol was
82.7% and the difference between WT and ino80∆ under inositol depletion was 87.65% (Table
4.6). Thus, these results demonstrate that the Snf2p and Ino80p chromatin remodelers play a
critical role in inositol production, since without their presence inositol is unable to be
synthesized and cells cannot grow properly. As such, they may be involved in PAH1 regulation
which is induced by inositol.
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Growth Curve Analysis
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Figure 4.7: snf2Δ and ino80Δ have moderate to severe reductions in growth when grown without
inositol, indicating the important role of the Snf2p and Ino80p chromatin remodelers in INO1
activation.
A) WT, ino80Δ, and snf2Δ cells were grown in 10μM inositol SC media and were then washed and
diluted to an Absorbance600nm of 0.2 in SC media that represented either the inducing or repressing
conditions. Cells were grown in both inositol depleted media (inducing condition for the INO1 gene) or
inositol rich media that contained 100μM inositol (repressing condition). The optical density (A600nm)
was read for first 8 hours of exponential phase and then resumed at 24 hours and taken until stationary
phase was reached. B) Graph depicting only the 0μM inositol conditions.
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Table 4.4: 24th Hour Growth Analysis
Average O.D
0μM Inositol
Condition (24th Hour)
WT
4.65±0.35
snf2∆
0.37±0.07
ino80∆
0.30±0.08

Average O.D
100μM Inositol
(24th Hour)
5.8±0.28
6.3± 0.00
5.65±0.08

# of generations in # of generations in Generation Time
24 hours for 0μM 24 hours for
(min/generation)
Inositol
100μM Inositol
for 0μM Inositol
4.054135952
4.372989908
355.1928246
0.717671781
4.873428869
2006.488257
0.525143372
5.098220942
2742.108303

Generation Time
(min/generation) for
100μM Inositol
329.2941512
295.4798436
282.4514701

Table 4.5: Comparison of growth differences between 0μM Inositol to 100μM Inositol
Strain Comparison
Change in cell doubling time (Folds) Differnce in growth rate %
Wild Type 0μM Inositol Wild Type 100μM Inositol
1.079154012
7.33%
snf2Δ 0μM Inositol
snf2Δ 100μM Inositol
7.38541158
85.40%
ino80Δ 0μM Inositol
ino80Δ 100μM Inositol
11.55788708
90.01%

Table 4.6: Comparison of growth differences between strains in 0μM Inositol
Strain Comparison
Wild Type 0μM Inositol
Wild Type 0μM Inositol
snf2Δ 0μM Inositol

snf2Δ 0μM Inositol
ino80Δ 0μM Inositol
ino80Δ 0μM Inositol

Change in cell doubling time (Folds) Differnce in growth rate %
6.05231592
82.70%
8.977775579
87.65%
1.450415783
30.27%

Table 4.7: Comparison of growth differences between strains in 100μM Inositol
Strain Comparison
Change in cell doubling time (Folds) Differnce in growth rate %
Wild Type 100μM Inositol snf2Δ 100μM Inositol
1.117487271
10.32%
Wild Type 100μM Inositol ino80Δ 100μM Inositol
1.170583464
14.34%
ino80Δ 100μM Inositol snf2Δ 100μM Inositol
1.047222226
4.51%
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4.2.3 The snf2∆ mutant, but not the ino80∆ mutant, exhibits lower PAH1 expressions levels
than WT during stationary phase, suggesting a possible role of Snf2p as an activator of
PAH1 expression.

Once we confirmed the importance of Snf2p and Ino80p in inositol production we set out
to determine whether these chromatin remodelers actually impact PAH1 gene expression. We
accomplished this by employing RNA analysis and looked at PAH1 expression in WT, ino80∆,
and snf2∆. Cells were grown in 100μM inositol and were subsequently collected in both
exponential phase and stationary phase. Cells were collected in both phases so that we could
examine PAH1 expression in PAH1’s induced state.
Results showed that PAH1 expression levels were comparable between WT and the
ino80∆ mutant. While there is a significant difference within each strain between exponential
phase and stationary phase for both WT (0.0028±0.0002 and 0.0085±0.0019; p=0.05) and
ino80∆ (0.0045 ±0.0012 and 0.0141±0.0009; p=0.01), there was no significant difference in
PAH1 levels between the two strains in either exponential phase or more importantly in
stationary phase (Figure 4.8). Thus, these findings suggest that Ino80p does not play a role in
PAH1 activation.
Yet while Ino80p did not seem to play a role in PAH1 expression, the other chromatin
remodeler that we focused on, Snf2p, does seem to play a role. Our RNA results for PAH1 gene
expression in WT and the snf2∆ mutant show that PAH1 levels in the snf2∆mutant is
significantly lower than that in WT (0.0075±0.001 and 0.004±0.0007; p=0.022) during stationary
phase (Figure 4.9). Since PAH1 has the highest expression level in stationary phase when
inositol is present, this suggests that Snf2p is involved in PAH1 activation, since PAH1 levels are
significantly lower in the snf2∆ mutant, where Snf2p is not present.
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Figure 4.8: The ino80Δ mutant exhibits similar PAH1 gene expression levels to WT for both stationary
and exponential phases.
WT and ino80Δ mutant cells were grown to mid logarithmic phase as well as stationary phase in 100µM
inositol SC media. mRNA was then extracted from cells using acid phenol chloroform and purified
further with treatment of DNase. RNA was converted to cDNA and was amplified/quantified using
qPCR with primers targeting the open reading frame sequence of tested gene. Expression levels of
mRNA were normalized to the housekeeping gene ACT1. All experiments were done with at least two
repeat colonies and all qPCR reactions were done in triplicates. Data was graphed as a mean ± standard
deviation.
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Figure 4.9: The snf2Δ mutant exhibits lower PAH1 gene expression levels than WT at the stationary
phase.
WT and snf2Δ mutant cells were grown to mid logarithmic phase as well as stationary phase in 100µM
inositol SC media. mRNA was then extracted from cells using acid phenol chloroform and purified
further with treatment of DNase. RNA was converted to cDNA and was amplified/quantified using
qPCR with primers targeting the open reading frame sequence of tested gene. Expression levels of
mRNA were normalized to the housekeeping gene ACT1. All experiments were done with at least two
repeat colonies and all qPCR reactions were done in triplicates. Data was graphed as a mean ± standard
deviation.
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4.2.4 Snf2p is present at the PAH1 promoter.

Since our RNA results suggested that the chromatin remodeler Snf2p plays a role in
PAH1 activation, we wanted to confirm this finding further by detecting Snf2p at the promoter
region of PAH1. This was done by performing chromatin immunoprecipitation (ChIP), a process
by which proteins associated with specific regions of DNA are pulled down and targeted with an
antibody. In order to do this, we used a Snf2p antibody to pull down the Snf2p that was bound to
DNA in WT cells and employed quantitative real time PCR to examine the presence of Snf2p at
the PAH1 promoter region under inducing conditions.
Primers targeting multiple locations of the upstream regulatory sequence (URS) and the
open reading frame (ORF) of PAH1 were used and IP signals from qPCR were normalized to the
PAH1 input and mock samples. Since Snf2p should be mainly found at the promoter region, the
ORF primers served as our external control. Our results showed minimal IP signals at the ORF
region. However, there was a significant increase in IP signals in the promoter region that
covered the region of -1 to -200 base pairs upstream of the ORF in the PAH1 gene (p<0.01)
suggesting that Snf2p is present in that region (Figure 4.9). Furthermore, IP signals increased
even more drastically from the -200 to -400 base pair region compared to the ORF (p=0.027),
suggesting that Snf2p accumulates mainly in this region of the PAH1 promoter. Lastly, there was
an increase of IP signal found at the -400 to -600 base pair region upstream that was significantly
greater than signals found at the ORF (p=0.02), however the increase in IP signal was not nearly
as high as those found at -200 to -400 base pairs upstream. This therefore implies that Snf2p is
present at the -400 to -600 base pair region of the PAH1 promoter, but not to the same extent as
is found at -200 to -400 region (Figure 4.10). Taken together, these findings suggest that Snf2p is

130

found throughout the PAH1 promoter, but is most heavily concentrated at the region of -200 to 400 base pairs upstream of the ORF and is therefore involved in PAH1 gene induction.
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Figure 4.10: Snf2p is present at the PAH1 promoter region.
Quantitative real time PCR (qPCR) analysis of DNA from WT cells that was immunoprecipitated via
the process of chromatin immunoprecipitation (ChIP). WT cells were grown to stationary phase in
100µM inositol SC media, cross-linked, lysed, and quantified. This was followed by
immunoprecipitation with an antibody against Snf2p. The IP for the PAH1 promoter was graphed as
the average of the repeat samples ± standard deviation. It was normalized via the input samples (all of
the genomic DNA sequences from the collected lysate without any selection or immunoprecipitation)
and the mock samples (samples that represent the signal background, since all the ChIP steps were done
on these lysate samples but no antibody was added, thus theoretically having no immunoprecipitated
DNA).
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4.3 Discussion
Due to the fact that the PAH1 gene plays a pivotal role in the lipid biosynthetic pathway
and acts as a key regulator of many of these genes, it was important to get a better understanding
of how it itself is regulated. While there had previously been some research done to help clarify
this, not enough had been done to help define the parameters in which PAH1 was best induced.
Since this information is crucial for studying a gene, especially when experiments need to be
performed at peak gene expression, it was critical to determine the best inducing condition for
PAH1. In addition, no one had yet looked into the chromatin remodelers that affect PAH1 gene
expression. Since chromatin remodelers play a crucial role in modifying and restructuring the
nucleosome they therefore play an essential role in the regulation of gene expression. It was
therefore an important aspect of gene regulation that we wanted to examine in PAH1.
Through RNA analysis and qPCR, we were able to define the best condition for PAH1
gene induction. While PAH1 expression is significantly upregulated in response to the depletion
of the essential mineral zinc (Figure 4.3), it paled in comparison to the effects of high
concentrations of inositol and the stationary phase on PAH1 gene expression (Figures 4.4 and
4.5). While the stationary phase of growth had a greater impact on PAH1 induction than inositol
alone, since cells grown with excess inositol and collected in exponential phase did not have an
expression of PAH1 nearly as high, the two conditions combined gave the highest levels of
PAH1 transcription (Figure 4.6). Taken together, these results showed that while there may be
various conditions under which PAH1 is induced, it is most greatly induced when cells are grown
in excess inositol and have entered stationary phase.
Both the depletion of zinc and the addition of excess inositol in stationary phase were not
unlikely factors to induce the PAH1 gene. This is because the PAH1 promoter region contains
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both a UASINO ((Wimalarathna, 2011) as well as three upstream activating sequence zincresponsive elements (UASZRE) (Soto-Cardalda, 2012). The UASINO is the inositol sensitive
upstream activating sequence located in the promoter region of many genes in the lipid
biosynthetic pathway and is the binding site for activators such as Ino2p and Ino4p in response to
a need for inositol, while the three UASZRE are the binding sites for zinc responsive transcription
factors that localize under conditions of zinc deficiency (Soto-Cardalda, 2012). Thus, the
depletion of zinc or addition of inositol is recognized by these sites upstream of the PAH1 gene
and therefore upregulate in response to this condition.
Once we verified the inducing conditions of the PAH1 gene, we wanted to look into
which chromatin remodelers played a significant role in regulating PAH1 gene expression.
Chromatin remodeling plays one of the most important roles in gene regulation. Remodelers are
responsible for modifying and restructuring the nucleosome, one of the most basic levels of
DNA packaging that consists of DNA wrapped around eight histone proteins (Clapier and
Cairns, 2009). As such chromatin remodelers are responsible for making the highly packaged
DNA accessible so that transcription can occur. They therefore play an essential role in the
regulation of gene expression. Being that this is an area that has yet to be looked into in regard to
PAH1 expression, we therefore wanted to look into possible chromatin remodelers that may
affect PAH1 gene expression.
Since inositol plays such an important role in PAH1 upregulation in stationary phase cells
(Figure 4.6), we decided to look at the two chromatin remodelers that impact INO1 expression,
which is the gene responsible for the rate limiting step of de novo inositol synthesis, to see if they
might impact the PAH1 gene as well. These chromatin remodelers are Snf2p and Ino80p.
Another reason why we chose to look into these two chromatin remodelers was because PAH1
134

has been shown to regulate the INO1 gene (Figure 3.2A). It therefore may be possible that they
would use the same remodelers as another means to help keep gene expression in check. We
therefore decided to first demonstrate the importance of Snf2p and Ino80p in inositol production
by doing growth curve analysis using WT, snf2∆, and ino80∆ strains grown in both inducing and
repressing conditions. Growth analysis showed that while all strains grew well in media that
contained excess inositol (100μM), only the wild type strain grew well when no inositol was
present. Both snf2∆ and ino80∆ strains were unable to grow under inositol depleted conditions
(Figure 4.7B). This was due to the fact that in order to activate the INO1 gene, both Snf2p and
Ino80p chromatin remodelers had to be functional and present in order to activate INO1 and
allow transcription to begin. Thus when inositol was present and INO1 did not need to operate,
all strains grew fine. Yet when no inositol was present, the snf2∆ and ino80∆ strains were unable
to grow since INO1 was unable to activate.
Once we confirmed the crucial role of Snf2p and Ino80p chromatin remodelers in INO1
gene activation, we wanted to see if they played a role in regulating PAH1 as well. In order to do
this, we employed RNA analysis and studied PAH1 gene expression in the snf2∆ and ino80∆
strains and compared them to those in WT. Results showed that PAH1 expression levels in the
ino80∆ strain were similar to that in WT, specifically levels in the stationary phase, the phase in
which PAH1 gene expression is induced under excess inositol conditions (100μM inositol).
Thus, our findings suggested that Ino80p does not play a role in PAH1 gene regulation.
However, results from the snf2∆ mutant RNA analysis exhibited a significant change in
expression levels between the mutant strain and WT. The expression levels of PAH1 were
significantly reduced in the stationary phase of snf2∆ compared to that in WT suggesting that
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Snf2p plays a role in activating the PAH1 gene. This is a novel finding since there has been little
to no research conducted on PAH1 regulation in regard to factors that affect chromatin structure.
In order to confirm this finding further, we performed ChIP analysis to detect the
presence of Snf2p at the promoter region of PAH1 and to locate where on the promoter region it
specifically localizes. Our data showed that IP levels were significantly higher in the PAH1
promoter region than at the ORF, suggesting that Snf2p is present throughout the promoter
region but is most concentrated between the region of -200 to -400 base pairs. Interestingly,
PAH1 contains an upstream activating sequence zinc-responsive element (UASZRE) at the -200 to
-210 base pair region. This falls in the region in which we saw the highest IP values for the
presence of Snf2p at the PAH1 promoter. As mentioned earlier, the UASZRE is the binding sites
for zinc responsive transcription factors that localize under conditions of zinc deficiency (SotoCardalda et al., 2012). Since the depletion of zinc is a factor that induces PAH1 gene expression,
it would seem likely for Snf2p to localize in this region in order to aid in the activation process.
Taken together, our data suggests that Snf2p is present at this crucial region of the PAH1
promoter (-200 to -400 base pairs) and we hypothesize that the reason it accumulates there is
because when activation is necessary it makes the chromatin accessible where the UAS ZRE is
located and allows for further activation. Moreover, the second region with the highest IP values
(-400 to -600 base pairs) contains a UASINO at -585 to -593 of the PAH1 promoter region
(Wimalarathna et al., 2011). The UASINO is the inositol sensitive upstream activating sequence
located in the promoter region of many genes in the lipid biosynthetic pathway and is the binding
site for activators such as Ino2p and Ino4p in response to inositol. Since the addition of inositol
in the stationary phase is another factor that induces PAH1 gene expression, the presence of
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Snf2p at this location seems likely as well. Thus, our data suggests that the presence of the Snf2p
chromatin remodeler at the PAH1 promoter seem to be in regions where activation is necessary.
Interestingly, Snf2p is one of the chromatin remodelers important for INO1 regulation.
INO1 is one of the most crucial genes in inositol production and happens to be heavily regulated
by PAH1. PAH1 acts by repressing the INO1 gene. As was determined in Figure 3.3A, the pah1∆
strain has upregulated levels of INO1, thus confirming that when Pah1p is present it acts as a
repressor of INO1. Taken together, these findings suggest another mode by which PAH1 affects
INO1 expression, by possibly using the same remodeler to help keep gene expression in check.
We therefore hypothesize another model in which PAH1 control INO1 gene expression. If INO1
needs to be activated, the Snf2p chromatin remodeler will collect at the INO1 promoter, leaving
less of the remodeler available for PAH1 activation, which will then lessen the repressive role of
Pah1p on INO1. Conversely, if PAH1 is activated, more Snf2p will be localized at the PAH1
promoter region, forcing more away from INO1 and thus decreasing the activity of the INO1
gene. This model therefore suggests an additional way in which PAH1 can control INO1
expression.
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Chapter 5: The effect of PAH1 upon vacuolar morphology and V-ATPase pump activity
The effect of PAH1 upon vacuolar morphology and V-ATPase pump activity.
The role of the PAH1 gene in maintaining cell homeostasis has been shown to be quite
extensive. In addition to regulating the phospholipid biosynthetic pathway, its effect on various
organelles has been shown to be crucial. For instance, PAH1 plays a role in maintaining normal
nuclear and endoplasmic reticulum membrane morphology. When PAH1 is deleted, abnormal
expansion of the nuclear endoplasmic reticulum membrane occurs in the cell (Santos-Rosa et al.,
2005). This is due to the fact that many genes in the lipid biosynthetic pathway upregulate when
PAH1 is unavailable to repress them, and as such, cause an increase in membrane expansion. Yet
another organelle that is greatly impacted by the PAH1 gene is the vacuole. Morphological
studies have shown that pah1Δ cells exhibit a change in vacuolar morphology, with vacuoles
appearing fragmented as compared to WT (Sasser et al., 2012).
While vacuole fragmentation is a normal part of cell homeostasis and occurs in WT cells
prior to cell division, abnormal fragmentation is caused by defects in lipid synthesis. Under
normal conditions, vacuoles fragment and partition in yeast cells so that during daughter cell
formation, the newly budded cell can receive the organelle (Conradt et al., 1992). This is due to
the fact that in Saccharomyces cerevisiae , cytoplasmic organelles are not synthesized by the
daughter cell, but inherited from the mother. Thus, upon bud initiation, the main vacuole in the
mother cell will fragment into a collection of smaller vacuoles (Figure 5.1). A tubule-vesicular
structure develops from these smaller vacuoles and directs itself toward the newly budding
daughter cell (Conradt et al., 1992). In this way, the organelle is transferred and inherited by the
new cell. As the budding cell increases in its size, the small group of vacuoles starts to fuse back
into one large vacuole, both in the mother and daughter cells. Lastly, the cells form septa, which
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separate the two cells from each other. This cycle of vacuole fragmentation can then begin again
to be given to new daughter cells (Wiemken et al., 1970).
This process however is heavily impacted by the lipid biosynthetic pathway. Defects in
lipid metabolism are associated with abnormal vacuole fragmentation and disruptions in vacuolar
function. PAH1 has recently emerged as a key gene that influences proper vacuole morphology.
Its deletion has been associated with abnormal vacuole fragmentation, with vacuoles unable to
fuse back together. One study has shown that the lack of Pah1p phosphatase activity prevents the
binding of SNARES and is devoid of components of the HOPS tethering complex needed for
vacuolar fusion (Sasser et al; 2012). Thus, vacuolar morphology is implicated in pah1∆ mutant.
On the other hand, irregular vacuole morphology has also been related to atypical vacuolar
acidification as a result of dysfunctional V-ATPase pumps. Studies have shown that some
phenotypes of mutant cells with abnormal vacuoles include vacuole fragments that collect to one
area or disperse all over the cell. These cells can have working V-ATPase pumps or have a
defect in the assemblage of the V-ATPase pump (Weisman et al., 1987; Raymond et al., 1992).
Therefore, it is possible that PAH1 may affect the vacuole or may implicate the V-ATPase pump
and thus alter its morphology through the regulation of lipid biosynthesis.
In eukaryotic cells, vacuolar proton translocating ATPases (V-ATPases) play an
important role in acidifying the vacuole. They span the membrane of the vacuole and are quite
large, consisting of two main subunits, an integral one and a peripheral one (Figure 5.2). Their
role in vacuole homeostasis is essential as they regulate the pH by actively transporting
hydrogens from the cytoplasm into the organelle and thus maintain their acidic pH (pH ~6.0)
which allows it to carry out its normal physiological activities. There are 13 genes needed to
properly assemble the V-ATPase (Table 5.1). If any of them are implicated, the pump will be
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unable to function properly. Interestingly, irregular vacuolar morphology has also been related to
atypical vacuolar acidification as a result of V-ATPase pumps that are not functional. Some of
the phenotypic characteristics include vacuoles that are fragmented. Since fragmented vacuoles
is a phenotype that is also seen in pah1Δ cells, and is this phenotype is often associated with
dysfunctional V-ATPase pumps there is a possibility that PAH1 can negatively impact one or
more genes of the V-ATPase pump.
Although it has been shown that PAH1 plays an important role in lipid synthesis and may
affect the vacuole through V-ATPase pump activity, to date, little research has been done on the
effect of PAH1 on V-ATPases. We therefore wanted to better understand how Pah1p affects
vacuolar morphology and its functional activity. In order to test this, electron microscopy was
performed to visualize the morphological changes of the vacuole in the absence of Pah1p. While
there are many types of microscopy that can detect differences in cellular structure, electron
microscopy is one of the best types to visualize morphological differences. To date, it has yet to
be used to look at vacuolar morphology in pah1Δ cells. Subsequently, RNA analysis of VATPase pump genes were examined followed by calcium chloride and pH sensitivity assays.
Lastly, we concluded our experiments by measuring vacuolar pH, in order to gauge the ability of
the V-ATPase pump to acidify the vacuole. This was followed by RNA analysis of other fusion
genes in the lipid biosynthetic pathway that could affect the vacuole.
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A)

B)

Figure 5.1: Vacuole fragmentation in Saccharomyces cerevisiae
A) Diagram illustrating vacuolar development in Saccharomyces cerevisiae (Konarzewska, 2015) B) EM
image of budding yeast cell with fragmented vacuole.
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Figure 5.2: Vacuolar proton translocation ATPase diagram.

Table 5.1: V-ATPase encoding genes (Konarzewska, 2015).

Subunit

Molecular
mass
(kDa)

Integral or
peripheral

VMA1
VMA2
VMA4
VMA5
VMA7
VMA8
VMA10
VMA13

A
B
E
C
F
D
G
H

69
60
27
42
14
32
16
54

peripheral
peripheral
peripheral
peripheral
peripheral
peripheral
peripheral
peripheral

ATP binding subunit
ATP binding subunit
Assembly of V1 and V0
Activation of V-ATPase
Assembly of V1 and V0
Assembly of V1 and V0
Activation of V-ATPase
Activation of V-ATPase

VPH1
VMA3
VMA6
VMA11
VMA16

a
c
d
c'
c''

100
165
36
17
23

integral
integral
peripheral
integral
integral

H+ transport
H+ transport
Assembly of V1 and V0
H+ transport
H+ transport

Gene

Proposed function

V1

V0
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5.1 Materials and methods
5.1.1 Vacuolar Morphology: Electron Microscopy
WT and pah1∆ were grown from a single colony until mid-logarithmic phase
(exponential phase) and stationary phase in SC media with 0.002% (w/v) of myo-inositol. Cells
were fixed with glutaraldehyde, calcium chloride, and sodium cacodylate buffer for one hour on
ice. The fixative was removed and cells were washed twice with the sodium cacodylate buffer .
Cells were then treated with lyticase for about 30 minutes at room temperature to break open the
cell wall. Following, cells were washed with buffer and then treated with osmium tetroxide for
two hours on ice. They were then washed with the buffer and left overnight in 4°C. The next day,
cells were dehydrated with 50%, 60%, and 70% ethanol, followed by an overnight incubation
with 70% ethanol and 3% uranyl acetate reagent. Cells were washed with 80%, 90%, and 100%
ethanol, followed by two incubations/washes with propylene oxide. A 1:1 ratio of propylene
oxide and resin was added, followed by fresh resin to embed and placed in the oven to set.
Samples were cut into ultra-thin sections and prepared for imaging using the Leica UCT
Ultramicrotome. EM microscopy was performed using the Fei Technai Spirit Transmission
Electron Microscope.
5.1.2 RNA analysis: Total mRNA preparation and quantification
WT and pah1Δ cells (Table 3.1) were grown from a single colony until mid-logarithmic
phase (0.8 A600) in SC media with 10μM myo-inositol, followed by an additional two hours in
the presence of 100μM myo-inositol. RNA was extracted from yeast cells through acid phenol
(pH 4.3) chloroform extraction in which the cells were resuspended in TES (10mM EDTA;
10mM Tris-HCl pH 7.5; 0.5% SDS), and then incubated at 65°C with equal parts acid phenol for
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60 minutes. This was followed by a 5 minute incubation on ice before centrifugation at 4°C. The
top layer of the sample was transferred to a new test tube and mixed with equal parts acid phenol
for a second time. Samples were incubated on ice for 5 minutes before centrifugation at 4°C and
then separated by transferring the top layer of the sample to a fresh test tube and mixing with
equal parts chloroform. Samples were centrifuged, then separated again from their bottom layer
and transferred to a new test tube. Ethanol precipitation was then performed by adding 1 mL of
100% ethanol and 40μL of 3M NaOAc to the sample. The samples were then stored in dry ice
for 20 minutes, followed by a 15 minute centrifugation. The supernatant was discarded and
pellets were washed in ethanol (70%) and centrifuged again for three minutes. The supernatant
was removed and the pellets were left to dry for 10 minutes. This was followed by resuspending
the pellets in RNA sample buffer. RNA concentration was quantified by reading absorbance at
260nm (A260). Subsequently, total RNA was stored at -80oC until further use.

5.1.3 DNase Treatment of RNA samples

DNase treatment was performed to remove any DNA from the isolated RNA samples.
RNA was mixed with 10X buffer (0.1 M Tris-HCl pH 8, 5mM CaCl2 and 0.025M MgCl2),
DNase, and DEPC water. Samples were placed in 37°C water bath for 60 minutes, followed by
phenol:chloroform extraction. A 3:1 ratio of phenol:chloroform was added to the samples, mixed
and then placed on ice for a five minute incubation. Samples were then centrifuged for 10
minutes and then the top layer was transferred to a new test tube to be used for ethanol
precipitation. Ethanol (100%) and 20μL of 3M NaOAc were added to supernatant, mixed and
then placed on dry ice for 20 minutes. Samples were centrifuged for 13 minutes, followed by
removal of supernatant, and a washing of the pellet in 70% ethanol. This was followed by
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centrifugation and the removal of the supernatant. Pellets were placed in a speed vacuum to dry
and then resuspended in TE buffer that was prepared using DEPC water. RNA concentration was
again quantified by reading absorbance at 260nm.
5.1.4 Preparation of cDNA: First Strand Synthesis

In order to prepare the cDNA needed for qRT-PCR, the SuperScript III First Strand
Synthesis SuperMix kit from Invitrogen (Catalog: 11752-050) was used. The reaction was
performed using a polymerase chain reaction (PCR) thermocycler. Each DNase free mRNA
sample (1 μg) was mixed with 2x RT Reaction mix, RT enzyme mix, and DEPC water. Samples
were placed in the PCR thermocycler and underwent the reaction using the following
thermocycler program: 10 minute incubation at 25°C, 30 minute incubation at 50°C, and 5
minute incubation at 85°C. Samples were then cooled on ice for a few minutes before adding E.
coli RNase H and then placed in a 37°C waterbath for 20-30 minutes. First strand synthesis
samples were stored at -20°C until further use.

5.1.5 Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)

The cDNA prepared from first strand synthesis was amplified and quantified using qRTPCR. The SYBR GreenER® qPCR Supermix universal kit from Invitrogen (catalog number:
11762-500) was used to quantify cDNA templates. Forward and reverse primers were used that
targeted the open reading frame (ORF) in the qPCR reaction. Primers used in this study are
shown in Table 5.1.
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Table 5.2: List of primers used for qRT-PCR for RNA analysis
VMA1 primers:
Forward:
5’ GCCGTTTGTCTCGTACCATT 3’
Reverse:
5’ AACATGGGAACCCAACAGAG 3’
VMA2 primers:
Forward:
5’ AACGGAACGTCATGTGTTGA 3’
Reverse:
5’ AGTGATGGACCCGTTACGAC 3’
VMA4 primers:
Forward:
5’ CATTGACGGCAACTTCAAGA 3’
Reverse:
5’ CTTGTACTCGTCCCGGTTGT 3’
VMA5 primers:
Forward:
5’ TAACTTGGCTGCTGCTGAGA 3’
Reverse:
5’ TCAGCATCCTCTGCAATCAC 3’
VMA7 primers:
Forward:
5’ TTATTGTTAGCCGGGATTGG 3’
Reverse:
5’ GTTTTCCGCGATATGTTGGT 3’
VMA8 primers:
Forward:
5’ CTTGGCCGAAGTTTCCTATG 3’
Reverse:
5’ AGATTTCCTTGGCTCGTTGA 3’
VMA10 primers:
Forward:
5’ TGGACTGGTACCTCGTGACA 3’
Reverse:
5’ TCAGTCTTGGCTTGCTTCAA 3’
VMA13 primers:
Forward:
5’ AACTGGCCGTGATACCAGAG 3’
Reverse:
5’ GGGTTAAAGGTCAGCAACCA 3’
VPH1 primers:
Forward:
5’ TTGGTGAAATGATCGCAAGA 3’
Reverse:
5’ TGTGGGTAAACCAGCATTGA 3’
VMA3 primers:
Forward:
5’ TTTCTTTGGTGCCATTGGTT 3’
Reverse:
5’ TGGCAATGATACCAGCCATA 3’
VMA6 primers:
Forward:
5’ TTGCCTACGTTGAGTGTTGC 3’
Reverse:
5’ CAGGTTCCGGAATTTCTTCA 3’
VMA11 primers:
Forward:
5’ GCCATTTATGGGCTTGTTGT 3’
Reverse:
5’ACGTCACCGACCATACCAAT 3’
VMA16 primers:
Forward:
5’ GTGGTTGCCATTTACGGTCT 3’
Reverse:
5’ TACCGACAGCGATACCACAA 3’
ACT1 primers:
Forward:
5’ CCAAGCCGTTTTGTCCTTGT 3’
Reverse:
5’ ACCGGCCAAATCGATTCTC 3’
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FAB1 primers:
Forward:
Reverse:
VPS34 primers:
Forward:
Reverse:
VPS1 primers:
Forward:
Reverse:
ATG18 primers:
Forward:
Reverse:

5’ TCCTCGATAGCAACAGCGAC 3’
5’ GTGCGCGCATAGGAATTCTG 3’
5’ CCCAAGAAGGTGCCATTGA 3’
ACCCAGCCTTGTAGCGGTAA 3’
5’ TCACTGTTGTCGGTTCCCAG3’
5’ TCCCTCGTTCTGGTGCTTTC 3’
5’ GTGGCAACACAGAGACCAGT 3’
5’ TGTTACCGCCGTTACTGCTT 3’

The reaction setup for each sample contained the following: 10μL of SYBR GreenER®
qPCR Supermix, 0.4 μL each of forward and reverse primers, 0.4 μL of ROX reference dye, 1
μL of the cDNA template, and RNA and DNA free water to a volume of 20μL. Samples were
added to a 96 well plate and then sealed and placed in the Applied Biosystems 7500 real time
PCR machine. The program used had a 2 minute incubation at 50°C, followed by 10 minutes at
95°C, and 40 cycles of 15 seconds at 90°C and 1 minute at 60°C. PCR reactions were performed
in triplicates.

5.1.6 Analysis of RNA quantity
A ΔCT value was obtained by subtracting the respective gene CT from the CT value of the
constitutive housekeeping gene (ACT1). Therefore, the relative mRNA levels were expressed as
2^-(ΔCT). Data results were graphed as a mean of the repeats ±standard deviation.
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5.1.7 Growth analysis on SC and YPD plates (CaCl2 and pH)
The yeast strains that were used in this experiment are shown in Table 5.3. Individual
colonies of WT, vma3∆, and pah1Δ were incubated overnight in SC + 100mM inositol media
(dextrose-nitrogen base-amino acids). On the following day, each strain's OD was measured and
then either diluted or concentrated so that all strains contained the same OD for their starting
point. The strains were then diluted 100 fold in SC medium and 5ul of each diluted strain were
plated on SC+ inositol plates that contained 60mM of CaCl2 for the calcium chloride sensitivity
assay and on YPD plates buffered to pH 5.5 and pH 7.0 for the pH sensitivity assay. Plates were
incubated at 30°C for two days before analyzed.

Table 5.3: List of strains used in Chapter 5
Strain

Genome type
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ

WT (BY4741)
vma3Δ
pah1Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Δvma3
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Δpah1

5.1.8 Growth analysis in liquid broth
WT, pah1∆, and vma3Δ cells were grown in SC media containing 100μM of inositol.
Media was buffered to pH 7. Growth experiments were performed in duplicates where the
optical density (OD) of the cells and pH of the growth medium was measured every two hours
for 8 hours and then resumed at 24 hours to 30 hours at 30°C.
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5.1.9 Vacuolar pH analysis
WT, pah1Δ and vma3Δ cells were grown until stationary phase in SC media with 100μM
of inositol buffered to pH 7.0. Cells were then incubated with 1mM of BCECF-AM dye for 30 to
40 minutes at 30°C in the dark. Cells were then spun down, washed twice with media, and
resuspended in fresh media. Cells were then stored on ice. Next, calibration samples were made
for all three strains. Cells with the BCECF dye were incubated with 15μM of nigericin and the
calibration buffers (50mM HEPES , 50mM MES, 10mM 2-deoxyglucose , 50mM potassium
chloride, 50mM sodium chloride, 0.2M ammonium acetate, 10mM 2-deoxyglucose ) that
ranged from pH 5.0 to pH 7.0 for thirty minutes at 30°C. The unknown samples were prepared
by resuspending cells with BCECF with 1mM MES buffer at pH 7. All samples were plated in a
96 well plate. The SpectraMas M5 microplate reader was used to measure the excitation
wavelength (450nm and 490nm) with emission wavelength of 535nm. The calibration curves
were made by taking the ratio of fluorescence at 490nm to 450nm. The fluorescence ratio was
then plotted against pH (Figure 5.3A and 5.3B). Unknown samples were then plotted on standard
curve to determine their pH.

A)
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Figure 5.3: Calibration curve for vacuolar pH determination of cells (WT, pah1∆, vma3∆) grown in pH
7.0 medium. A) Repeat 1 B) Repeat 2.
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5.2 Results
5.2.1 Vacuolar morphology in the pah1Δ strain is distorted in both exponential and
stationary phase cells, resulting in fragmented vacuoles.
A previous study has shown that pah1Δ cells exhibit fragmented vacuoles (Sasser et al.
2012). Unlike WT cells however, pah1Δ cells are unable to bind SNARES and are devoid of
components of the HOPS tethering complex needed for vacuolar fusion. This morphological
defect in the vacuole was exhibited for pah1Δ cells in the exponential phase and was captured
using a Zeiss Axio Observer Z1 inverted microscope. We however confirmed in chapter 4 that
the PAH1 gene is upregulated in the stationary phase of growth when grown in the presence of
100μM inositol. As a result, we wanted to look at the vacuolar morphology of pah1Δ in the
exponential phase of growth as well as the stationary phase and confirm the morphology when
PAH1 is at inducing conditions. In addition, electron microscope (EM) is known for its high
magnification and high resolution properties making it ideal to examine morphological structures
in cells. We therefore decided to use this type of microscopy since it had not been used to
visualize the vacuolar defect in the pah1Δ cells prior to this.
Results showed that while WT cells had many fragmented vacuoles, due to the normal
fragmentation process that occurs in vacuoles during cell division, there was also a good
percentage that contained large singular vacuoles. This was greatly contrasted to the pah1Δ cells,
which mainly exhibited fragmented vacuoles (Figure 5.4A). Both the exponential phase and the
stationary phase displayed vacuoles that were unable to fuse their fragments back together,
demonstrating that the necessary fusion machinery is unavailable in pah1Δ cells no matter at
what stage of growth they are in. This is likely due to the fact that the phosphatase activity
encoded by PAH1 is unavailable in the mutant and as such impacts the lipid biosynthetic
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pathway which produces lipids, such as phosphatidylinositol 3-phosphate, that are required for
SNARE activity and vacuole fusion. However, upon quantification, it was seen that the number
of fragmented vacuoles between WT and pah1Δ cells greatly differed in exponential phase and
stationary phase. In exponential phase, about 74.1% of wild type cells contained fragmented
vacuoles compared to the 96.4% of pah1Δ cells that had fragmented vacuoles (Figure 4.5B). In
stationary phase however, only 49.89% of wild type cells contained fragmented vacuoles, a
significant decrease from exponential phase, while pah1Δ cells contained 97% fragmented
vacuole, a value similar to that in exponential phase (Figure 5.4B). Thus, stationary phase cells
showed a much more significant difference in the number of fragmented vacuoles. This is due to
the fact that in exponential phase, cells are at their peak stage of growth and are constantly
dividing. Thus, our results showed that a large percentage of WT cells had fragmented vacuole in
this stage, due to the normal process of cell division. However, once they reached stationary
phase their growth rate steadied and less cells were dividing, leaving only a smaller number of
cells with fragmented vacuoles. For pah1Δ cells however, their lack of fusion machinery resulted
in fragmented vacuoles in almost all cells regardless of their stage in growth.
Lastly, it should be noted that in accordance with previous studies, a portion of the pah1Δ
cells examined in stationary phase had undergone apoptosis, a phenotype that is seen in pah1Δ
stationary cells as a result of the excess fatty acids that accumulate due to the blockage of TAG
synthesis (Fakas et al.; 2011). We had therefore collected cells just prior to entering stationary
phase, when PAH1 induction has been shown to occur, but there were still cell that already
exhibited the hallmarks of apoptosis.
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Figure 5.4: The pah1∆ mutant strain has fragmented vacuoles in both exponential and stationary phases
of growth, but has a more significant difference in stationary phase when compared to WT.
A) Electron microscopy images of vacuoles in WT and pah1∆ cells in both exponential and stationary
phase. B) Quantification of fragmented vacuoles in all cell lines tested.
WT and pah1∆ were grown in SC media and subsequently washed and collected at exponential phase of
growth and stationary phase. Cells were fixed, treated with lyticase to break open the cell wall, and
treated with additional fixative. They were then dehydrated with 50%, 60%, and 70% ethanol, followed
by an overnight incubation with 70% ethanol and 3% uranyl acetate reagent. Cells were washed with
80%, 90%, and 100% ethanol, followed by two washes of propylene oxide. A 1:1 ratio of propylene
oxide and resin was added, followed by fresh resin, which was placed in oven to set. Samples were cut
and prepared for imaging.
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5.2.2 The effect of PAH1 deletion on genes encoding V-ATPases

Since the morphology of vacuoles in pah1∆ is distorted (Figure 5.4A), we wanted to see
if other functions of the vacuole were implicated as well. One important aspect of vacuolar
homeostasis is the acidification of the vacuole via the V-ATPase pump. In order to maintain an
acidic pH, the V-ATPase pump must be functional. V-ATPases are responsible for transporting
hydrogen ions into the vacuole. This assures that there is an acidic vacuolar interior and that
normal physiological processes that are associated with this organelle can occur. Interestingly
enough, inhibition of V-ATPase function is directly related to a distortion in vacuole
morphology. This distortion occurs as a result of the inability of the V-ATPase pump to function.
V-ATPases thus play a crucial role in the morphology of the vacuole. As such, since pah1Δ cells
have the fragmented vacuole phenotype, we were interested in looking at whether the V-ATPase
pump was implicated. We therefore performed RNA analysis on the genes that encode the
proteins that comprise the V-ATPase pump. Cells were collected right before stationary phase
and their RNA was isolated. We then treated them with DNase and converted the RNA to cDNA
before performing qPCR. Results showed that none of the V-ATPase pump genes were
downregulated or negatively implicated, which would render them transcriptionally inactive
(Figure 5.5). In fact, multiple of these V-ATPase encoding genes actually had an upregulation of
gene expression compared to WT. This is unsurprising given the regulatory role of PAH1 and the
fact that its deletion has been shown to cause an increase in gene expression (Santos-Rosa et al.,
2005). Based off of these results it is likely that the V-ATPase is still able to function properly
since the genes of the pump transcribe just as well or even better compared to WT.
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PAH1 impact on V-ATPase gene expression levels
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Figure 5.5: The pah1∆ cells exhibit higher or similar expression levels of V-ATPase genes to WT, with
no genes being downregulated.
WT and pah1∆ cells were grown to stationary phase in SC media that contained 100μM inositol. mRNA
was extracted from cells using acid phenol chloroform and purified further with treatment of DNase.
RNA was converted to cDNA and was amplified/quantified using qPCR with primers targeting the open
reading frame sequence of tested gene. Expression levels of mRNA were normalized to the housekeeping
gene ACT1. All experiments were done with at least two repeat colonies and all qPCR reactions were
done in triplicates. Data was graphed as a mean ± standard deviation.
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5.2.3 The effects of CaCl2 and pH upon thePAH1 deletion strain
Based off of our RNA findings, it seemed that the V-ATPase pump was not implicated
in pah1Δ cells. In order to confirm this finding further we decided to perform growth analysis
experiments to determine if pah1Δ is able to withstand conditions that cells without functional
V-ATPases cannot. We used vma3∆ as our negative control, since VMA3 is one of the genes that
encodes a portion of the V-ATPase pump and without which will render the pump inactive.
Previous studies have shown that vma3∆ cells were sensitive to CaCl2. This is due to the fact that
cytoplasmic calcium levels are maintained within a physiological range by transporting the
calcium cation into the vacuole via the Ca+2/H+ antiporter. This process is driven by vacuolar
hydrogen ATPases. Mutants that lack functional V-ATPases amass calcium into the vacuole at
slower rates and therefore exhibit minimal growth in the presence of elevated calcium levels as
compared to wild type (Ohya et al., 1991; Clemens et al., 1999; Förster et al., 2000). In addition,
studies have shown that cells that do not have functioning V-ATPases cannot acidify the vacuole
and as such are unable to survive well in high pH conditions. We therefore wanted to examine
whether pah1Δ would follow the same conditional phenotype or would be able to withstand
these conditions rendering their V-ATPases functional. We thus performed a growth sensitivity
assay by conducting a serial dilution experiment using CaCl2 plates as well as a serial dilution
experiment using different pHs as well as a pH growth curve.
For WT cells, we observed that cells grew well on SC plus 100uM inositol plates that
contained 60 mM CaCl2 and that the last visible growth was seen at 108 fold dilution (Figure
5.6A). For the vma3Δ cells, which are sensitive to CaCl2, the last visible growth was at 104 fold
dilution (Figure 5.6A). For the pah1Δ strain, the last visible growth was seen at 106 fold dilution.
The pah1Δ strain was therefore able to grow better than the vma3Δ cells in the presence of
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CaCl2. We then followed this experiment by performing a similar type of sensitivity assay,
except this time used plates that were buffered to a specific pH (pH 5.5 and pH 7.0). Cells that do
not have properly functioning V-ATPases are unable to grow well in non-acidic medium. As
such, we decided to perform growth curve analysis of cells grown in both acidic and neutral
conditions to see whether pah1∆ could handle a more neutral growth environment. Results
showed that all three strains grew well in the more acidic pH, with all reaching the 10 -6 dilution,
and WT extending a little further and reaching the 10-8 dilution (Figure 5.5B). Results differed
vastly though for the pH 7.0 plates. While WT still grew relatively the same and reached growth
at the 10-8 dilution, the vma3∆ mutant was unable to grow at all and exhibited no growth at the
lowest dilution of 10-2 . However, pah1∆ cells grew well and had comparable growth to WT
when it grew on more acidic medium, reaching the 10-6 dilution (Figure 5.6C). Thus, these
results suggest that pah1∆ cells are more similar to WT in regard to a functional V-ATPase.
In order to quantify the above results, we decided to perform a growth curve to measure
optical density of cells grown in different pHs since this condition most clearly exhibited the
difference between pah1∆ cells and vma3∆ cells. Results showed that similar to the serial
dilution plates, all cells grew well in the acidic media that was buffered to pH 5.5 and all had
similar number of generations and generation times (Table 5.6). By the 24th hour of growth
analysis in pH 5.5, WT had 4.2 generations of cells and a generation time of 343.8
minutes/generation. The pah1∆ mutant had 4.6 generations and a generation time of 312.5
minutes/generation and the vma3∆ mutant had 4.7 generations and a generation time of 306.3
minutes/generation (Figure 5.7, Table 5.6). AT pH 7 however the V-ATPase pump had to work
harder and thus cells that did not have properly functioning pumps were unable to survive well.
Results showed that vma3∆ cells that grew in media buffered to pH 7.0 were not able to grow
158

much since they did not have properly functioning V-ATPase pumps. At 24 hours, they only
reached an O.D of 1.2 ± 0.14 and had about 2.4 generations with a generation time of 612.1
minutes/generation. WT cells however grew fine in the more neutral media. At the 24th hour
analysis, they reached an O.D of 5.67 ± 1.46 and had about 4.5 generations with a generation
time of 321.9 minutes/generation (Figure 5.8, Table 5.6). In terms of their growth, they grew
47.4% better than vma3∆ (Table 5.5). Thus, both our negative control and positive control
exhibited expected results. Results for our experimental strain showed that pah1∆ grew fine
under neutral conditions in accordance with our serial dilution experiment. At hour 24, it had an
O.D of 5.03 ± 0.21 and had about 4.98 generations with a generation time of 289.3
minutes/generation. They grew 53.7% better than the vma3∆ mutant did. Thus, pah1∆ exhibited
results that were significantly more similar to WT than to vma3∆ (Figure 5.9). Taken together
with the RNA analysis, these findings suggest that V-ATPase pump activity functions properly
in the pah1∆ mutant despite its morphological abnormalities.
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Figure 5.6: The pah1∆ cells exhibit cellular growth more similar to WT than to vma3∆ when grown in
the presence of CaCl2 and neutral pH.
WT, pah1𝜟, and vma3∆ cellular growth on A) SC+inositol plates containing 60mM CaCl2 B) YPD plates
buffered to pH 5.0 and C) YPD plates buffered to pH 7.0. Cells were diluted to same O.D and dive serial
dilutions were performed and plated for each strain. YPD plates were grown for 3 days at 30°C.
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Figure 5.7: The pah1∆ mutant strain grows well in pH 5.5 media, similar to WT and vma3∆ cells.
WT, pah1∆, and vma3∆ were grown in SC media and subsequently washed and diluted to an optical
density (OD) of 0.2 in SC media with 100 µM inositol buffered to pH 5.5. The OD was then taken every 2
hours for the first 8 hours and then grown overnight and resumed at the 24th hour and continued until
stationary phase.

Table 5.4: Growth rate percentage and fold change for cells grown in pH 5.5 media
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Growth Curve in pH 7 Medium
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Figure 5.8: The pah1∆ mutant strain grows well in pH 7.0 media and exhibits similar growth pattern to
WT, unlike vma3∆ which does not grow well.
WT, pah1∆, and vma3∆ were grown in SC media and subsequently washed and diluted to an optical
density (OD) of 0.2 in SC media with 100 µM inositol buffered to pH 7.0. The OD was then taken every 2
hours for the first 8 hours and then grown overnight and resumed at the 24th hour and continued until
stationary phase.

Table 5.5: Growth rate percentage and fold change affected by pH change to pH 7.0
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Figure 5.9: The pah1∆ cells grow fine in pH 7.0 media, heavily suggesting that they do not implicate the
v-ATPase pump.
WT, pah1∆, and vma3∆ were grown in SC media and subsequently washed and diluted to an optical
density (OD) of 0.2 in SC media with 100 µM inositol buffered to pH 7.0. The OD was then taken every 2
hours for the first 8 hours and then grown overnight and resumed at the 24th hour and continued until
stationary phase.

Table 5.6: pH Growth Experiment 24th Hour analysis

Average O.D Average O.D
pH 5.5
pH 7.0
# of generations in # of generations in 24
Condition (24th Hour) (24th Hour) 24 hours for pH 5.5
hours for pH 7.0
Wild Type 4.875±0.275
5.67±1.46
4.18820875
4.47331573
pah1Δ
6.5±0.173
5.03±0.208
4.60778945
4.976927447
vma3Δ
6.067±0.153
1.2±0.141
4.700908133
2.352536159
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Generation Time
(min/generation)
for pH 5.5
343.8224038
312.5142795
306.3237909

Generation Time
(min/generation)
for pH 7.0
321.9088674
289.3351401
612.1053633

5.2.4 The pah1∆ strain exhibits a vacuolar pH that is significantly similar to WT and not
vma3∆ cells.
The CaCl2 and pH sensitivity assays and growth analyses suggested that the vma3∆ VATPase pump was not negatively implicated by the deletion of the PAH1 gene, despite the fact
that morphology is altered. In order to further confirm these results and characterize the vacuole
conditions in pah1∆ better, the vacuolar acidification assay was employed. This assay was used
to measure vacuolar pH to fully confirm the functionality of the pump. The experiment was
performed in media that was neutral in pH (pH 7.0) since at these conditions the pump would
have to continuously work to acidify the vacuole. The assay was performed on cells entering the
stationary phase of growth (with 100µM inositol) since this is when PAH1 induction is at its
peak.
Results showed that WT cells that were grown in media buffered to pH 7.0 maintained the
acidic pH of their vacuoles and remained within the normal physiological pH range of 5.5-6.2.
The vacuolar pH measured for the WT vacuoles was 6.0± 0.07. The pH measured for the
vacuoles of vma3Δ, our negative control, however was not within the normal range. They had an
average vacuolar pH of 6.6 ± 0.11, confirming that these cells were unable to maintain the
acidity required and were defective in vacuolar acidification at pH 7. The vacuolar pH measured
in pah1Δ cells however was 5.9 ± 0.03 and fell within the normal range of acidic pH values for
the vacuole (Figure 5.10). These results suggest that acidification is well maintained in pah1Δ
cells when grown in an extracellular environment that is neutral. They are thus similar to WT in
this respect and did not show any significant difference in pH value (p=0.11). The pah1Δ cells
however did show a significant difference to vma3Δ cells (p=0.0066), whose vacuoles were
unable to properly acidify in a more neutral to basic growth environment. These finding
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therefore suggest that V-ATPase pump functioning is not affected in pah1Δ cells despite the fact
that vacuolar morphology is distorted.
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Figure 5.10: The pah1∆ cells exhibit a vacuolar pH similar to WT, indicating that v-ATPase pump
activity is not affected by deletion of PAH1.
WT, pah1∆, and vma3∆ were grown in SC media with 100µM inositol and subsequently washed and
diluted and grown overnight in SC media with 100 µM inositol buffered to pH 7.0. Cells were grown to
stationary phase, spun down, diluted to same cell number and treated with BCECF dye. Cells were
grown for 40 minutes at 30ºC and then collected and washed. Calibration samples in a range of pHs
were prepared and incubated for 40 minutes with nigericin. Experimental and calibration samples were
plated on 96 well plate. The excitation wavelength at 450nm and 490nm with emission wavelength of
535nm was measured using the SpectraMas M5 microplate reader. Calibration curve was generated by
calculating the ratio of fluorescence at 490nm to 450nm for each calibration sample.
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5.2.5 Upregulation of genes involved in vacuolar fusion and fission may play a role in the
fragmented vacuole phenotype in pah1∆.

Since our previous findings indicated that vacuolar acidification is unaffected in the
pah1∆ mutant, we decided to look into other genes involved in vacuolar fusion that may be
affected. There are a number of different genes that are employed and necessary for proper
vacuolar fission and fusion to occur. Some of the key genes involved in this process include
VPS1, a gene which encodes a dyamin like GTPase that generates force which supports the
progression of fission (Rooji et al., 2010), and VPS34, a phosphatidylinositol (PI) 3-kinase
encoding gene that synthesizes PI-3-phosphate, a lipid necessary for vacuolar fission and fusion
(Herman and Emr, 1990). In addition, FAB1 encodes for the vacuolar membrane kinase which
produces phosphatidylinositol (3,5)P2, a step which is crucial for vacuole vesiculation, while
ATG18 helps regulate Fab1p activity (Cooke et al., 1998; Zeiger and Mayer; 2012). Since these
genes play a crucial role in vacuolar homeostasis, we decided to examine their expression levels
in pah1∆ cells to see if PAH1 affects their expression levels and could thus be a contributing
factor to the mutant vacuole phenotype.
Results showed that for all four genes tested, expression was upregulated in pah1∆cells
compared to WT in stationary phase (Figure 5.11). The upregulation of these genes in
pah1∆cells was not surprising given our previous findings that PAH1 negatively regulates many
genes in the biosynthetic pathway. However what was surprising was to find that genes such as
VPS34 was overexpressed, despite the fact that previous research has found the vacuole to be
devoid of multiple components of the fusion machinery, including Vps34p (Sasser et al., 2012).
These findings therefore suggest that the inability of vacuolar fusion does not arise from a defect
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in v-ATPase gene expression or the downregulation of these genes, but is rather a recruitment
issue of proteins that are unable to be brought to the vacuole.
In addition, our results also yielded another possible explanation as to why there is an
increased amount of vacuole fragmentation in pah1∆. Interestingly, the deletion of FAB1 in
previous studies has been shown to cause an inability of the vacuole to fragment, denoting its
important role in the fission process (Weisman, 2003; Zieger and Mayer, 2012). Thus, cells with
this defect only contain single enlarged vacuoles. This phenotype is also seen with the deletion of
VPS34 and ATG18 (Zieger and Mayer, 2012). It is therefore possible that the upregulation of
these genes as compared to WT can contribute to the fragmented phenotype since their
overexpression would lead to increased fission.
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Figure 5.11: Upregulation of vacuolar fission genes in the pah1∆ strain.
WT and pah1∆ cells were grown to stationary phase in SC media that contained 100μM inositol. mRNA
was extracted from cells using acid phenol chloroform and purified further with treatment of DNase.
RNA was converted to cDNA and was amplified/quantified using qPCR with primers targeting the open
reading frame sequence of tested gene. Expression levels of mRNA were normalized to the housekeeping
gene ACT1. All experiments were done with at least two repeat colonies and all qPCR reactions were
done in triplicates. Data was graphed as a mean ± standard deviation.
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5.3 Discussion
The effect of PAH1 and the phosphatase enzyme it encodes is not merely limited to the
lipid biosynthetic pathway. Research has shown that its influence is actually widespread
throughout the cell and impacts multiple organelles. One such organelle is the vacuole. While it
has been documented that vacuolar morphology is implicated in the pah1∆ cell and exhibits a
fragmented vacuole phenotype (Sasser et al.; 2012), limited information is available on how else
PAH1 affects vacuole homeostasis. Since normal vacuolar morphology is compromised in the
pah1∆ mutant we therefore wanted to test if other factors involved in vacuolar homeostasis are
affected. Many times, atypical vacuole morphology is connected to irregular vacuolar
acidification as a result of dysfunctional V-ATPase pumps. Studies have shown that some
phenotypes of mutant cells with abnormal vacuoles include vacuole fragments that collect to one
area or disperse all over the cell. These cells can have working V-ATPase pumps or have a
defect in the assemblage of the V-ATPase pump (Weisman et al., 1987; Raymond et al., 1992).
Since PAH1 plays such an important role in lipid synthesis, it could affect the V-ATPase pump
and thus alter its morphology. In additional, overall vacuole homeostasis could be impacted. We
therefore wanted to look into these other factors that implicate vacuolar morphology and see if
PAH1 affects them.
In order to test this, we started off by performing electron microscopy on the pah1∆
mutant to characterize the vacuole phenotype. This was important for two reasons. First,
previously published studies have only imaged cells in the exponential phase of growth.
However, as was determined by earlier experiments (Chapter 4), PAH1 is induced in stationary
phase of growth when grown with excess inositol. We therefore wanted to characterize the
phenotype not only in exponential phase, but also during PAH1’s highest induction stage, which
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is during stationary phase. Secondly, there has yet to be any published studies imaging vacuolar
morphology for pah1∆ cells using electron microscopy. Since this form of microscopy is
renowned for its high resolution and magnification and can clearly capture detail of cell
structure, we decided to employ it.
Our results showed that while WT cells had normal fragmentation of the vacuole due to
the process of cell division, many cells also contained large singular vacuoles in both exponential
and stationary phases of growth. This greatly differed from the vacuoles seen in pah1∆ in which
vacuoles were fragmented. This phenotype was found in both exponential and stationary phases
of growth for pah1∆, demonstrating that the lack of PAH1 phosphatase activity directly impacts
vacuole fusion regardless of an increased induction of PAH1 in the stationary phase. This is
unsurprising since even in exponential phase, PAH1 transcription is still active, though not to the
extent it is at during stationary phase. Still, the lack of PAH1 means that the phosphatase activity
encoded by it is unavailable and as such impacts the lipid biosynthetic pathway which produces
lipids, such as phosphatidylinositol 3-phosphate, that are required for SNARE activity and
vacuole fusion. Thus, both exponential and stationary phase cells in pah1∆ exhibit the
fragmented vacuole phenotype. It should also be noted that another difference between cells in
both phases of growth was that there were a number of pah1∆ cells that had undergone apoptosis
in stationary phase. This is due to the toxic buildup of fatty acids that occurs in the mutant since
PAH1 is unavailable to convert PA into DAG which eventually is converted into TAG.
Therefore, even though we collected cells slightly prior to stationary phase, some cells
underwent apoptosis.
Once we confirmed the morphological distortion of the vacuoles of pah1∆ cells, we set
out to determine if the V-ATPase pump is implicated. In order to do this, we performed RNA
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analysis on the genes which encode the necessary proteins that make up the pump.
Downregulation or unavailability of just one gene will essentially make the pump inactive so it
was important to test all genes in the study. Results showed that not only were RNA levels
comparable to that of WT, some genes were even upregulated (Figure 5.5). This result was not
surprising since our previous findings have shown that the deletion of PAH1 causes the
upregulation of many genes in the lipid biosynthetic pathway. However, it suggested that VATPase pumps were functional, based off of the RNA analysis.
In order to confirm the above finding, we performed sensitive assays and growth curve
analysis using conditions that cells without functional V-ATPases would not be able to
withstand. These conditions include higher concentrations of CaCl2 in growth medium as well as
a more neutral to basic pH. We used the vma3∆ as our negative control, since VMA3 is one of the
genes that encodes for a protein of the V-ATPase pump. Results showed that while WT grew
fine in 60mM CaCl2 and vma3∆ did not, the pah1∆ mutant grew fairly well. Results were even
stronger when cells were grown in varying pHs. While all cells grew well in the acidic pH 5.5
media, only vma3∆ did not grow well in pH 7.0. The pah1∆ mutant grew just as well in pH 7.0
as it had in pH 5.5, similar to WT. This was yet again confirmed when we performed growth
curve analysis and actually quantified the serial dilution using optical density. Therefore, our
results heavily suggested that V-ATPases are functional in the pah1∆ mutant despite the
morphological distortion of the vacuole.
In order to verify our findings and characterize the vacuolar condition of pah1∆ we
performed one last experiment to show that the V-ATPase pump in pah1∆ mutant is not
negatively implicated and can function properly. We employed a vacuolar pH assay in which we
measured the internal pH of the vacuole to determine whether or not the pump was able to
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perform acidification. Results showed as we expected. While vma3∆ vacuoles did not fall into
the normal acidic vacuolar pH range of 5.5-6.2 when cells were grown in pH 7.0 media, both
WT and pah1∆ did. This therefore confirmed our previous findings and validated our conclusion
that the V-ATPase pumps in pah1∆ function as they should and are not implicated as a result of
the fragmented phenotype. Thus, individual fragments of the vacuole each have properly
functioning V-ATPases.
Since our findings indicated that vacuolar acidification is unaffected in the pah1∆ mutant
and that overall vacuole function is seemingly not impacted, we decided to look into other genes
involved in vacuolar fusion and fission that may be implicated and could cause the fragmented
phenotype. Results showed that for all four genes tested, expression was upregulated in
pah1∆cells compared to WT in stationary phase (Figure 5.11). The upregulation of these genes
in pah1∆cells was not surprising given our previous findings that PAH1 negatively regulates
many genes in the biosynthetic pathway. These findings therefore suggest that the inability of
vacuole fusion does not arise from a defect in gene expression or the downregulation of these
genes needed, but is rather a recruitment issue of proteins that are unable to be brought into the
vacuole. In addition, our results also yielded another possible explanation for the increased
amount of vacuole fragmentation in pah1∆. Interestingly, the deletion of FAB1 in previous
studies has been shown to cause an inability to fragment, which denotes its important role in the
fission process (Weisman, 2003; Zieger and Mayer, 2012). Thus, cells with this defect only
contain single enlarged vacuoles. This phenotype is also seen with the deletion of VPS34 and
ATG18. It is therefore possible that the upregulation and the overexpression of these genes as
compared to WT, can contribute to the fragmented phenotype, regardless of their absence in the
vacuole. Future studies therefore can be performed to confirm this hypothesis and connect the
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overexpression of these genes to vacuolar fragmentation in the pah1∆ mutant as well as other
impacts it may have on the cell.
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Chapter 6: Concluding Remarks
Concluding Remarks
Our study has looked into three important areas with respect to PAH1. We have
elucidated the ways in which it impacts the lipid biosynthetic pathway, the modes in which it
itself is regulated, and the influence it has on vacuolar morphology and function. Future areas of
study include further elucidating the role that PAH1 plays in regulating apoptosis and as well as
identifying additional mechanisms of control over PAH1, such as the histone modifying enzymes
involved. Overall, the findings of this thesis can be used to further understand the functional role
of PAH1 and can provide insights into the ways in which PAH1 affects cell homeostasis.
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Abstract
In yeast, PAH1 plays an important role in cell homeostasis and lipid biosynthesis. Here,
we showed that PAH1 is most greatly induced at the stationary stage compared to other induction
conditions. Subsequently, we observed that the absence of Pah1p leads to unusual upregulated
expression of certain V-ATPase genes and a more acidic vacuole internal environment,
suggesting an important role for Pah1p in maintaining the V-ATPase pump. These observations
provide evidence for PAH1 induction and its role in vacuolar acidification. As such, we provide
evidence which describes novel insight into the role of PAH1 in vacuole homeostasis.

Key words: PAH1; vacuole; V-ATPase; fragmentation; pump activity; acidic pH.
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Introduction
The regulation of phospholipid composition in membranes is essential for correct cellular
growth and development (Cardozo-Gizzi and Caputo, 2013). Saccharomyces cerevisiae is a
common model system used to better understand phospholipid synthesis and its regulation. There
are four main phospholipids found in Saccharomyces cerevisiae, including phosphatidylinositol,
phosphatidylserine, phosphatidylethanolamine, and phosphatidylcholine (Carman and Henry,
1999; Santos-Rosa et al., 2005). The synthesis of these and other phospholipids, as well as
membrane biogenesis in general, is mainly regulated by the crucial phospholipid precursors,
inositol and choline (Kelley et al., 1988; Dowd et al., 2001; Boumann et al., 2006; Gaspar et al.,
2006). PA phosphatase (PAP) enzymes are responsible for catalyzing the reaction that
dephosphorylates PA, which in turn produces DAG and a phosphate group (Figure 1A) (Han et
al, 2007). This reaction is crucial in lipid biosynthesis, since DAG can be used to either generate
triacylglycerol (TAG), which stores energy and fatty acids in lipid droplets or can be used to
generate the phospholipids, phosphatidylethanolamine (PE), and phosphotidylcholine (PC) via
the Kennedy pathway (Siniossoglou, 2009). The concentrations of PA and DAG are crucial in
maintaining the production of phospholipid levels, as well as determining the types of
phospholipids that are synthesized (Pascual and Carman, 2012). Since PAP enzymes are
responsible for regulating PA and DAG levels, they play a critical role in regulating the lipid
biosynthetic pathway.
While Saccharomyces cerevisiae contain four PAP enzymes, PAH1 encodes for the PA
phosphatase, Pah1p, which is the only PAP enzyme responsible for de novo TAG and
phospholipid synthesis (Han et al., 2006; O’Hara et al., 2006). It is part of a subfamily of PA
phosphatases that depend on the presence of Mg2+ for proper function (Han et al., 2006) and are
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found in higher organisms as well including flies, worms, plants, mice and humans (Golden et
al., 2009; Nakamura et al., 2009; Han and Carman, 2010; Eastmond et al., 2011; Ugrankar et al.,
2011; Fang et al., 2014). Since it is a PAP enzyme, Pah1p is necessary for catalyzing the key
step of dephosphorylating PA to form DAG.
The role of the PAH1 in maintaining cell homeostasis has been shown to be quite
extensive. Yet one organelle that is greatly impacted by the PAH1 gene is the vacuole.
Morphological studies have shown that pah1Δ cells exhibit a change in vacuolar morphology,
with vacuoles appearing fragmented as compared to WT (Sasser et al., 2012). While vacuole
fragmentation is a normal part of cell homeostasis and occurs in WT cells prior to cell division,
abnormal fragmentation is caused by defects in lipid synthesis. Under normal conditions,
vacuoles fragment and partition in yeast cells so that during daughter cell formation, the newly
budded cell can receive the organelle (Conradt et al., 1992). This is due to the fact that in
Saccharomyces cerevisiae, cytoplasmic organelles are not synthesized by the daughter cell, but
rather, are inherited from the mother. This process however is heavily impacted by the lipid
biosynthetic pathway. Defects in lipid metabolism are associated with abnormal vacuole
fragmentation and disruptions in vacuolar function. PAH1 has recently emerged as a key gene
that influences proper vacuole morphology. Its deletion has been associated with abnormal
vacuole fragmentation, with vacuoles being unable to fuse back together. One study has shown
that the lack of Pah1p phosphatase activity prevents the binding of SNARES and is devoid of
components of the HOPS tethering complex needed for vacuolar fusion (Sasser et al; 2012).
Thus, vacuolar morphology is implicated in pah1∆ mutant. On the other hand, irregular vacuole
morphology has also been related to atypical vacuolar acidification as a result of dysfunctional
V-ATPase pumps. Studies have shown that some phenotypes of mutant cells with abnormal
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vacuoles include vacuole fragments that collect to one area or disperse all over the cell. These
cells can have working V-ATPase pumps or have a defect in the assemblage of the V-ATPase
pump (Weisman et al., 1987; Raymond et al., 1992). Therefore, it is possible that PAH1 may
affect the vacuole or may implicate the V-ATPase pump and thus alter its morphology through
the regulation of lipid biosynthesis.
Although it has been shown that PAH1 plays an important role in lipid synthesis and may
affect the vacuole through V-ATPase pump activity, to date, little research has been done on the
effect of PAH1 on V-ATPases. We therefore wanted to better understand how Pah1p affects
vacuolar morphology and its functional activity. In order to test this, RNA analysis was used to
determine the best conditions for PAH1 induction, a condition to be used in subsequent
experiments. Once determined, a growth curve sensitivity assay and the measurement of
vacuolar pH were employed. Lastly, we examined how Pah1p affects the V-ATPase pump by
performing RNA analysis of all V-ATPase genes.
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Materials and methods
Yeast strains:
Strain

Genome type
MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ

WT (BY4741)
vma3Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Δvma3

pah1Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Δpah1

Growth curve sensitivity assay:
Individual colonies of wild type (WT), vma3∆, and pah1Δ were incubated overnight in SC media
(dextrose-nitrogen base-amino acids) with 100mM inositol. Cells were diluted to an optical
density of (A600) of around 0.2-0.3 and grown in SC media with 100μM inositol buffered to pH
7.0. The optical density was subsequently recorded for every two hours over an eight hour period
and then resumed at 24 hours until stationary phase was reached. For sensitivity analysis on
plates, individual colonies of WT, vma3∆, and pah1Δ were incubated overnight in SC media
(dextrose-nitrogen base-amino acids) with 100mM inositol. On the following day, each strain's
OD was measured and then either diluted or concentrated so that all strains contained the same
OD for their starting point. The strains were then diluted 100 fold in SC medium and 5ul of each
diluted strain were plated on YPD plates buffered to pH 5.5 and pH 7.0 for the pH sensitivity
assay. Plates were incubated at 30°C for three days before analyzed.
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Vacuolar pH analysis:
WT, pah1Δ and vma3Δ cells were grown until stationary phase in SC media with 100μM of
inositol buffered to pH 7.0. Cells were then incubated with 1mM of BCECF-AM dye for 30 to
40 minutes at 30°C in the dark. Cells were then spun down, washed twice with media, and
resuspended in fresh media. Cells were then stored on ice. Next, calibration samples were made
for all three strains. Cells with the BCECF dye were incubated with 15μM of nigericin and the
calibration buffers (50mM HEPES , 50mM MES, 10mM 2-deoxyglucose , 50mM potassium
chloride, 50mM sodium chloride, 0.2M ammonium acetate, 10mM 2-deoxyglucose ) that
ranged from pH 5.0 to pH 7.0 for thirty minutes at 30°C. The unknown samples were prepared
by resuspending cells with BCECF with 1mM MES buffer at pH 7. All samples were plated in a
96 well plate. The SpectraMas M5 microplate reader was used to measure the excitation
wavelength (450nm and 490nm) with emission wavelength of 535nm. The calibration curves
were made by taking the ratio of fluorescence at 490nm to 450nm. The fluorescence ratio was
then plotted against pH (Figure 5.3A and 5.3B). Unknown samples were then plotted on standard
curve to determine their pH.
Total mRNA preparation and quantification
Cells were grown from a single colony until desired optical density in SC media and collected.
RNA was extracted from yeast cells through acid phenol (pH 4.3) chloroform extraction in
which the cells were resuspended in TES (10mM EDTA; 10mM Tris-HCl pH 7.5; 0.5% SDS),
and then incubated at 65°C with equal parts acid phenol for 60 minutes. This was followed by
phenol-chloroform extraction and ethanol precipitation. Remaining pellets were resuspended in
RNA sample buffer (10mM Tris HCl pH 8, 2mM EDTA, 1% SDS, 10% glycerol, and 1%
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βmercaptoethanol). RNA concentration was quantified by reading absorbance at 260nm.
Subsequently, total RNA was stored at -80°C until further use.
DNase Treatment of RNA samples
DNase treatment was performed to remove any DNA from the isolated RNA samples. RNA was
mixed with 10X buffer (0.1 M Tris-HCl pH 8, 5mM CaCl2 and 0.025M MgCl2), DNase, and
DEPC water. Samples were placed in 37°C water bath for 60 minutes, followed by
phenol:chloroform extraction and ethanol precipitation. Pellets were placed in a speed vacuum to
dry and then resuspended in TE buffer that was prepared using DEPC water. RNA concentration
was again quantified by reading absorbance at 260nm.
Preparation of cDNA: First Strand Synthesis
In order to prepare the cDNA needed for qRT-PCR, the SuperScript III First Strand Synthesis
SuperMix kit from Invitrogen (Catalog: 11752-050) was used. The reaction was performed using
a polymerase chain reaction (PCR) thermocycler. First strand synthesis samples were stored at 20°C until further use.
Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and analysis:
The cDNA prepared from first strand synthesis was amplified and quantified using qRT-PCR.
The SYBR GreenER® qPCR Supermix universal kit from Invitrogen (catalog number: 11762500) was used to quantify cDNA templates. Forward and reverse primers were used that targeted
the open reading frame (ORF) in the qPCR reaction. Samples were added to a 96 well plate and
then sealed and placed in the Applied Biosystems 7500 real time PCR machine. PCR reactions
were performed in triplicates. A ΔCT value was obtained by subtracting the respective gene CT
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from the CT value of the constitutive housekeeping gene (ACT1). Therefore, the relative mRNA
levels were expressed as 2^-(ΔCT). Data results were graphed as a mean of the repeats ±standard
deviation.
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Results
1. Pah1p is most greatly expressed at nearing stationary phase.
Since the impact of a gene’s effect on the cell is greatest when the gene is at its highest
expression level, it was important to find the best conditions at which the gene is induced for
further experimentation. Previous studies have shown that the PAH1 promoter region includes
both UASZRE sequences (Soto-Cardalda, 2012) as well as a UASINO (Wimalarathna, 2011),
indicating that both zinc and inositol impact the induction of PAH1 (Soto-Cardalda et al., 2012;
Pascual et al., 2013). However, it is still unknown in regard to which of these factors can
upregulate PAH1 expression at its maximum levels as a comparison study has yet to be
performed. In order to test the effect of Pah1p in vacuolar conditions, we first wanted to
determine the best inducing conditions of PAH1.
RNA analysis was performed to determine the conditions for maximum Pah1p
upregulation. In the absence of zinc, PAH1 is significantly upregulated in WT cells compared to
the conditions with zinc. Next, we compared the levels of Pah1p in cells grown with normal zinc
levels, but with 100µM inositol added (Figure 1B). Cells were collected in both the exponential
phase and stationary phase of cell growth. Again, PAH1 mRNA levels demonstrated a significant
difference between cells collected in exponential phase and those in stationary phase. PAH1 was
substantially upregulated in stationary phase compared to levels in exponential phase (Figure
1C). When compared, it can be seen that cells grown with 100µM inositol and collected in
stationary phase were significantly higher than cells grown in media without zinc (0.017 ±
0.0004 and 0.0056 ± 0.00061; p=0.023) (Figure 1C). This novel finding demonstrated that while
PAH1 can be upregulated in various environments, it is most highly induced when cells enter
stationary phase and have excess inositol in their media.
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2. The absence of Pah1p can lead to vacuolar fragmentation at stationary phase.
Since we now determined the best inducing condition of PAH1, we continued to examine
its effect on vacuole morphology and homeostasis. A previous study has shown that pah1Δ cells
exhibit fragmented vacuoles in the exponential phase (Sasser et al. 2012). Here, we wanted to
look at the vacuolar morphology of pah1Δ in the exponential phase of growth as well as the
stationary phase and confirm the morphology when PAH1 is at inducing conditions.
Results showed that while WT cells had many fragmented vacuoles at the exponential
stage, the morphology could be attributed to the normal fragmentation process that occurs in
vacuoles during cell division. In the stationary phase, most cells contained large singular
vacuoles. This was greatly contrasted to the pah1Δ cells, which mainly exhibited fragmented
vacuoles. Both the exponential phase and the stationary phase displayed vacuoles that were
unable to fuse their fragments back together, demonstrating that the necessary fusion machinery
is unavailable in pah1Δ cells no matter at what stage of growth they are in (Figure 2A). It was
seen that the number of fragmented vacuoles between WT and pah1Δ cells greatly differed in
exponential phase and stationary phase. In exponential phase, about 74.1% of wild type cells
contained fragmented vacuoles compared to the 96.4% of pah1Δ cells that had fragmented
vacuoles (Figure 2B). In stationary phase however, only 49.89% of wild type cells contained
fragmented vacuoles, a significant decrease from exponential phase, while pah1Δ cells contained
97% fragmented vacuole, a value similar to that in exponential phase (Figure 2B). Thus,
stationary phase cells showed a much more significant difference in the number of fragmented
vacuoles. This is due to the fact that in exponential phase, cells are at their peak stage of growth
and are constantly dividing. Thus, our results showed that a large percentage of WT cells had
fragmented vacuole in this stage, due to the normal process of cell division. However, once they
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reached stationary phase their growth rate steadied and less cells were dividing, leaving only a
smaller number of cells with fragmented vacuoles. For pah1Δ cells however, their lack of fusion
machinery resulted in fragmented vacuoles in almost all cells regardless of their stage in growth.

3. The absence of Pah1p can sustain growth in neutral environments suggesting maintenance of
V-ATPase pump activity
Since the morphology of vacuoles in pah1∆ is distorted, we wanted to see if other
functions of the vacuole were implicated as well. One important aspect of vacuolar homeostasis
is the acidification of the vacuole via the V-ATPase pump. In order to maintain an internal acidic
pH in the vacuole, the V-ATPase pump must be functional. V-ATPases are responsible for
transporting hydrogen ions into the vacuole. This ensures that there is an acidic vacuolar interior
and that normal vacuolar processes can occur. Interestingly enough, inhibition of V-ATPase
function is directly related to a distortion in vacuole morphology. This distortion occurs as a
result of the inability of the V-ATPase pump to function. V-ATPases thus play a crucial role in
the morphology of the vacuole. However, not all defects in vacuole morphology impact VATPase pump activity and thus must be determined. As such, since pah1Δ cells have the
fragmented vacuole phenotype, we wanted to look at whether the V-ATPase pump are
implicated or not. One of the most basic ways to determine functional V-ATPase pump activity
is via a pH sensitivity growth assay. Strains that do not contain a functional V-ATPase are
unable to grow well in an environment with a neutral and basic pH (Kane, 2006). We therefore
decided to perform growth sensitivity analysis experiments to determine if pah1Δ is able to
withstand conditions that cells without functional V-ATPases cannot. The vma3Δ strain was used
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as the negative control, since it does not contain a functional V-ATPase pump and should not
grow well in a neutral pH.
Results showed that WT cells, vma3Δ cells and pah1Δ cells grew well in the more acidic
pH, with all reaching the 10-6 dilution, and WT extending a little further and reaching the 10 -8
dilution (Figure 3A). Results differed vastly though for the pH 7.0 plates. While WT still grew
relatively the same and reached growth at the 10-8 dilution, the vma3∆ mutant was unable to
grow at all and exhibited no growth at the lowest dilution of 10 -2. However, pah1∆ cells grew
well and had comparable growth to WT when it grew on more acidic medium, reaching the 10 -6
dilution (Figure 3A). We then performed a growth curve experiment to further quantify the
above findings. Results showed that while all strains grew well in the acidic medium, both WT
and pah1∆ cells also grew well in pH 7.0 liquid medium, while vma3∆ cells did not. WT grew
1.9 folds better than vma3∆, while pah1∆ cells grew 2.1 fold better than vma3∆ in the neutral
environment (Figure 3B). Thus, these results suggest that pah1∆ cells are more similar to WT
with regard to growth in neutral environments and likely V-ATPase activity.

4. The absence of Pah1p leads to a more acidic vacuole and an upregulation of V-ATPase genes
in stationary phase.
The pH sensitivity growth assays suggested that the pah1∆ V-ATPase pump was not
negatively implicated by the deletion of the PAH1 gene, despite the fact that morphology is
altered (Figure 2). In order to further confirm these results and characterize the vacuole
conditions in pah1∆ better, we employed the vacuolar acidification assay. This assay was used to
measure vacuolar pH to fully confirm the functionality of the pump. The experiment was
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conducted with media that was neutral (pH 7.0), since at these conditions the pump would have
to continuously work to acidify the vacuole. The assay was performed on cells entering the
stationary phase of growth (with 100µM inositol) since this is when PAH1 induction is at its
peak. Results showed that WT cells that were grown in media buffered to pH 7.0 maintained the
acidic pH of their vacuoles and remained within the normal physiological pH range of ~6.0
(Graham and Stevens, 1999). The vacuolar pH measured for the WT vacuoles was 6.00± 0.04
(Figure 3A). The pH measured for the vacuoles of vma3Δ, our negative control, however was not
within the normal range. They had an average vacuolar pH of 6.72 ± 0.11, confirming that these
cells were unable to maintain the acidity required, and thus they were defective in vacuolar
acidification at pH 7. The vacuolar pH measured in pah1Δ cells however was 5.89 ± 0.001
(Figure 3A). These results suggest that acidification is well maintained in pah1Δ cells when
grown in a neutral extracellular environment and remains within the normal physiological range.
Interestingly, the difference in pH between WT and pah1Δ cells was significant (p=0.047),
suggesting that pah1Δ cells are better at acidifying the cell than WT. These findings therefore
suggest that V-ATPase pump functioning is not downregulated in pah1Δ cells despite the fact
that vacuolar morphology is distorted and is actually better than WT.
Since the acidification assay experiment in which vacuolar pH was measured suggested
that pah1Δ cells can actually acidify their vacuoles better than WT. We therefore decided to
perform RNA analysis on the genes that encode for the components that comprise the V-ATPase
pump. There are 13 genes that are responsible for making up the two main domains of the VATPase pump. All genes must be functional in order for pump activity to work properly
(Graham et al., 2000; Kane, 2005). Therefore, if even one gene is implicated, pump function is
altered. Conversely, it may be that if one or more genes is upregulated, pH levels regulated by V189

ATPase pump activity can be affected. Cells were collected right before stationary phase and
their RNA was isolated. We then treated them with DNase and converted the RNA to cDNA
before performing qPCR. Results showed that none of the V-ATPase pump genes were
downregulated or negatively implicated, which would render them transcriptionally inactive. In
fact, multiple of these V-ATPase encoding genes actually had an upregulation of gene expression
compared to WT (Figure 4B). This is unsurprising given the regulatory role of PAH1 and the fact
that its deletion has been shown to cause an increase in gene expression (Santos-Rosa et al.,
2005), however its effect has mainly been proven on genes that contain a UASINO. These results
lead us to believe that perhaps the pump functions better as a result of this upregulation. Based
off of these results it is likely that the V-ATPase is still able to function properly and possibly
better since the genes of the pump transcribe just as well or even greater compared to WT.
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Discussion
The effect of PAH1 and the phosphatase enzyme it encodes is not merely limited to the
lipid biosynthetic pathway. It has shown that its influence is actually widespread throughout the
cell and impacts multiple organelles. One such organelle is the vacuole. While it has been
documented that vacuolar morphology is implicated in the pah1∆ cell and exhibits a fragmented
vacuole phenotype (Sasser et al.; 2012), limited information is available on how else PAH1
affects vacuole homeostasis. Since normal vacuolar morphology is compromised in the pah1∆
mutant we therefore wanted to test if other factors involved in vacuolar homeostasis are affected.
Many times, abnormal vacuolar morphology is also associated with abnormal vacuolar
acidification due to dysfunctional V-ATPase pumps. Some of the phenotypic characteristics of
abnormal vacuoles include fragmented vacuoles that cluster to one region or are distributed
randomly throughout the cell. These mutants seem to either have functional V-ATPase or are
partially defective in the assembly of V-ATPase (Weisman et al., 1987; Raymond et al., 1992).
Since PAH1 plays such an important role in lipid synthesis, it could affect the V-ATPase pump
and thus alter its morphology. In additional, overall vacuole homeostasis could be impacted. We
therefore wanted to look into these other factors that implicate vacuolar morphology and see if
PAH1 affects them.
In order to test this, we started off by performing electron microscopy on the pah1∆
mutant to characterize the vacuole phenotype. This was important because we wanted to
characterize the phenotype not only in exponential phase, but also during PAH1’s highest
induction stage, which is during stationary phase. Additionally, electron microscopy is renowned
for its high resolution and magnification that can clearly capture detail of cell structure. We thus
decided to employ it.
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Our results showed that while WT cells had normal fragmentation of the vacuole due to
the process of cell division, many cells also contained large singular vacuoles in both exponential
and stationary phases of growth. This greatly differed from the vacuoles seen in pah1∆ in which
vacuoles were fragmented. This phenotype was found in both exponential and stationary phases
of growth for pah1∆, demonstrating that the lack of PAH1 phosphatase activity directly impacts
vacuole fusion regardless of an increased induction of PAH1 in the stationary phase. This is
unsurprising since even in exponential phase, PAH1 transcription is still active, though not to the
extent it is at during stationary phase. Still, the lack of PAH1 means that the phosphatase activity
encoded by it is unavailable and as such impacts the lipid biosynthetic pathway which produces
lipids, such as phosphatidylinositol 3-phosphate, that are required for SNARE activity and
vacuole fusion. Thus, both exponential and stationary phase cells in pah1∆ exhibit the
fragmented vacuole phenotype.
In order to determine if the fragmented vacuole phenotype impacts V-ATPase pump
activity, we started off by performing growth sensitivity assays. This was important because
strains defective in V-ATPase pump activity have been shown to be unable to grow in neutral
pHs (Kane, 2006). In the sensitive assays, we observed that all cells grew well in the acidic pH
5.5 media, only vma3∆ did not grow well in pH 7.0. The pah1∆ mutant grew just as well in pH
7.0 as it had in pH 5.5, similar to WT. Further growth analysis in liquid broth, showed that while
there was no significant difference in growth between WT and the pah1∆ mutant, both WT and
pah1∆ cells each exhibited around a 2 fold greater difference in growth when compared to
vma3∆. Furthermore, the V-ATPase pump in pah1∆ mutant is not negatively implicated and can
function properly as was determined by the acidification determination assay in which vacuolar
pH was measured. While vma3∆ vacuoles did not fall into the normal acidic vacuolar pH range
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of around 6.0 when cells were grown in pH 7.0 media, both WT and pah1∆ did. This therefore
confirmed that the V-ATPase pumps in pah1∆ function as they should and are not implicated as
a result of the fragmented phenotype. Interestingly, however, was that pah1∆ cells actually
exhibited a slightly more acidic vacuolar pH than WT that was significantly different. Therefore,
our results suggested that while V-ATPases are functional in the pah1∆ mutant despite the
morphological distortion of the vacuole, they may actually work better at acidification.
In order to determine the cause of an increased vacuolar acidification in the absence of
Pah1p, we decided to look into genes involved in the structure of the V-ATPase pump. Previous
findings have demonstrated that defects in any one of the 13 genes can render the pump inactive,
so it is likely that an overexpression could have the reverse effect. RNA analysis results showed
that there are multiple genes of the V-ATPase pump upregulated in the pah1∆ mutant compared
to WT during stationary phase. Interestingly, of the genes that are upregulated, two of them,
VMA1 and VMA2, encode for ATP binding subunits that help regulate ATPase activity and
proton transport (Shao et al., 2003), while another, VMA16, encodes for a proteolipid subunit
that is responsible for hydrogen ion translocation (Hirata et al., 1997). Thus, they are extremely
important for pump activity and acidification and their overexpression can likely be responsible
for the slightly more acidic pH found in the pah1∆ mutant. The reason for the upregulation of
these specific genes and why Pah1p impacts them is still unclear. More analysis will need to be
done to determine the explanation for this.
In addition, our results also yielded another possible explanation for the increased amount
of vacuole fragmentation in pah1∆ that was determined by Sasser et al., and which we thought
might impact the V-ATPase pump. Recent studies have shown that de-acidification of the
vacuole actually induces vacuolar fusion and that mutated vacuoles that retained their internal
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acidic pH had a blockage of this fusion (Desfougères et al., 2016). Since pah1∆ cells contain a
slightly more acidic vacuolar pH than WT, it may be possible that their acidity could be a
contributing factor to the fragmented vacuole phenotype as well if they are unable to deacidify
properly. Whether the slightly more acidic pH in pah1∆ cells could play such a role in the
morphological defect remains unanswered, especially since the vacuolar pH of pah1∆ cells still
remains within the normal physiological range. Future studies would need to be performed to
confirm this hypothesis and connect the increased vacuolar acidity to vacuolar fragmentation in
the pah1∆ mutant as well as other impacts it may have on the cell. In addition,
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Figure 1: PAH1 undergoes maximum induction during stationary phase of growth with excess inositol in
medium. A) PAH1 catalyzes the reaction that dephosphorylates phosphatidic acid (PA) and coverts it into
diacylglycerol (DAG), which can be used to produce triacylglycerol (TAG). B) RNA analysis of the effect of
different inducing conditions on PAH1 gene expression. WT cells were grown to mid logarithmic phase
(1.0±0.2 A600nm) in 10µM inositol SC media and were subsequently washed and grown in respective media.
mRNA was then extracted from cells using acid phenol chloroform and purified further with treatment of
DNase. RNA was converted to cDNA and was amplified/quantified using qPCR with primers targeting the
open reading frame sequence of PAH1. Expression levels of mRNA were normalized to the housekeeping gene
ACT1. All experiments were done with at least two repeat colonies and all qPCR reactions were done in
triplicates. Data was graphed as a mean ± standard deviation.
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Figure 2: The absence of Pah1p can lead to vacuolar fragmentation at exponential and stationary phases
of growth. A) Electron microscopy images of WT and pah1∆ cells in exponential and stationary phases of
growth. B) Quantification of cells with fragmented vacuoles in WT and pah1∆ cells in both exponential and
stationary phases of growth. WT and pah1∆ were grown in SC media and subsequently washed and collected
at exponential phase of growth and stationary phase. Cells were fixed with glutaraldehyde, treated with
lyticase, and subsequently fixed again with osmium tetroxide. They were dehydrated with 50%, 60%, and 70%
ethanol, followed by an overnight incubation with 70% ethanol and 3% uranyl acetate reagent. Cells were
washed with 80%, 90%, and 100% ethanol, followed by two washes of propylene oxide. A 1:1 ratio of
propylene oxide and resin was added, followed by fresh resin, which was placed in oven to set. Samples were
cut into ultra-thin sections and prepared for imaging using the Leica UCT Ultramicrotome. EM microscopy
was performed using the Fei Technai Spirit Transmission Electron Microscope.
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Figure 3: pah1∆ cells can grow in neutral pH suggesting that the absence of Pah1p does not affect
vacuolar pump activity. A) pH sensitivity assay and serial dilution plates depicting the ability of pah1∆ cells
to grow well on both acidic (pH 5.5) and neutral (pH 7.0) agar plates unlike the V-ATPase deficient vma3∆
mutant. B) Growth Curve analysis and quantification of WT, pah1∆ and vma3∆ cells in pH 5.5 and pH 7.0
liquid media. WT: (●), pah1∆ (■), vma3∆ (▲).

197

Figure 4: The pah1∆ mutant has an internal vacuole pH within the normal physiological range, yet is
more acidic than WT, and genes involved in V-ATPase pump structure and activity are upregulated in
pah1∆ cells during stationary phase. A) Vacuolar acidification assay showing that pah1∆ cells have an
internal vacuole pH comparable to WT and that which is within the normal physiological range, indicating that
vacuolar pump activity and the acidification process in unaffected in pah1∆ cells. B) RNA analysis showing
the upregulation of multiple genes of the V-ATPase pump. Expression levels of mRNA were normalized to the
housekeeping gene ACT1. Data was graphed as a mean ± standard deviation. WT: ( ░ ) and pah1∆: ( █ ).
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